channel_count
int64 1
1
| characteristics_ch1
stringlengths 6
9.77k
| contact_address
stringlengths 1
229
| contact_city
stringlengths 1
47
| contact_country
stringclasses 71
values | contact_institute
stringlengths 2
128
| contact_name
stringlengths 4
74
| contact_zip
stringclasses 1
value | data_processing
stringlengths 4
10.6k
| extract_protocol_ch1
stringlengths 6
14.3k
| geo_accession
stringlengths 9
10
| instrument_model
stringclasses 13
values | last_update_date
stringlengths 11
11
| library_selection
stringclasses 6
values | library_source
stringclasses 5
values | library_strategy
stringclasses 1
value | molecule_ch1
stringclasses 7
values | organism_ch1
stringclasses 1
value | platform_id
stringclasses 13
values | relation
stringlengths 0
2.61k
| sample
stringlengths 9
10
| series_id
stringlengths 8
29
| singlecellprobability
float64 0
1
| source_name_ch1
stringlengths 1
253
| status
stringlengths 21
21
| submission_date
stringlengths 11
11
| taxid_ch1
stringclasses 1
value | title
stringlengths 1
120
| type
stringclasses 1
value | sra
stringlengths 47
49
⌀ | biosample
stringlengths 51
51
⌀ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | age: 61,tissue: adipose tissue,log10 body mass index: 1.338948892,log10 basal metabolic rate (kcal): 1548,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.381044137,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.333436702,plasma free fatty acids under the curve ogtt (mmol/l * min): 24.3,fat mass (%): 27.4,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.87958325,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 270,log10 homair (insulin resistance index based on homa): 0.188397198,log10 homais (insulin secretion index based on homa): 1.77120239,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.498186452,insgenin (insulinogenic index): 1.871572936,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.431797842,log10 matsuda insulin sensitivity index: 0.769064012,muscle mass (%): 38.7,lg10 serum c-reactive protein (mg/l): 0.212187604,lg10 plasma adiponectin (mg/l): 0.939519253,ogtt fasting plasma free fatty acid (mmol/l): 0.35,ogtt 30 min plasma free fatty acid (mmol/l): 0.28,ogtt 120 min plasma free fatty acid (mmol/l): 0.05,ogtt fasting plasma glucose (mmol/l): 5.6,ogtt 30 min plasma glucose (mmol/l): 8.6,ogtt 120 min plasma glucose (mmol/l): 7.6,log10 il1 receptor antagonist (pg/ml): 2.595628474,log10 il1 beta (pg/ml): -0.721246399,log10 ogtt fasting plasma insulin (mu/l): 0.792391689,ogtt 30 min plasma insulin (mu/l): 1.63748973,ogtt 120 min plasma insulin (mu/l): 1.753583059,log10 ogtt fasting plasma proinsulin (pm/l): 1.238046103,ogtt 30 min plasma proinsulin (pm/l): 1.596597096,ogtt 120 min plasma proinsulin (pm/l): 1.911690159,log10 bioimpedance: Resistance: 2.748188027,log10 bioimpedance (reactance): 1.73239376,waist to hip ratio: 0.890625,log10 serum bilirubin (umol/l): 1.255272505,log10 serum alanine aminotransfrase (u/l): 2.071882007,log10 creatinine (umol/l): 1.934498451,log10 total cholesterol (mmol/l): 0.800717078,log10 ldl cholesterol (mmol/l): 0.612783857,log10 hdl cholesterol (mmol/l): 0.204119983,log10 total triglycerides (mmol/l): 0.23299611,log10 serum apoa1 (g/l): 0.245512668,log10 serum apob (g/l): 0.136720567,log10 urinary albumin excretion rate (ug/min): 0.755487266 | 675 Charles E. Young Dr. S. MRL 3220 | Los Angeles | USA | University of California Los Angeles | Mete,,Civelek | Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 âk. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA | Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturerâs instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501) | GSM1098368 | Illumina HiSeq 2000 | May 15 2019 | size fractionation | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249267,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978195 | GSM1098368 | GSE45159 | 0.042174 | adipose tissue | Public on Apr 01 2013 | Mar 14 2013 | 9606 | METSIM7436 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX249267 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01978195 |
|
1 | age: 57,tissue: adipose tissue,log10 body mass index: 1.440479134,log10 basal metabolic rate (kcal): 1472,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.767579447,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.937603777,plasma free fatty acids under the curve ogtt (mmol/l * min): 22.2,fat mass (%): 24.8,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.794415866,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 228,log10 homair (insulin resistance index based on homa): 0.505451467,log10 homais (insulin secretion index based on homa): 2.117271296,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.910314846,insgenin (insulinogenic index): 2.339503744,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.856789289,log10 matsuda insulin sensitivity index: 0.432215057,muscle mass (%): 41.4,lg10 serum c-reactive protein (mg/l): 0.662757832,lg10 plasma adiponectin (mg/l): 0.544068044,ogtt fasting plasma free fatty acid (mmol/l): 0.35,ogtt 30 min plasma free fatty acid (mmol/l): 0.23,ogtt 120 min plasma free fatty acid (mmol/l): 0.07,ogtt fasting plasma glucose (mmol/l): 5.5,ogtt 30 min plasma glucose (mmol/l): 9.3,ogtt 120 min plasma glucose (mmol/l): 5.5,log10 il1 receptor antagonist (pg/ml): 2.678982471,log10 il1 beta (pg/ml): NA,log10 ogtt fasting plasma insulin (mu/l): 1.117271296,ogtt 30 min plasma insulin (mu/l): 2.180412633,ogtt 120 min plasma insulin (mu/l): 1.977266212,log10 ogtt fasting plasma proinsulin (pm/l): 1.424881637,ogtt 30 min plasma proinsulin (pm/l): 1.868056362,ogtt 120 min plasma proinsulin (pm/l): 1.91750551,log10 bioimpedance: Resistance: 2.753583059,log10 bioimpedance (reactance): 1.770852012,waist to hip ratio: 1.06185567,log10 serum bilirubin (umol/l): 1.176091259,log10 serum alanine aminotransfrase (u/l): 1.380211242,log10 creatinine (umol/l): 1.838849091,log10 total cholesterol (mmol/l): 0.832508913,log10 ldl cholesterol (mmol/l): 0.701567985,log10 hdl cholesterol (mmol/l): -0.075720714,log10 total triglycerides (mmol/l): 0.383815366,log10 serum apoa1 (g/l): 0.093421685,log10 serum apob (g/l): 0.230448921,log10 urinary albumin excretion rate (ug/min): 0.790759615 | 675 Charles E. Young Dr. S. MRL 3220 | Los Angeles | USA | University of California Los Angeles | Mete,,Civelek | Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 âk. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA | Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturerâs instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501) | GSM1098369 | Illumina HiSeq 2000 | May 15 2019 | size fractionation | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249268,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978196 | GSM1098369 | GSE45159 | 0.257978 | adipose tissue | Public on Apr 01 2013 | Mar 14 2013 | 9606 | METSIM7482 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX249268 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01978196 |
|
1 | age: 50,tissue: adipose tissue,log10 body mass index: 1.498615312,log10 basal metabolic rate (kcal): 1704,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.601836376,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 7.160711732,plasma free fatty acids under the curve ogtt (mmol/l * min): 16.35,fat mass (%): 24.8,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.801708359,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 172.5,log10 homair (insulin resistance index based on homa): 0.196820744,log10 homais (insulin secretion index based on homa): 1.673941999,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.434393235,insgenin (insulinogenic index): 1.938019097,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.360612345,log10 matsuda insulin sensitivity index: 0.830887163,muscle mass (%): 42.1,lg10 serum c-reactive protein (mg/l): -0.494850022,lg10 plasma adiponectin (mg/l): 1.28780173,ogtt fasting plasma free fatty acid (mmol/l): 0.37,ogtt 30 min plasma free fatty acid (mmol/l): 0.15,ogtt 120 min plasma free fatty acid (mmol/l): 0.04,ogtt fasting plasma glucose (mmol/l): 6,ogtt 30 min plasma glucose (mmol/l): 10,ogtt 120 min plasma glucose (mmol/l): 4.5,log10 il1 receptor antagonist (pg/ml): 2.230295614,log10 il1 beta (pg/ml): NA,log10 ogtt fasting plasma insulin (mu/l): 0.770852012,ogtt 30 min plasma insulin (mu/l): 1.804139432,ogtt 120 min plasma insulin (mu/l): 1.139879086,log10 ogtt fasting plasma proinsulin (pm/l): 0.77815125,ogtt 30 min plasma proinsulin (pm/l): 1.230448921,ogtt 120 min plasma proinsulin (pm/l): 1.240549248,log10 bioimpedance: Resistance: 2.633468456,log10 bioimpedance (reactance): 1.643452676,waist to hip ratio: 0.972727273,log10 serum bilirubin (umol/l): 1.230448921,log10 serum alanine aminotransfrase (u/l): 1.491361694,log10 creatinine (umol/l): 1.892094603,log10 total cholesterol (mmol/l): 0.704150517,log10 ldl cholesterol (mmol/l): 0.505149978,log10 hdl cholesterol (mmol/l): 0.103803721,log10 total triglycerides (mmol/l): 0.056904851,log10 serum apoa1 (g/l): 0.089905111,log10 serum apob (g/l): -0.045757491,log10 urinary albumin excretion rate (ug/min): 1.121145747 | 675 Charles E. Young Dr. S. MRL 3220 | Los Angeles | USA | University of California Los Angeles | Mete,,Civelek | Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 âk. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA | Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturerâs instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501) | GSM1098370 | Illumina HiSeq 2000 | May 15 2019 | size fractionation | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249269,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978197 | GSM1098370 | GSE45159 | 0.224733 | adipose tissue | Public on Apr 01 2013 | Mar 14 2013 | 9606 | METSIM7530 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX249269 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01978197 |
|
1 | age: 49,tissue: adipose tissue,log10 body mass index: 1.382269942,log10 basal metabolic rate (kcal): 1731,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.524492232,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.750072755,plasma free fatty acids under the curve ogtt (mmol/l * min): 16.5,fat mass (%): 15.5,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.497851837,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 15,log10 homair (insulin resistance index based on homa): 0.020729485,log10 homais (insulin secretion index based on homa): 1.522878745,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.168821463,insgenin (insulinogenic index): 2.040898888,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.074487305,log10 matsuda insulin sensitivity index: 1.081552736,muscle mass (%): 48.6,lg10 serum c-reactive protein (mg/l): -0.37675071,lg10 plasma adiponectin (mg/l): 0.602059991,ogtt fasting plasma free fatty acid (mmol/l): 0.27,ogtt 30 min plasma free fatty acid (mmol/l): 0.17,ogtt 120 min plasma free fatty acid (mmol/l): 0.05,ogtt fasting plasma glucose (mmol/l): 5.9,ogtt 30 min plasma glucose (mmol/l): 7.5,ogtt 120 min plasma glucose (mmol/l): 4.1,log10 il1 receptor antagonist (pg/ml): 2.296423849,log10 il1 beta (pg/ml): NA,log10 ogtt fasting plasma insulin (mu/l): 0.602059991,ogtt 30 min plasma insulin (mu/l): 1.522444234,ogtt 120 min plasma insulin (mu/l): 0.949390007,log10 ogtt fasting plasma proinsulin (pm/l): 1.340444115,ogtt 30 min plasma proinsulin (pm/l): 1.418301291,ogtt 120 min plasma proinsulin (pm/l): 1.44870632,log10 bioimpedance: Resistance: 2.640481437,log10 bioimpedance (reactance): 1.653212514,waist to hip ratio: 0.895,log10 serum bilirubin (umol/l): 1.176091259,log10 serum alanine aminotransfrase (u/l): 1.255272505,log10 creatinine (umol/l): 1.913813852,log10 total cholesterol (mmol/l): 0.615950052,log10 ldl cholesterol (mmol/l): 0.418301291,log10 hdl cholesterol (mmol/l): 0.127104798,log10 total triglycerides (mmol/l): -0.161150909,log10 serum apoa1 (g/l): 0.064457989,log10 serum apob (g/l): -0.200659451,log10 urinary albumin excretion rate (ug/min): 0.552574628 | 675 Charles E. Young Dr. S. MRL 3220 | Los Angeles | USA | University of California Los Angeles | Mete,,Civelek | Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 âk. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA | Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturerâs instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501) | GSM1098371 | Illumina HiSeq 2000 | May 15 2019 | size fractionation | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249270,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978198 | GSM1098371 | GSE45159 | 0.137998 | adipose tissue | Public on Apr 01 2013 | Mar 14 2013 | 9606 | METSIM7611 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX249270 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01978198 |
|
1 | age: 47,tissue: adipose tissue,log10 body mass index: 1.517447814,log10 basal metabolic rate (kcal): 1895,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.239936646,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 7.059702127,plasma free fatty acids under the curve ogtt (mmol/l * min): 32.1,fat mass (%): 26.8,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.818582177,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 135,log10 homair (insulin resistance index based on homa): 0.547419141,log10 homais (insulin secretion index based on homa): 1.932053683,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.533225352,insgenin (insulinogenic index): 2.109056724,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.401555618,log10 matsuda insulin sensitivity index: 0.595214804,muscle mass (%): 42.1,lg10 serum c-reactive protein (mg/l): 0.681241237,lg10 plasma adiponectin (mg/l): 0.908485019,ogtt fasting plasma free fatty acid (mmol/l): 0.45,ogtt 30 min plasma free fatty acid (mmol/l): 0.31,ogtt 120 min plasma free fatty acid (mmol/l): 0.15,ogtt fasting plasma glucose (mmol/l): 6.4,ogtt 30 min plasma glucose (mmol/l): 9.7,ogtt 120 min plasma glucose (mmol/l): 5,log10 il1 receptor antagonist (pg/ml): 2.980898323,log10 il1 beta (pg/ml): NA,log10 ogtt fasting plasma insulin (mu/l): 1.093421685,ogtt 30 min plasma insulin (mu/l): 1.919601024,ogtt 120 min plasma insulin (mu/l): 1.06069784,log10 ogtt fasting plasma proinsulin (pm/l): 1.315970345,ogtt 30 min plasma proinsulin (pm/l): 1.603144373,ogtt 120 min plasma proinsulin (pm/l): 1.588831726,log10 bioimpedance: Resistance: 2.630427875,log10 bioimpedance (reactance): 1.681241237,waist to hip ratio: 1.009009009,log10 serum bilirubin (umol/l): 1.342422681,log10 serum alanine aminotransfrase (u/l): 1.662757832,log10 creatinine (umol/l): 1.991226076,log10 total cholesterol (mmol/l): 0.781755375,log10 ldl cholesterol (mmol/l): 0.612783857,log10 hdl cholesterol (mmol/l): -0.026872146,log10 total triglycerides (mmol/l): 0.440909082,log10 serum apoa1 (g/l): 0.004321374,log10 serum apob (g/l): 0.008600172,log10 urinary albumin excretion rate (ug/min): NA | 675 Charles E. Young Dr. S. MRL 3220 | Los Angeles | USA | University of California Los Angeles | Mete,,Civelek | Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 âk. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA | Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturerâs instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501) | GSM1098372 | Illumina HiSeq 2000 | May 15 2019 | size fractionation | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249271,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978199 | GSM1098372 | GSE45159 | 0 | adipose tissue | Public on Apr 01 2013 | Mar 14 2013 | 9606 | METSIM7693 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX249271 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01978199 |
|
1 | age: 61,tissue: adipose tissue,log10 body mass index: 1.398532633,log10 basal metabolic rate (kcal): 1581,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.501448642,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.437773362,plasma free fatty acids under the curve ogtt (mmol/l * min): 22.35,fat mass (%): 21.8,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 10.02375435,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 321,log10 homair (insulin resistance index based on homa): 0.323595824,log10 homais (insulin secretion index based on homa): 1.800717078,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.489029868,insgenin (insulinogenic index): 1.712055185,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.400468911,log10 matsuda insulin sensitivity index: 0.678959223,muscle mass (%): 55.8,lg10 serum c-reactive protein (mg/l): 0.071882007,lg10 plasma adiponectin (mg/l): 1.029383778,ogtt fasting plasma free fatty acid (mmol/l): 0.34,ogtt 30 min plasma free fatty acid (mmol/l): 0.22,ogtt 120 min plasma free fatty acid (mmol/l): 0.09,ogtt fasting plasma glucose (mmol/l): 6,ogtt 30 min plasma glucose (mmol/l): 9.4,ogtt 120 min plasma glucose (mmol/l): 8.6,log10 il1 receptor antagonist (pg/ml): 2.435716988,log10 il1 beta (pg/ml): NA,log10 ogtt fasting plasma insulin (mu/l): 0.897627091,ogtt 30 min plasma insulin (mu/l): 1.56937391,ogtt 120 min plasma insulin (mu/l): 1.7930916,log10 ogtt fasting plasma proinsulin (pm/l): 1.146128036,ogtt 30 min plasma proinsulin (pm/l): 1.456366033,ogtt 120 min plasma proinsulin (pm/l): 1.910624405,log10 bioimpedance: Resistance: 2.63447727,log10 bioimpedance (reactance): 1.681241237,waist to hip ratio: 0.927835052,log10 serum bilirubin (umol/l): 1.146128036,log10 serum alanine aminotransfrase (u/l): 1.447158031,log10 creatinine (umol/l): 1.903089987,log10 total cholesterol (mmol/l): 0.7355989,log10 ldl cholesterol (mmol/l): 0.509202522,log10 hdl cholesterol (mmol/l): 0.170261715,log10 total triglycerides (mmol/l): 0.113943352,log10 serum apoa1 (g/l): 0.133538908,log10 serum apob (g/l): -0.070581074,log10 urinary albumin excretion rate (ug/min): 0.764787289 | 675 Charles E. Young Dr. S. MRL 3220 | Los Angeles | USA | University of California Los Angeles | Mete,,Civelek | Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 âk. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA | Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturerâs instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501) | GSM1098373 | Illumina HiSeq 2000 | May 15 2019 | size fractionation | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249272,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978200 | GSM1098373 | GSE45159 | 0.006222 | adipose tissue | Public on Apr 01 2013 | Mar 14 2013 | 9606 | METSIM7717 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX249272 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01978200 |
|
1 | age: 57,tissue: adipose tissue,log10 body mass index: 1.39498930656603,log10 basal metabolic rate (kcal): 1645,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.50062976688509,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.47079015248221,plasma free fatty acids under the curve ogtt (mmol/l * min): 10.2,fat mass (%): 12.2,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.74483383749955,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 222,log10 homair (insulin resistance index based on homa): -0.500898235252165,log10 homais (insulin secretion index based on homa): 1.52287874523691,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.5520085915843,insgenin (insulinogenic index): 1.8866726285976,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.4160717760782,log10 matsuda insulin sensitivity index: 0.534404469414011,muscle mass (%): 51.4,lg10 serum c-reactive protein (mg/l): NA,lg10 plasma adiponectin (mg/l): 0.944482672150169,ogtt fasting plasma free fatty acid (mmol/l): 0.42,ogtt 30 min plasma free fatty acid (mmol/l): 0.05,ogtt 120 min plasma free fatty acid (mmol/l): 0.02,ogtt fasting plasma glucose (mmol/l): 5.3,ogtt 30 min plasma glucose (mmol/l): 6.1,ogtt 120 min plasma glucose (mmol/l): 8.4,log10 il1 receptor antagonist (pg/ml): NA,log10 il1 beta (pg/ml): NA,log10 ogtt fasting plasma insulin (mu/l): 0.477121254719662,ogtt 30 min plasma insulin (mu/l): 1.63144376901317,ogtt 120 min plasma insulin (mu/l): 1.48995847942483,log10 ogtt fasting plasma proinsulin (pm/l): NA,ogtt 30 min plasma proinsulin (pm/l): NA,ogtt 120 min plasma proinsulin (pm/l): NA,log10 bioimpedance: Resistance: 2.58658730467175,log10 bioimpedance (reactance): 1.63346845557959,waist to hip ratio: 0.885416667,log10 serum bilirubin (umol/l): 1.04139268515822,log10 serum alanine aminotransfrase (u/l): 1.43136376415899,log10 creatinine (umol/l): 1.90848501887865,log10 total cholesterol (mmol/l): 0.751279103983342,log10 ldl cholesterol (mmol/l): 0.301029995663981,log10 hdl cholesterol (mmol/l): 0.444044795918076,log10 total triglycerides (mmol/l): -0.0132282657337552,log10 serum apoa1 (g/l): 0.257678574869184,log10 serum apob (g/l): -0.0604807473813815,log10 urinary albumin excretion rate (ug/min): 0.949742008220188 | 675 Charles E. Young Dr. S. MRL 3220 | Los Angeles | USA | University of California Los Angeles | Mete,,Civelek | Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 âk. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA | Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturerâs instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501) | GSM1098374 | Illumina HiSeq 2000 | May 15 2019 | size fractionation | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249273,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978201 | GSM1098374 | GSE45159 | 0.3539 | adipose tissue | Public on Apr 01 2013 | Mar 14 2013 | 9606 | METSIM7897 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX249273 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01978201 |
|
1 | age: 66,tissue: adipose tissue,log10 body mass index: 1.305339969,log10 basal metabolic rate (kcal): 1547,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.263886322,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 5.997708097,plasma free fatty acids under the curve ogtt (mmol/l * min): 13.8,fat mass (%): 21.9,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.582141982,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 142.5,log10 homair (insulin resistance index based on homa): -0.045114567,log10 homais (insulin secretion index based on homa): 1.661645681,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.232538718,insgenin (insulinogenic index): 1.705696868,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.154545692,log10 matsuda insulin sensitivity index: 1.085902215,muscle mass (%): 46.1,lg10 serum c-reactive protein (mg/l): -0.102372909,lg10 plasma adiponectin (mg/l): 1.037426498,ogtt fasting plasma free fatty acid (mmol/l): 0.28,ogtt 30 min plasma free fatty acid (mmol/l): 0.13,ogtt 120 min plasma free fatty acid (mmol/l): 0.04,ogtt fasting plasma glucose (mmol/l): 5.2,ogtt 30 min plasma glucose (mmol/l): 9.3,ogtt 120 min plasma glucose (mmol/l): 2.9,log10 il1 receptor antagonist (pg/ml): 2.080193419,log10 il1 beta (pg/ml): NA,log10 ogtt fasting plasma insulin (mu/l): 0.591064607,ogtt 30 min plasma insulin (mu/l): 1.586587305,ogtt 120 min plasma insulin (mu/l): 1.021189299,log10 ogtt fasting plasma proinsulin (pm/l): 1.071882007,ogtt 30 min plasma proinsulin (pm/l): 1.503790683,ogtt 120 min plasma proinsulin (pm/l): 1.613841822,log10 bioimpedance: Resistance: 2.73479983,log10 bioimpedance (reactance): 1.740362689,waist to hip ratio: 0.880434783,log10 serum bilirubin (umol/l): 1.113943352,log10 serum alanine aminotransfrase (u/l): 1.278753601,log10 creatinine (umol/l): 1.959041392,log10 total cholesterol (mmol/l): 0.777426822,log10 ldl cholesterol (mmol/l): 0.571708832,log10 hdl cholesterol (mmol/l): 0.222716471,log10 total triglycerides (mmol/l): 0.146128036,log10 serum apoa1 (g/l): 0.170261715,log10 serum apob (g/l): 0.033423755,log10 urinary albumin excretion rate (ug/min): 1.329163104 | 675 Charles E. Young Dr. S. MRL 3220 | Los Angeles | USA | University of California Los Angeles | Mete,,Civelek | Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 âk. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA | Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturerâs instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501) | GSM1098375 | Illumina HiSeq 2000 | May 15 2019 | size fractionation | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249274,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978202 | GSM1098375 | GSE45159 | 0.22761 | adipose tissue | Public on Apr 01 2013 | Mar 14 2013 | 9606 | METSIM7927 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX249274 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01978202 |
|
1 | age: 55,tissue: adipose tissue,log10 body mass index: 1.39614807,log10 basal metabolic rate (kcal): 1556,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.661568137,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.781389161,plasma free fatty acids under the curve ogtt (mmol/l * min): 7.8,fat mass (%): 18.4,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.784634846,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 186,log10 homair (insulin resistance index based on homa): 0.127248819,log10 homais (insulin secretion index based on homa): 1.655305503,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.502263204,insgenin (insulinogenic index): 1.95568775,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.447839958,log10 matsuda insulin sensitivity index: 0.830764204,muscle mass (%): 44.9,lg10 serum c-reactive protein (mg/l): 0.133538908,lg10 plasma adiponectin (mg/l): 1.225309282,ogtt fasting plasma free fatty acid (mmol/l): 0.11,ogtt 30 min plasma free fatty acid (mmol/l): 0.08,ogtt 120 min plasma free fatty acid (mmol/l): 0.03,ogtt fasting plasma glucose (mmol/l): 5.8,ogtt 30 min plasma glucose (mmol/l): 9.8,ogtt 120 min plasma glucose (mmol/l): 4.6,log10 il1 receptor antagonist (pg/ml): 2.209515015,log10 il1 beta (pg/ml): NA,log10 ogtt fasting plasma insulin (mu/l): 0.716003344,ogtt 30 min plasma insulin (mu/l): 1.815577748,ogtt 120 min plasma insulin (mu/l): 1.459392488,log10 ogtt fasting plasma proinsulin (pm/l): 0.913813852,ogtt 30 min plasma proinsulin (pm/l): 1.285557309,ogtt 120 min plasma proinsulin (pm/l): 1.457881897,log10 bioimpedance: Resistance: 2.682145076,log10 bioimpedance (reactance): 1.653212514,waist to hip ratio: 1.086956522,log10 serum bilirubin (umol/l): 0.84509804,log10 serum alanine aminotransfrase (u/l): 1.51851394,log10 creatinine (umol/l): 1.86923172,log10 total cholesterol (mmol/l): 0.643452676,log10 ldl cholesterol (mmol/l): 0.372912003,log10 hdl cholesterol (mmol/l): 0.181843588,log10 total triglycerides (mmol/l): -0.026872146,log10 serum apoa1 (g/l): 0.158362492,log10 serum apob (g/l): -0.13076828,log10 urinary albumin excretion rate (ug/min): 0.943331206 | 675 Charles E. Young Dr. S. MRL 3220 | Los Angeles | USA | University of California Los Angeles | Mete,,Civelek | Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 âk. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA | Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturerâs instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501) | GSM1098376 | Illumina HiSeq 2000 | May 15 2019 | size fractionation | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249275,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978203 | GSM1098376 | GSE45159 | 0.159709 | adipose tissue | Public on Apr 01 2013 | Mar 14 2013 | 9606 | METSIM7948 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX249275 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01978203 |
|
1 | age: 52,tissue: adipose tissue,log10 body mass index: 1.321147221,log10 basal metabolic rate (kcal): 1552,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.408547286,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.356931614,plasma free fatty acids under the curve ogtt (mmol/l * min): 16.5,fat mass (%): 11.8,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.911391988,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 291,log10 homair (insulin resistance index based on homa): -0.141596493,log10 homais (insulin secretion index based on homa): 1.441208699,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.218115186,insgenin (insulinogenic index): 1.329720249,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.159446873,log10 matsuda insulin sensitivity index: 1.067256369,muscle mass (%): 49.7,lg10 serum c-reactive protein (mg/l): -0.468521083,lg10 plasma adiponectin (mg/l): 0.886490725,ogtt fasting plasma free fatty acid (mmol/l): 0.36,ogtt 30 min plasma free fatty acid (mmol/l): 0.17,ogtt 120 min plasma free fatty acid (mmol/l): 0.02,ogtt fasting plasma glucose (mmol/l): 5.6,ogtt 30 min plasma glucose (mmol/l): 9.7,ogtt 120 min plasma glucose (mmol/l): 6.6,log10 il1 receptor antagonist (pg/ml): 2.112806017,log10 il1 beta (pg/ml): NA,log10 ogtt fasting plasma insulin (mu/l): 0.462397998,ogtt 30 min plasma insulin (mu/l): 1.243038049,ogtt 120 min plasma insulin (mu/l): 1.567026366,log10 ogtt fasting plasma proinsulin (pm/l): 0.944482672,ogtt 30 min plasma proinsulin (pm/l): 1.089905111,ogtt 120 min plasma proinsulin (pm/l): 1.767897616,log10 bioimpedance: Resistance: 2.667452953,log10 bioimpedance (reactance): 1.662757832,waist to hip ratio: 0.873684211,log10 serum bilirubin (umol/l): 1.176091259,log10 serum alanine aminotransfrase (u/l): 1.278753601,log10 creatinine (umol/l): 1.939519253,log10 total cholesterol (mmol/l): 0.79518459,log10 ldl cholesterol (mmol/l): 0.600972896,log10 hdl cholesterol (mmol/l): 0.271841607,log10 total triglycerides (mmol/l): -0.142667504,log10 serum apoa1 (g/l): 0.214843848,log10 serum apob (g/l): 0.025305865,log10 urinary albumin excretion rate (ug/min): 1.000876478 | 675 Charles E. Young Dr. S. MRL 3220 | Los Angeles | USA | University of California Los Angeles | Mete,,Civelek | Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 âk. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA | Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturerâs instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501) | GSM1098377 | Illumina HiSeq 2000 | May 15 2019 | size fractionation | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249276,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978204 | GSM1098377 | GSE45159 | 0.161784 | adipose tissue | Public on Apr 01 2013 | Mar 14 2013 | 9606 | METSIM7954 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX249276 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01978204 |
|
1 | age: 47,tissue: adipose tissue,log10 body mass index: 1.378849373,log10 basal metabolic rate (kcal): 1910,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.824074583,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 7.066533729,plasma free fatty acids under the curve ogtt (mmol/l * min): 17.25,fat mass (%): 14.5,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.813781191,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 192,log10 homair (insulin resistance index based on homa): -0.00154691,log10 homais (insulin secretion index based on homa): 1.500602351,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.125090713,insgenin (insulinogenic index): 1.7307266,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.0253878,log10 matsuda insulin sensitivity index: 1.073796653,muscle mass (%): 51.8,lg10 serum c-reactive protein (mg/l): -0.48148606,lg10 plasma adiponectin (mg/l): 1.136720567,ogtt fasting plasma free fatty acid (mmol/l): 0.38,ogtt 30 min plasma free fatty acid (mmol/l): 0.17,ogtt 120 min plasma free fatty acid (mmol/l): 0.03,ogtt fasting plasma glucose (mmol/l): 5.9,ogtt 30 min plasma glucose (mmol/l): 8.8,ogtt 120 min plasma glucose (mmol/l): 6.3,log10 il1 receptor antagonist (pg/ml): 2.201096565,log10 il1 beta (pg/ml): NA,log10 ogtt fasting plasma insulin (mu/l): 0.579783597,ogtt 30 min plasma insulin (mu/l): 1.474216264,ogtt 120 min plasma insulin (mu/l): 0.924279286,log10 ogtt fasting plasma proinsulin (pm/l): 1.167317335,ogtt 30 min plasma proinsulin (pm/l): 1.605305046,ogtt 120 min plasma proinsulin (pm/l): 1.596597096,log10 bioimpedance: Resistance: 2.620136055,log10 bioimpedance (reactance): 1.698970004,waist to hip ratio: 0.878787879,log10 serum bilirubin (umol/l): 1.301029996,log10 serum alanine aminotransfrase (u/l): 1.322219295,log10 creatinine (umol/l): 1.838849091,log10 total cholesterol (mmol/l): 0.72916479,log10 ldl cholesterol (mmol/l): 0.45331834,log10 hdl cholesterol (mmol/l): 0.326335861,log10 total triglycerides (mmol/l): 0.10720997,log10 serum apoa1 (g/l): 0.290034611,log10 serum apob (g/l): -0.080921908,log10 urinary albumin excretion rate (ug/min): 1.124938736 | 675 Charles E. Young Dr. S. MRL 3220 | Los Angeles | USA | University of California Los Angeles | Mete,,Civelek | Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 âk. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA | Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturerâs instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501) | GSM1098378 | Illumina HiSeq 2000 | May 15 2019 | size fractionation | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249277,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978205 | GSM1098378 | GSE45159 | 0.304591 | adipose tissue | Public on Apr 01 2013 | Mar 14 2013 | 9606 | METSIM7988 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX249277 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01978205 |
|
1 | age: 61,tissue: adipose tissue,log10 body mass index: 1.458333616,log10 basal metabolic rate (kcal): 1736,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.361796869,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.640702401,plasma free fatty acids under the curve ogtt (mmol/l * min): 16.95,fat mass (%): 27.6,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.747353829,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 151.5,log10 homair (insulin resistance index based on homa): 0.3680595,log10 homais (insulin secretion index based on homa): 1.870208761,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.603772075,insgenin (insulinogenic index): 2.349106039,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.528273777,log10 matsuda insulin sensitivity index: 0.647879221,muscle mass (%): 46.7,lg10 serum c-reactive protein (mg/l): -0.031517051,lg10 plasma adiponectin (mg/l): 1.173186268,ogtt fasting plasma free fatty acid (mmol/l): 0.3,ogtt 30 min plasma free fatty acid (mmol/l): 0.17,ogtt 120 min plasma free fatty acid (mmol/l): 0.05,ogtt fasting plasma glucose (mmol/l): 5.9,ogtt 30 min plasma glucose (mmol/l): 7.6,ogtt 120 min plasma glucose (mmol/l): 7,log10 il1 receptor antagonist (pg/ml): 2.273695588,log10 il1 beta (pg/ml): NA,log10 ogtt fasting plasma insulin (mu/l): 0.949390007,ogtt 30 min plasma insulin (mu/l): 1.858537198,ogtt 120 min plasma insulin (mu/l): 1.694605199,log10 ogtt fasting plasma proinsulin (pm/l): 1.173186268,ogtt 30 min plasma proinsulin (pm/l): 1.565847819,ogtt 120 min plasma proinsulin (pm/l): 1.745074792,log10 bioimpedance: Resistance: 2.617000341,log10 bioimpedance (reactance): 1.662757832,waist to hip ratio: 0.990196078,log10 serum bilirubin (umol/l): 1.079181246,log10 serum alanine aminotransfrase (u/l): 1.755874856,log10 creatinine (umol/l): 1.939519253,log10 total cholesterol (mmol/l): 0.874481818,log10 ldl cholesterol (mmol/l): 0.716003344,log10 hdl cholesterol (mmol/l): 0.064457989,log10 total triglycerides (mmol/l): 0.387389826,log10 serum apoa1 (g/l): 0.139879086,log10 serum apob (g/l): 0.190331698,log10 urinary albumin excretion rate (ug/min): 1.167136416 | 675 Charles E. Young Dr. S. MRL 3220 | Los Angeles | USA | University of California Los Angeles | Mete,,Civelek | Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 âk. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA | Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturerâs instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501) | GSM1098379 | Illumina HiSeq 2000 | May 15 2019 | size fractionation | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249278,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978206 | GSM1098379 | GSE45159 | 0.313981 | adipose tissue | Public on Apr 01 2013 | Mar 14 2013 | 9606 | METSIM8054 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX249278 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01978206 |
|
1 | age: 58,tissue: adipose tissue,log10 body mass index: 1.407569229,log10 basal metabolic rate (kcal): 1683,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.69162975,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.741064217,plasma free fatty acids under the curve ogtt (mmol/l * min): 9.15,fat mass (%): 16.5,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.46454575,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): -1.5,log10 homair (insulin resistance index based on homa): 0.117639498,log10 homais (insulin secretion index based on homa): 1.619788758,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.2974541,insgenin (insulinogenic index): 2.171099313,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.210479043,log10 matsuda insulin sensitivity index: 0.96744496,muscle mass (%): 49.1,lg10 serum c-reactive protein (mg/l): -0.124938737,lg10 plasma adiponectin (mg/l): 0.86332286,ogtt fasting plasma free fatty acid (mmol/l): 0.16,ogtt 30 min plasma free fatty acid (mmol/l): 0.09,ogtt 120 min plasma free fatty acid (mmol/l): 0.03,ogtt fasting plasma glucose (mmol/l): 5.9,ogtt 30 min plasma glucose (mmol/l): 7.3,ogtt 120 min plasma glucose (mmol/l): 4,log10 il1 receptor antagonist (pg/ml): 2.145600358,log10 il1 beta (pg/ml): NA,log10 ogtt fasting plasma insulin (mu/l): 0.698970004,ogtt 30 min plasma insulin (mu/l): 1.597695186,ogtt 120 min plasma insulin (mu/l): 1.278753601,log10 ogtt fasting plasma proinsulin (pm/l): 1.021189299,ogtt 30 min plasma proinsulin (pm/l): 1.413299764,ogtt 120 min plasma proinsulin (pm/l): 1.523746467,log10 bioimpedance: Resistance: 2.632457292,log10 bioimpedance (reactance): 1.698970004,waist to hip ratio: 0.940594059,log10 serum bilirubin (umol/l): 1.176091259,log10 serum alanine aminotransfrase (u/l): 1.380211242,log10 creatinine (umol/l): 1.857332496,log10 total cholesterol (mmol/l): 0.769377326,log10 ldl cholesterol (mmol/l): 0.505149978,log10 hdl cholesterol (mmol/l): 0.324282455,log10 total triglycerides (mmol/l): 0.064457989,log10 serum apoa1 (g/l): 0.285557309,log10 serum apob (g/l): -0.026872146,log10 urinary albumin excretion rate (ug/min): 0.920818754 | 675 Charles E. Young Dr. S. MRL 3220 | Los Angeles | USA | University of California Los Angeles | Mete,,Civelek | Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 âk. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA | Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturerâs instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501) | GSM1098380 | Illumina HiSeq 2000 | May 15 2019 | size fractionation | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249279,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978207 | GSM1098380 | GSE45159 | 0.350909 | adipose tissue | Public on Apr 01 2013 | Mar 14 2013 | 9606 | METSIM8067 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX249279 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01978207 |
|
1 | age: 67,tissue: adipose tissue,log10 body mass index: 1.411121148,log10 basal metabolic rate (kcal): 1667,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.92540635,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 7.124992201,plasma free fatty acids under the curve ogtt (mmol/l * min): 46.65,fat mass (%): 32.9,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 10.04644195,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 421.5,log10 homair (insulin resistance index based on homa): 0.178273325,log10 homais (insulin secretion index based on homa): 1.851937465,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.364344586,insgenin (insulinogenic index): 1.699364638,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.267898856,log10 matsuda insulin sensitivity index: 0.829071452,muscle mass (%): 28.3,lg10 serum c-reactive protein (mg/l): 0.033423755,lg10 plasma adiponectin (mg/l): 1.012837225,ogtt fasting plasma free fatty acid (mmol/l): 0.76,ogtt 30 min plasma free fatty acid (mmol/l): 0.49,ogtt 120 min plasma free fatty acid (mmol/l): 0.13,ogtt fasting plasma glucose (mmol/l): 5.3,ogtt 30 min plasma glucose (mmol/l): 9.7,ogtt 120 min plasma glucose (mmol/l): 8.8,log10 il1 receptor antagonist (pg/ml): 2.465888243,log10 il1 beta (pg/ml): NA,log10 ogtt fasting plasma insulin (mu/l): 0.806179974,ogtt 30 min plasma insulin (mu/l): 1.63447727,ogtt 120 min plasma insulin (mu/l): 1.416640507,log10 ogtt fasting plasma proinsulin (pm/l): 0.903089987,ogtt 30 min plasma proinsulin (pm/l): 1.369215857,ogtt 120 min plasma proinsulin (pm/l): 1.713490543,log10 bioimpedance: Resistance: 2.716003344,log10 bioimpedance (reactance): 1.633468456,waist to hip ratio: 1.018691589,log10 serum bilirubin (umol/l): 1.602059991,log10 serum alanine aminotransfrase (u/l): 1.748188027,log10 creatinine (umol/l): 1.785329835,log10 total cholesterol (mmol/l): 0.804139432,log10 ldl cholesterol (mmol/l): 0.552668216,log10 hdl cholesterol (mmol/l): 0.387389826,log10 total triglycerides (mmol/l): -0.207608311,log10 serum apoa1 (g/l): 0.318063335,log10 serum apob (g/l): -0.022276395,log10 urinary albumin excretion rate (ug/min): 1.412536907 | 675 Charles E. Young Dr. S. MRL 3220 | Los Angeles | USA | University of California Los Angeles | Mete,,Civelek | Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 âk. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA | Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturerâs instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501) | GSM1098381 | Illumina HiSeq 2000 | May 15 2019 | size fractionation | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249280,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978208 | GSM1098381 | GSE45159 | 0.244681 | adipose tissue | Public on Apr 01 2013 | Mar 14 2013 | 9606 | METSIM8135 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX249280 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01978208 |
|
1 | age: 66,tissue: adipose tissue,log10 body mass index: 1.488375019,log10 basal metabolic rate (kcal): 1607,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.090305286,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.447204097,plasma free fatty acids under the curve ogtt (mmol/l * min): 30.3,fat mass (%): 31.5,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.830515207,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 178.5,log10 homair (insulin resistance index based on homa): 0.26565623,log10 homais (insulin secretion index based on homa): 1.71856556,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.647177512,insgenin (insulinogenic index): 2.344306825,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.596410144,log10 matsuda insulin sensitivity index: 0.676142101,muscle mass (%): 35.2,lg10 serum c-reactive protein (mg/l): 0.687528961,lg10 plasma adiponectin (mg/l): 0.857332496,ogtt fasting plasma free fatty acid (mmol/l): 0.34,ogtt 30 min plasma free fatty acid (mmol/l): 0.33,ogtt 120 min plasma free fatty acid (mmol/l): 0.12,ogtt fasting plasma glucose (mmol/l): 6.1,ogtt 30 min plasma glucose (mmol/l): 8.4,ogtt 120 min plasma glucose (mmol/l): 7,log10 il1 receptor antagonist (pg/ml): 2.415891078,log10 il1 beta (pg/ml): NA,log10 ogtt fasting plasma insulin (mu/l): 0.832508913,ogtt 30 min plasma insulin (mu/l): 1.961421094,ogtt 120 min plasma insulin (mu/l): 1.603144373,log10 ogtt fasting plasma proinsulin (pm/l): 1.260071388,ogtt 30 min plasma proinsulin (pm/l): 1.640481437,ogtt 120 min plasma proinsulin (pm/l): 1.92992956,log10 bioimpedance: Resistance: 2.62324929,log10 bioimpedance (reactance): 1.568201724,waist to hip ratio: 1,log10 serum bilirubin (umol/l): 1.255272505,log10 serum alanine aminotransfrase (u/l): 1.51851394,log10 creatinine (umol/l): 2.004321374,log10 total cholesterol (mmol/l): 0.687528961,log10 ldl cholesterol (mmol/l): 0.471291711,log10 hdl cholesterol (mmol/l): 0.139879086,log10 total triglycerides (mmol/l): 0.103803721,log10 serum apoa1 (g/l): 0.149219113,log10 serum apob (g/l): -0.017728767,log10 urinary albumin excretion rate (ug/min): 0.913979329 | 675 Charles E. Young Dr. S. MRL 3220 | Los Angeles | USA | University of California Los Angeles | Mete,,Civelek | Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 âk. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA | Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturerâs instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501) | GSM1098382 | Illumina HiSeq 2000 | May 15 2019 | size fractionation | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249281,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978209 | GSM1098382 | GSE45159 | 0.379856 | adipose tissue | Public on Apr 01 2013 | Mar 14 2013 | 9606 | METSIM8305 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX249281 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01978209 |
|
1 | age: 64,tissue: adipose tissue,log10 body mass index: 1.346110948,log10 basal metabolic rate (kcal): 1511,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.29129487,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.063351044,plasma free fatty acids under the curve ogtt (mmol/l * min): 16.05,fat mass (%): 23,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.47370575,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): -57,log10 homair (insulin resistance index based on homa): 0.087465911,log10 homais (insulin secretion index based on homa): 1.472100453,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.317666442,insgenin (insulinogenic index): 2.698535493,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.247605064,log10 matsuda insulin sensitivity index: 0.962807002,muscle mass (%): 51.8,lg10 serum c-reactive protein (mg/l): -0.468521083,lg10 plasma adiponectin (mg/l): 0.770852012,ogtt fasting plasma free fatty acid (mmol/l): 0.38,ogtt 30 min plasma free fatty acid (mmol/l): 0.15,ogtt 120 min plasma free fatty acid (mmol/l): 0.03,ogtt fasting plasma glucose (mmol/l): 6.4,ogtt 30 min plasma glucose (mmol/l): 6.8,ogtt 120 min plasma glucose (mmol/l): 4.6,log10 il1 receptor antagonist (pg/ml): 1.920018916,log10 il1 beta (pg/ml): -1.045757491,log10 ogtt fasting plasma insulin (mu/l): 0.633468456,ogtt 30 min plasma insulin (mu/l): 1.575187845,ogtt 120 min plasma insulin (mu/l): 1.404833717,log10 ogtt fasting plasma proinsulin (pm/l): 0.919078092,ogtt 30 min plasma proinsulin (pm/l): 1.298853076,ogtt 120 min plasma proinsulin (pm/l): 1.558708571,log10 bioimpedance: Resistance: 2.704150517,log10 bioimpedance (reactance): 1.740362689,waist to hip ratio: 0.835164835,log10 serum bilirubin (umol/l): 1.51851394,log10 serum alanine aminotransfrase (u/l): 1.278753601,log10 creatinine (umol/l): 1.954242509,log10 total cholesterol (mmol/l): 0.673941999,log10 ldl cholesterol (mmol/l): 0.485721426,log10 hdl cholesterol (mmol/l): 0.068185862,log10 total triglycerides (mmol/l): 0.113943352,log10 serum apoa1 (g/l): 0.049218023,log10 serum apob (g/l): -0.060480747,log10 urinary albumin excretion rate (ug/min): 0.717519207 | 675 Charles E. Young Dr. S. MRL 3220 | Los Angeles | USA | University of California Los Angeles | Mete,,Civelek | Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 âk. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA | Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturerâs instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501) | GSM1098383 | Illumina HiSeq 2000 | May 15 2019 | size fractionation | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249282,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978210 | GSM1098383 | GSE45159 | 0.335999 | adipose tissue | Public on Apr 01 2013 | Mar 14 2013 | 9606 | METSIM10062 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX249282 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01978210 |
|
1 | age: 63,tissue: adipose tissue,log10 body mass index: 1.471049685,log10 basal metabolic rate (kcal): 1575,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.352348725,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.546157171,plasma free fatty acids under the curve ogtt (mmol/l * min): 16.35,fat mass (%): 34.7,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.640244936,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 126,log10 homair (insulin resistance index based on homa): -0.04769199,log10 homais (insulin secretion index based on homa): 1.535113202,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.459663837,insgenin (insulinogenic index): 2.052651199,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.418732057,log10 matsuda insulin sensitivity index: 0.954161986,muscle mass (%): 43.6,lg10 serum c-reactive protein (mg/l): 1.671635597,lg10 plasma adiponectin (mg/l): 1.037426498,ogtt fasting plasma free fatty acid (mmol/l): 0.31,ogtt 30 min plasma free fatty acid (mmol/l): 0.18,ogtt 120 min plasma free fatty acid (mmol/l): 0.02,ogtt fasting plasma glucose (mmol/l): 5.6,ogtt 30 min plasma glucose (mmol/l): 8.3,ogtt 120 min plasma glucose (mmol/l): 4.8,log10 il1 receptor antagonist (pg/ml): 2.253434935,log10 il1 beta (pg/ml): -1.045757491,log10 ogtt fasting plasma insulin (mu/l): 0.556302501,ogtt 30 min plasma insulin (mu/l): 1.7355989,ogtt 120 min plasma insulin (mu/l): 1.51851394,log10 ogtt fasting plasma proinsulin (pm/l): 0.995635195,ogtt 30 min plasma proinsulin (pm/l): 1.416640507,ogtt 120 min plasma proinsulin (pm/l): 1.81756537,log10 bioimpedance: Resistance: 2.682145076,log10 bioimpedance (reactance): 1.748188027,waist to hip ratio: 0.96713615,log10 serum bilirubin (umol/l): 1.255272505,log10 serum alanine aminotransfrase (u/l): 1.643452676,log10 creatinine (umol/l): 1.939519253,log10 total cholesterol (mmol/l): 0.831229694,log10 ldl cholesterol (mmol/l): 0.668385917,log10 hdl cholesterol (mmol/l): 0.247973266,log10 total triglycerides (mmol/l): -0.031517051,log10 serum apoa1 (g/l): 0.152288344,log10 serum apob (g/l): 0.103803721,log10 urinary albumin excretion rate (ug/min): 0.794598101 | 675 Charles E. Young Dr. S. MRL 3220 | Los Angeles | USA | University of California Los Angeles | Mete,,Civelek | Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 âk. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA | Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturerâs instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501) | GSM1098384 | Illumina HiSeq 2000 | May 15 2019 | size fractionation | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249283,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978211 | GSM1098384 | GSE45159 | 0.033852 | adipose tissue | Public on Apr 01 2013 | Mar 14 2013 | 9606 | METSIM10252 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX249283 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01978211 |
|
1 | age: 64,tissue: adipose tissue,log10 body mass index: 1.390135575,log10 basal metabolic rate (kcal): 1652,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.50833036,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.562124232,plasma free fatty acids under the curve ogtt (mmol/l * min): 15.75,fat mass (%): 26,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.656424863,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 159,log10 homair (insulin resistance index based on homa): 0.165541077,log10 homais (insulin secretion index based on homa): 1.80760623,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.452139252,insgenin (insulinogenic index): 2.005291245,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.378960847,log10 matsuda insulin sensitivity index: 0.851154631,muscle mass (%): 41.7,lg10 serum c-reactive protein (mg/l): -0.853871964,lg10 plasma adiponectin (mg/l): 1.184691431,ogtt fasting plasma free fatty acid (mmol/l): 0.26,ogtt 30 min plasma free fatty acid (mmol/l): 0.16,ogtt 120 min plasma free fatty acid (mmol/l): 0.05,ogtt fasting plasma glucose (mmol/l): 5.4,ogtt 30 min plasma glucose (mmol/l): 8.5,ogtt 120 min plasma glucose (mmol/l): 4.8,log10 il1 receptor antagonist (pg/ml): 1.988380565,log10 il1 beta (pg/ml): -1.045757491,log10 ogtt fasting plasma insulin (mu/l): 0.785329835,ogtt 30 min plasma insulin (mu/l): 1.766412847,ogtt 120 min plasma insulin (mu/l): 1.397940009,log10 ogtt fasting plasma proinsulin (pm/l): 0.944482672,ogtt 30 min plasma proinsulin (pm/l): 1.206825876,ogtt 120 min plasma proinsulin (pm/l): 1.401400541,log10 bioimpedance: Resistance: 2.675778342,log10 bioimpedance (reactance): 1.672097858,waist to hip ratio: 0.892156863,log10 serum bilirubin (umol/l): 1.414973348,log10 serum alanine aminotransfrase (u/l): 1.113943352,log10 creatinine (umol/l): 1.897627091,log10 total cholesterol (mmol/l): 0.757396029,log10 ldl cholesterol (mmol/l): 0.456366033,log10 hdl cholesterol (mmol/l): 0.436162647,log10 total triglycerides (mmol/l): -0.096910013,log10 serum apoa1 (g/l): 0.26245109,log10 serum apob (g/l): -0.142667504,log10 urinary albumin excretion rate (ug/min): 0.688658402 | 675 Charles E. Young Dr. S. MRL 3220 | Los Angeles | USA | University of California Los Angeles | Mete,,Civelek | Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 âk. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA | Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturerâs instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501) | GSM1098385 | Illumina HiSeq 2000 | May 15 2019 | size fractionation | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249284,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978212 | GSM1098385 | GSE45159 | 0.301725 | adipose tissue | Public on Apr 01 2013 | Mar 14 2013 | 9606 | METSIM10271 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX249284 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01978212 |
|
1 | age: 54,tissue: adipose tissue,log10 body mass index: 1.523322968,log10 basal metabolic rate (kcal): 1590,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.516464277,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.982376966,plasma free fatty acids under the curve ogtt (mmol/l * min): 19.2,fat mass (%): 26.2,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.987974524,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 91.5,log10 homair (insulin resistance index based on homa): 0.965671971,log10 homais (insulin secretion index based on homa): 2.109144469,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.792398694,insgenin (insulinogenic index): 2.221972816,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.629011823,log10 matsuda insulin sensitivity index: 0.207130077,muscle mass (%): 41.3,lg10 serum c-reactive protein (mg/l): 0.305351369,lg10 plasma adiponectin (mg/l): 0.792391689,ogtt fasting plasma free fatty acid (mmol/l): 0.27,ogtt 30 min plasma free fatty acid (mmol/l): 0.2,ogtt 120 min plasma free fatty acid (mmol/l): 0.07,ogtt fasting plasma glucose (mmol/l): 7.7,ogtt 30 min plasma glucose (mmol/l): 10.5,ogtt 120 min plasma glucose (mmol/l): 6,log10 il1 receptor antagonist (pg/ml): 2.514786748,log10 il1 beta (pg/ml): -1.045757491,log10 ogtt fasting plasma insulin (mu/l): 1.431363764,ogtt 30 min plasma insulin (mu/l): 2.020361283,ogtt 120 min plasma insulin (mu/l): 1.907948522,log10 ogtt fasting plasma proinsulin (pm/l): 1.465382851,ogtt 30 min plasma proinsulin (pm/l): 1.671172843,ogtt 120 min plasma proinsulin (pm/l): 1.790285164,log10 bioimpedance: Resistance: 2.643452676,log10 bioimpedance (reactance): 1.681241237,waist to hip ratio: 1.037383178,log10 serum bilirubin (umol/l): 0.903089987,log10 serum alanine aminotransfrase (u/l): 1.792391689,log10 creatinine (umol/l): 1.908485019,log10 total cholesterol (mmol/l): 0.757396029,log10 ldl cholesterol (mmol/l): 0.613841822,log10 hdl cholesterol (mmol/l): -0.013228266,log10 total triglycerides (mmol/l): 0.204119983,log10 serum apoa1 (g/l): 0.049218023,log10 serum apob (g/l): 0.11058971,log10 urinary albumin excretion rate (ug/min): 1.402718583 | 675 Charles E. Young Dr. S. MRL 3220 | Los Angeles | USA | University of California Los Angeles | Mete,,Civelek | Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 âk. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA | Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturerâs instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501) | GSM1098386 | Illumina HiSeq 2000 | May 15 2019 | size fractionation | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249285,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978213 | GSM1098386 | GSE45159 | 0.224697 | adipose tissue | Public on Apr 01 2013 | Mar 14 2013 | 9606 | METSIM10277 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX249285 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01978213 |
|
1 | age: 65,tissue: adipose tissue,log10 body mass index: 1.35868671,log10 basal metabolic rate (kcal): 1640,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.729115454,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.625796971,plasma free fatty acids under the curve ogtt (mmol/l * min): 22.2,fat mass (%): 31.8,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.811374694,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 226.5,log10 homair (insulin resistance index based on homa): 0.058763341,log10 homais (insulin secretion index based on homa): 1.641568533,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.406335758,insgenin (insulinogenic index): 2.024560295,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.345883213,log10 matsuda insulin sensitivity index: 0.894695546,muscle mass (%): 43.7,lg10 serum c-reactive protein (mg/l): -0.537602002,lg10 plasma adiponectin (mg/l): 0.785329835,ogtt fasting plasma free fatty acid (mmol/l): 0.28,ogtt 30 min plasma free fatty acid (mmol/l): 0.24,ogtt 120 min plasma free fatty acid (mmol/l): 0.08,ogtt fasting plasma glucose (mmol/l): 5.6,ogtt 30 min plasma glucose (mmol/l): 7.8,ogtt 120 min plasma glucose (mmol/l): 7.7,log10 il1 receptor antagonist (pg/ml): 2.244722323,log10 il1 beta (pg/ml): -1.045757491,log10 ogtt fasting plasma insulin (mu/l): 0.662757832,ogtt 30 min plasma insulin (mu/l): 1.63748973,ogtt 120 min plasma insulin (mu/l): 1.544068044,log10 ogtt fasting plasma proinsulin (pm/l): 1.086359831,ogtt 30 min plasma proinsulin (pm/l): 1.397940009,ogtt 120 min plasma proinsulin (pm/l): 1.743509765,log10 bioimpedance: Resistance: 2.771587481,log10 bioimpedance (reactance): 1.86332286,waist to hip ratio: 0.908163265,log10 serum bilirubin (umol/l): 1.146128036,log10 serum alanine aminotransfrase (u/l): 1.544068044,log10 creatinine (umol/l): 1.838849091,log10 total cholesterol (mmol/l): 0.618048097,log10 ldl cholesterol (mmol/l): 0.460897843,log10 hdl cholesterol (mmol/l): 0.06069784,log10 total triglycerides (mmol/l): 0.008600172,log10 serum apoa1 (g/l): 0.056904851,log10 serum apob (g/l): -0.070581074,log10 urinary albumin excretion rate (ug/min): 1.068715812 | 675 Charles E. Young Dr. S. MRL 3220 | Los Angeles | USA | University of California Los Angeles | Mete,,Civelek | Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 âk. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA | Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturerâs instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501) | GSM1098387 | Illumina HiSeq 2000 | May 15 2019 | size fractionation | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249286,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978214 | GSM1098387 | GSE45159 | 0.214832 | adipose tissue | Public on Apr 01 2013 | Mar 14 2013 | 9606 | METSIM10346 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX249286 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01978214 |
|
1 | age: 66,tissue: adipose tissue,log10 body mass index: 1.39073176,log10 basal metabolic rate (kcal): 1706,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.457694434,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.505502737,plasma free fatty acids under the curve ogtt (mmol/l * min): 30.45,fat mass (%): 22.1,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.714245518,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 108,log10 homair (insulin resistance index based on homa): -0.061702705,log10 homais (insulin secretion index based on homa): 1.391206626,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.20588073,insgenin (insulinogenic index): 1.539076099,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.138649995,log10 matsuda insulin sensitivity index: 1.059985451,muscle mass (%): 44,lg10 serum c-reactive protein (mg/l): -0.086186148,lg10 plasma adiponectin (mg/l): 1.089905111,ogtt fasting plasma free fatty acid (mmol/l): 0.46,ogtt 30 min plasma free fatty acid (mmol/l): 0.37,ogtt 120 min plasma free fatty acid (mmol/l): 0.03,ogtt fasting plasma glucose (mmol/l): 6.1,ogtt 30 min plasma glucose (mmol/l): 9.1,ogtt 120 min plasma glucose (mmol/l): 4.5,log10 il1 receptor antagonist (pg/ml): 2.03762567,log10 il1 beta (pg/ml): -0.537602002,log10 ogtt fasting plasma insulin (mu/l): 0.505149978,ogtt 30 min plasma insulin (mu/l): 1.311753861,ogtt 120 min plasma insulin (mu/l): 1.492760389,log10 ogtt fasting plasma proinsulin (pm/l): 1.029383778,ogtt 30 min plasma proinsulin (pm/l): 1.209515015,ogtt 120 min plasma proinsulin (pm/l): 1.725094521,log10 bioimpedance: Resistance: 2.63748973,log10 bioimpedance (reactance): 1.62324929,waist to hip ratio: 0.891089109,log10 serum bilirubin (umol/l): 1.447158031,log10 serum alanine aminotransfrase (u/l): 1.361727836,log10 creatinine (umol/l): 1.908485019,log10 total cholesterol (mmol/l): 0.820201459,log10 ldl cholesterol (mmol/l): 0.558708571,log10 hdl cholesterol (mmol/l): 0.411619706,log10 total triglycerides (mmol/l): -0.050609993,log10 serum apoa1 (g/l): 0.290034611,log10 serum apob (g/l): -0.004364805,log10 urinary albumin excretion rate (ug/min): 0.854484654 | 675 Charles E. Young Dr. S. MRL 3220 | Los Angeles | USA | University of California Los Angeles | Mete,,Civelek | Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 âk. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA | Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturerâs instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501) | GSM1098388 | Illumina HiSeq 2000 | May 15 2019 | size fractionation | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249287,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978215 | GSM1098388 | GSE45159 | 0.055601 | adipose tissue | Public on Apr 01 2013 | Mar 14 2013 | 9606 | METSIM10381 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX249287 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01978215 |
|
1 | age: 61,tissue: adipose tissue,log10 body mass index: 1.446085957,log10 basal metabolic rate (kcal): 1642,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.197906938,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.474299238,plasma free fatty acids under the curve ogtt (mmol/l * min): 11.4,fat mass (%): 30.6,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.927037169,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 217.5,log10 homair (insulin resistance index based on homa): 0.260071388,log10 homais (insulin secretion index based on homa): 1.666785321,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.331548761,insgenin (insulinogenic index): 1.635899539,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.224688417,log10 matsuda insulin sensitivity index: 0.831199215,muscle mass (%): 40.2,lg10 serum c-reactive protein (mg/l): 0.376576957,lg10 plasma adiponectin (mg/l): 0.716003344,ogtt fasting plasma free fatty acid (mmol/l): 0.22,ogtt 30 min plasma free fatty acid (mmol/l): 0.12,ogtt 120 min plasma free fatty acid (mmol/l): 0.02,ogtt fasting plasma glucose (mmol/l): 6.3,ogtt 30 min plasma glucose (mmol/l): 12.1,ogtt 120 min plasma glucose (mmol/l): 3.4,log10 il1 receptor antagonist (pg/ml): 2.190835748,log10 il1 beta (pg/ml): -0.744727495,log10 ogtt fasting plasma insulin (mu/l): 0.812913357,ogtt 30 min plasma insulin (mu/l): 1.683947131,ogtt 120 min plasma insulin (mu/l): 1.11058971,log10 ogtt fasting plasma proinsulin (pm/l): 1.243038049,ogtt 30 min plasma proinsulin (pm/l): 1.463892989,ogtt 120 min plasma proinsulin (pm/l): 1.633468456,log10 bioimpedance: Resistance: 2.661812686,log10 bioimpedance (reactance): 1.672097858,waist to hip ratio: 0.979166667,log10 serum bilirubin (umol/l): 0.84509804,log10 serum alanine aminotransfrase (u/l): 1.397940009,log10 creatinine (umol/l): 1.982271233,log10 total cholesterol (mmol/l): 0.733999287,log10 ldl cholesterol (mmol/l): 0.517195898,log10 hdl cholesterol (mmol/l): 0.201397124,log10 total triglycerides (mmol/l): -0.031517051,log10 serum apoa1 (g/l): 0.193124598,log10 serum apob (g/l): -0.036212173,log10 urinary albumin excretion rate (ug/min): 0.707570176 | 675 Charles E. Young Dr. S. MRL 3220 | Los Angeles | USA | University of California Los Angeles | Mete,,Civelek | Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 âk. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA | Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturerâs instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501) | GSM1098389 | Illumina HiSeq 2000 | May 15 2019 | size fractionation | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249288,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978216 | GSM1098389 | GSE45159 | 0.349677 | adipose tissue | Public on Apr 01 2013 | Mar 14 2013 | 9606 | METSIM10389 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX249288 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01978216 |
|
1 | age: 60,tissue: adipose tissue,log10 body mass index: 1.458797192,log10 basal metabolic rate (kcal): 1612,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.506289531,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.932673993,plasma free fatty acids under the curve ogtt (mmol/l * min): 37.95,fat mass (%): 24.5,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 10.33315535,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 534,log10 homair (insulin resistance index based on homa): 0.669874502,log10 homais (insulin secretion index based on homa): 2.076588435,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.854882693,insgenin (insulinogenic index): 1.981810931,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.775034891,log10 matsuda insulin sensitivity index: 0.291652646,muscle mass (%): 40,lg10 serum c-reactive protein (mg/l): 0.77524626,lg10 plasma adiponectin (mg/l): 0.591064607,ogtt fasting plasma free fatty acid (mmol/l): 0.55,ogtt 30 min plasma free fatty acid (mmol/l): 0.42,ogtt 120 min plasma free fatty acid (mmol/l): 0.1,ogtt fasting plasma glucose (mmol/l): 6.3,ogtt 30 min plasma glucose (mmol/l): 12.2,ogtt 120 min plasma glucose (mmol/l): 10.3,log10 il1 receptor antagonist (pg/ml): 2.48248769,log10 il1 beta (pg/ml): -1.045757491,log10 ogtt fasting plasma insulin (mu/l): 1.222716471,ogtt 30 min plasma insulin (mu/l): 2.045322979,ogtt 120 min plasma insulin (mu/l): 2.047664195,log10 ogtt fasting plasma proinsulin (pm/l): 1.571708832,ogtt 30 min plasma proinsulin (pm/l): 1.996949248,ogtt 120 min plasma proinsulin (pm/l): 2.253338005,log10 bioimpedance: Resistance: 2.682145076,log10 bioimpedance (reactance): 1.591064607,waist to hip ratio: 1.018867925,log10 serum bilirubin (umol/l): 0.84509804,log10 serum alanine aminotransfrase (u/l): 1.505149978,log10 creatinine (umol/l): 1.903089987,log10 total cholesterol (mmol/l): 0.852479994,log10 ldl cholesterol (mmol/l): 0.59439255,log10 hdl cholesterol (mmol/l): -0.045757491,log10 total triglycerides (mmol/l): 0.781036939,log10 serum apoa1 (g/l): 0.161368002,log10 serum apob (g/l): 0.255272505,log10 urinary albumin excretion rate (ug/min): NA | 675 Charles E. Young Dr. S. MRL 3220 | Los Angeles | USA | University of California Los Angeles | Mete,,Civelek | Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 âk. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA | Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturerâs instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501) | GSM1098390 | Illumina HiSeq 2000 | May 15 2019 | size fractionation | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249289,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978217 | GSM1098390 | GSE45159 | 0.271433 | adipose tissue | Public on Apr 01 2013 | Mar 14 2013 | 9606 | METSIM10419 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX249289 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01978217 |
|
1 | age: 50,tissue: adipose tissue,log10 body mass index: 1.408203206,log10 basal metabolic rate (kcal): 1528,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.345195522,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.556232233,plasma free fatty acids under the curve ogtt (mmol/l * min): 27.3,fat mass (%): 19.8,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.789533645,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 249,log10 homair (insulin resistance index based on homa): -0.180748617,log10 homais (insulin secretion index based on homa): 1.492915522,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.384640101,insgenin (insulinogenic index): 1.803457116,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.346939463,log10 matsuda insulin sensitivity index: 1.042419386,muscle mass (%): 44.5,lg10 serum c-reactive protein (mg/l): -0.494850022,lg10 plasma adiponectin (mg/l): 0.838849091,ogtt fasting plasma free fatty acid (mmol/l): 0.57,ogtt 30 min plasma free fatty acid (mmol/l): 0.29,ogtt 120 min plasma free fatty acid (mmol/l): 0.03,ogtt fasting plasma glucose (mmol/l): 5.3,ogtt 30 min plasma glucose (mmol/l): 9.3,ogtt 120 min plasma glucose (mmol/l): 5.5,log10 il1 receptor antagonist (pg/ml): 2.29307514,log10 il1 beta (pg/ml): NA,log10 ogtt fasting plasma insulin (mu/l): 0.447158031,ogtt 30 min plasma insulin (mu/l): 1.655138435,ogtt 120 min plasma insulin (mu/l): 1.456366033,log10 ogtt fasting plasma proinsulin (pm/l): 0.897627091,ogtt 30 min plasma proinsulin (pm/l): 1.320146286,ogtt 120 min plasma proinsulin (pm/l): 1.593286067,log10 bioimpedance: Resistance: 2.698100546,log10 bioimpedance (reactance): 1.698970004,waist to hip ratio: 0.979166667,log10 serum bilirubin (umol/l): 1.278753601,log10 serum alanine aminotransfrase (u/l): 1.278753601,log10 creatinine (umol/l): 1.959041392,log10 total cholesterol (mmol/l): 0.791690649,log10 ldl cholesterol (mmol/l): 0.655138435,log10 hdl cholesterol (mmol/l): 0.164352856,log10 total triglycerides (mmol/l): -0.036212173,log10 serum apoa1 (g/l): 0.173186268,log10 serum apob (g/l): 0.079181246,log10 urinary albumin excretion rate (ug/min): 0.745699227 | 675 Charles E. Young Dr. S. MRL 3220 | Los Angeles | USA | University of California Los Angeles | Mete,,Civelek | Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 âk. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA | Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturerâs instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501) | GSM1098391 | Illumina HiSeq 2000 | May 15 2019 | size fractionation | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249290,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978218 | GSM1098391 | GSE45159 | 0.241196 | adipose tissue | Public on Apr 01 2013 | Mar 14 2013 | 9606 | METSIM10691 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX249290 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01978218 |
|
1 | age: 56,tissue: adipose tissue,log10 body mass index: 1.365955279,log10 basal metabolic rate (kcal): 1618,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.611891944,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.649892647,plasma free fatty acids under the curve ogtt (mmol/l * min): 12,fat mass (%): 13.3,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.938109326,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 225,log10 homair (insulin resistance index based on homa): 0.179551791,log10 homais (insulin secretion index based on homa): 1.586265724,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.455986239,insgenin (insulinogenic index): 1.943494516,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.392468317,log10 matsuda insulin sensitivity index: 0.79182238,muscle mass (%): 48,lg10 serum c-reactive protein (mg/l): -0.142667504,lg10 plasma adiponectin (mg/l): 0.86923172,ogtt fasting plasma free fatty acid (mmol/l): 0.2,ogtt 30 min plasma free fatty acid (mmol/l): 0.12,ogtt 120 min plasma free fatty acid (mmol/l): 0.04,ogtt fasting plasma glucose (mmol/l): 6.3,ogtt 30 min plasma glucose (mmol/l): 9.3,ogtt 120 min plasma glucose (mmol/l): 7.3,log10 il1 receptor antagonist (pg/ml): 2.272445019,log10 il1 beta (pg/ml): NA,log10 ogtt fasting plasma insulin (mu/l): 0.73239376,ogtt 30 min plasma insulin (mu/l): 1.692846919,ogtt 120 min plasma insulin (mu/l): 1.583198774,log10 ogtt fasting plasma proinsulin (pm/l): 0.73239376,ogtt 30 min plasma proinsulin (pm/l): 1.227886705,ogtt 120 min plasma proinsulin (pm/l): 1.568201724,log10 bioimpedance: Resistance: 2.636487896,log10 bioimpedance (reactance): 1.591064607,waist to hip ratio: 0.87,log10 serum bilirubin (umol/l): 1.041392685,log10 serum alanine aminotransfrase (u/l): 1.146128036,log10 creatinine (umol/l): 1.880813592,log10 total cholesterol (mmol/l): 0.667452953,log10 ldl cholesterol (mmol/l): 0.437750563,log10 hdl cholesterol (mmol/l): 0.184691431,log10 total triglycerides (mmol/l): -0.045757491,log10 serum apoa1 (g/l): 0.1430148,log10 serum apob (g/l): -0.102372909,log10 urinary albumin excretion rate (ug/min): 1.166331422 | 675 Charles E. Young Dr. S. MRL 3220 | Los Angeles | USA | University of California Los Angeles | Mete,,Civelek | Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 âk. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA | Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturerâs instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501) | GSM1098392 | Illumina HiSeq 2000 | May 15 2019 | size fractionation | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249291,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978219 | GSM1098392 | GSE45159 | 0.105401 | adipose tissue | Public on Apr 01 2013 | Mar 14 2013 | 9606 | METSIM10830 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX249291 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01978219 |
|
1 | age: 52,tissue: adipose tissue,log10 body mass index: 1.41615038,log10 basal metabolic rate (kcal): 1711,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.466969775,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.75548099,plasma free fatty acids under the curve ogtt (mmol/l * min): 18.75,fat mass (%): 20.6,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.82336724,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 222,log10 homair (insulin resistance index based on homa): -0.005243055,log10 homais (insulin secretion index based on homa): 1.549671922,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.155912689,insgenin (insulinogenic index): 1.562984086,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.061113054,log10 matsuda insulin sensitivity index: 1.061962987,muscle mass (%): 46.2,lg10 serum c-reactive protein (mg/l): -0.522878745,lg10 plasma adiponectin (mg/l): 0.977723605,ogtt fasting plasma free fatty acid (mmol/l): 0.33,ogtt 30 min plasma free fatty acid (mmol/l): 0.2,ogtt 120 min plasma free fatty acid (mmol/l): 0.04,ogtt fasting plasma glucose (mmol/l): 5.7,ogtt 30 min plasma glucose (mmol/l): 10,ogtt 120 min plasma glucose (mmol/l): 4.9,log10 il1 receptor antagonist (pg/ml): 2.124699809,log10 il1 beta (pg/ml): NA,log10 ogtt fasting plasma insulin (mu/l): 0.591064607,ogtt 30 min plasma insulin (mu/l): 1.478566496,ogtt 120 min plasma insulin (mu/l): 1.064457989,log10 ogtt fasting plasma proinsulin (pm/l): 1.212187604,ogtt 30 min plasma proinsulin (pm/l): 1.480006943,ogtt 120 min plasma proinsulin (pm/l): 1.617000341,log10 bioimpedance: Resistance: 2.685741739,log10 bioimpedance (reactance): 1.748188027,waist to hip ratio: 0.94,log10 serum bilirubin (umol/l): 1.531478917,log10 serum alanine aminotransfrase (u/l): 1.255272505,log10 creatinine (umol/l): 1.924279286,log10 total cholesterol (mmol/l): 0.737192643,log10 ldl cholesterol (mmol/l): 0.499687083,log10 hdl cholesterol (mmol/l): 0.330413773,log10 total triglycerides (mmol/l): -0.26760624,log10 serum apoa1 (g/l): 0.222716471,log10 serum apob (g/l): -0.065501549,log10 urinary albumin excretion rate (ug/min): 0.62291013 | 675 Charles E. Young Dr. S. MRL 3220 | Los Angeles | USA | University of California Los Angeles | Mete,,Civelek | Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 âk. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA | Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturerâs instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501) | GSM1098393 | Illumina HiSeq 2000 | May 15 2019 | size fractionation | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249292,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978220 | GSM1098393 | GSE45159 | 0.218228 | adipose tissue | Public on Apr 01 2013 | Mar 14 2013 | 9606 | METSIM11138 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX249292 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01978220 |
|
1 | age: 53,tissue: adipose tissue,log10 body mass index: 1.367376327,log10 basal metabolic rate (kcal): 1589,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.187847951,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.299460806,plasma free fatty acids under the curve ogtt (mmol/l * min): 30,fat mass (%): 16.2,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.73470962,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 216,log10 homair (insulin resistance index based on homa): -0.305687354,log10 homais (insulin secretion index based on homa): 1.367976785,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.352529815,insgenin (insulinogenic index): 1.783546282,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.322343361,log10 matsuda insulin sensitivity index: 1.108767833,muscle mass (%): 47.3,lg10 serum c-reactive protein (mg/l): 0.045322979,lg10 plasma adiponectin (mg/l): 0.929418926,ogtt fasting plasma free fatty acid (mmol/l): 0.52,ogtt 30 min plasma free fatty acid (mmol/l): 0.34,ogtt 120 min plasma free fatty acid (mmol/l): 0.04,ogtt fasting plasma glucose (mmol/l): 5.3,ogtt 30 min plasma glucose (mmol/l): 7.7,ogtt 120 min plasma glucose (mmol/l): 6.9,log10 il1 receptor antagonist (pg/ml): 2.402089351,log10 il1 beta (pg/ml): NA,log10 ogtt fasting plasma insulin (mu/l): 0.322219295,ogtt 30 min plasma insulin (mu/l): 1.421603927,ogtt 120 min plasma insulin (mu/l): 1.67669361,log10 ogtt fasting plasma proinsulin (pm/l): 0.949390007,ogtt 30 min plasma proinsulin (pm/l): 1.316180099,ogtt 120 min plasma proinsulin (pm/l): 1.981818607,log10 bioimpedance: Resistance: 2.691965103,log10 bioimpedance (reactance): 1.698970004,waist to hip ratio: 0.989130435,log10 serum bilirubin (umol/l): 1.041392685,log10 serum alanine aminotransfrase (u/l): 1.230448921,log10 creatinine (umol/l): 1.995635195,log10 total cholesterol (mmol/l): 0.86569606,log10 ldl cholesterol (mmol/l): 0.689308859,log10 hdl cholesterol (mmol/l): 0.26245109,log10 total triglycerides (mmol/l): 0.071882007,log10 serum apoa1 (g/l): 0.257678575,log10 serum apob (g/l): 0.127104798,log10 urinary albumin excretion rate (ug/min): 0.749187554 | 675 Charles E. Young Dr. S. MRL 3220 | Los Angeles | USA | University of California Los Angeles | Mete,,Civelek | Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 âk. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA | Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturerâs instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501) | GSM1098394 | Illumina HiSeq 2000 | May 15 2019 | size fractionation | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249293,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978221 | GSM1098394 | GSE45159 | 0.161388 | adipose tissue | Public on Apr 01 2013 | Mar 14 2013 | 9606 | METSIM11295 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX249293 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01978221 |
|
1 | age: 47,tissue: adipose tissue,log10 body mass index: 1.37285687,log10 basal metabolic rate (kcal): 1498,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.239936646,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.329022795,plasma free fatty acids under the curve ogtt (mmol/l * min): 28.5,fat mass (%): 20.4,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.787086325,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 235.5,log10 homair (insulin resistance index based on homa): 0.165541077,log10 homais (insulin secretion index based on homa): 1.80760623,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.882330969,insgenin (insulinogenic index): 2.319528073,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.856571815,log10 matsuda insulin sensitivity index: 0.618762803,muscle mass (%): 46.4,lg10 serum c-reactive protein (mg/l): 0.049218023,lg10 plasma adiponectin (mg/l): 1,ogtt fasting plasma free fatty acid (mmol/l): 0.53,ogtt 30 min plasma free fatty acid (mmol/l): 0.29,ogtt 120 min plasma free fatty acid (mmol/l): 0.07,ogtt fasting plasma glucose (mmol/l): 5.4,ogtt 30 min plasma glucose (mmol/l): 9.1,ogtt 120 min plasma glucose (mmol/l): 5.7,log10 il1 receptor antagonist (pg/ml): 2.297235102,log10 il1 beta (pg/ml): NA,log10 ogtt fasting plasma insulin (mu/l): 0.785329835,ogtt 30 min plasma insulin (mu/l): 2.129689892,ogtt 120 min plasma insulin (mu/l): 2.003029471,log10 ogtt fasting plasma proinsulin (pm/l): 1.224014811,ogtt 30 min plasma proinsulin (pm/l): 1.83305782,ogtt 120 min plasma proinsulin (pm/l): 1.923244019,log10 bioimpedance: Resistance: 2.781755375,log10 bioimpedance (reactance): 1.880813592,waist to hip ratio: 0.956989247,log10 serum bilirubin (umol/l): 0.954242509,log10 serum alanine aminotransfrase (u/l): 1.653212514,log10 creatinine (umol/l): 1.991226076,log10 total cholesterol (mmol/l): 0.784617293,log10 ldl cholesterol (mmol/l): 0.541579244,log10 hdl cholesterol (mmol/l): 0.26245109,log10 total triglycerides (mmol/l): 0.255272505,log10 serum apoa1 (g/l): 0.276461804,log10 serum apob (g/l): 0.041392685,log10 urinary albumin excretion rate (ug/min): 1.021189299 | 675 Charles E. Young Dr. S. MRL 3220 | Los Angeles | USA | University of California Los Angeles | Mete,,Civelek | Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 âk. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA | Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturerâs instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501) | GSM1098395 | Illumina HiSeq 2000 | May 15 2019 | size fractionation | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249294,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978222 | GSM1098395 | GSE45159 | 0.142514 | adipose tissue | Public on Apr 01 2013 | Mar 14 2013 | 9606 | METSIM11401 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX249294 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01978222 |
|
1 | cell type: Induced endothelial cells from cultured foreskin fibroblast cells (Stegment) | 3333 Burnet Ave | Cincinnati | USA | Cincinnati Children's Hospital Medical Center | Rebekah,,Karns | Trimmed sequences were generated as fastq outputs and analyzed based on the TopHat/Cufflinks pipeline based on reference annotations produced by the Ensembl Gencode project. Differential and significant gene expression analysis was carried out using gene-level FPKM (fragments per kilobase of gene locus summarized mRNA per million reads) expression levels.,Gene-level expression was normalized and baselined to the 80th percentile of that sample's overall expression in GeneSpring v7.,Genome_build: GRCh37/hg19,Supplementary_files_format_and_content: Each sample has a corresponding .txt file with normalized FPKM | Using RNeasy Mini Kit (Qiagen), total RNA was extracted and quantitative polymerase chain reaction was performed using Taqman gene expression assays (Applied Biosystems),RNA-Seqâbased expression analysis was carried out using RNA samples converted into individual cDNA libraries using Illumina (San Diego, CA). TruSeq methods employed single reads of 50 base-lengths sequenced at 20-30 million read depths using the Illumina HiSeq 2500 instrument. | GSM1098572 | Illumina HiSeq 2500 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL16791 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249507,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978505 | GSM1098572 | GSE45176 | 0.008376 | Induced endothelial cell | Public on Apr 14 2013 | Mar 14 2013 | 9606 | iEC: Rep1 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX249507 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01978505 |
|
1 | cell type: Induced endothelial cells from cultured foreskin fibroblast cells (Stegment) | 3333 Burnet Ave | Cincinnati | USA | Cincinnati Children's Hospital Medical Center | Rebekah,,Karns | Trimmed sequences were generated as fastq outputs and analyzed based on the TopHat/Cufflinks pipeline based on reference annotations produced by the Ensembl Gencode project. Differential and significant gene expression analysis was carried out using gene-level FPKM (fragments per kilobase of gene locus summarized mRNA per million reads) expression levels.,Gene-level expression was normalized and baselined to the 80th percentile of that sample's overall expression in GeneSpring v7.,Genome_build: GRCh37/hg19,Supplementary_files_format_and_content: Each sample has a corresponding .txt file with normalized FPKM | Using RNeasy Mini Kit (Qiagen), total RNA was extracted and quantitative polymerase chain reaction was performed using Taqman gene expression assays (Applied Biosystems),RNA-Seqâbased expression analysis was carried out using RNA samples converted into individual cDNA libraries using Illumina (San Diego, CA). TruSeq methods employed single reads of 50 base-lengths sequenced at 20-30 million read depths using the Illumina HiSeq 2500 instrument. | GSM1098573 | Illumina HiSeq 2500 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL16791 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249508,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978506 | GSM1098573 | GSE45176 | 0.032723 | Induced endothelial cell | Public on Apr 14 2013 | Mar 14 2013 | 9606 | iEC: Rep2 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX249508 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01978506 |
|
1 | cell type: Human Dermal Microvascular Endothelial Cells (Lonza) | 3333 Burnet Ave | Cincinnati | USA | Cincinnati Children's Hospital Medical Center | Rebekah,,Karns | Trimmed sequences were generated as fastq outputs and analyzed based on the TopHat/Cufflinks pipeline based on reference annotations produced by the Ensembl Gencode project. Differential and significant gene expression analysis was carried out using gene-level FPKM (fragments per kilobase of gene locus summarized mRNA per million reads) expression levels.,Gene-level expression was normalized and baselined to the 80th percentile of that sample's overall expression in GeneSpring v7.,Genome_build: GRCh37/hg19,Supplementary_files_format_and_content: Each sample has a corresponding .txt file with normalized FPKM | Using RNeasy Mini Kit (Qiagen), total RNA was extracted and quantitative polymerase chain reaction was performed using Taqman gene expression assays (Applied Biosystems),RNA-Seqâbased expression analysis was carried out using RNA samples converted into individual cDNA libraries using Illumina (San Diego, CA). TruSeq methods employed single reads of 50 base-lengths sequenced at 20-30 million read depths using the Illumina HiSeq 2500 instrument. | GSM1098574 | Illumina HiSeq 2500 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL16791 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249509,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978507 | GSM1098574 | GSE45176 | 0.001947 | Human microvascular endothilial cell | Public on Apr 14 2013 | Mar 14 2013 | 9606 | Human microvascular endothelial cell | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX249509 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01978507 |
|
1 | cell type: Cultured foreskin fibroblast cells (Stegment) | 3333 Burnet Ave | Cincinnati | USA | Cincinnati Children's Hospital Medical Center | Rebekah,,Karns | Trimmed sequences were generated as fastq outputs and analyzed based on the TopHat/Cufflinks pipeline based on reference annotations produced by the Ensembl Gencode project. Differential and significant gene expression analysis was carried out using gene-level FPKM (fragments per kilobase of gene locus summarized mRNA per million reads) expression levels.,Gene-level expression was normalized and baselined to the 80th percentile of that sample's overall expression in GeneSpring v7.,Genome_build: GRCh37/hg19,Supplementary_files_format_and_content: Each sample has a corresponding .txt file with normalized FPKM | Using RNeasy Mini Kit (Qiagen), total RNA was extracted and quantitative polymerase chain reaction was performed using Taqman gene expression assays (Applied Biosystems),RNA-Seqâbased expression analysis was carried out using RNA samples converted into individual cDNA libraries using Illumina (San Diego, CA). TruSeq methods employed single reads of 50 base-lengths sequenced at 20-30 million read depths using the Illumina HiSeq 2500 instrument. | GSM1098575 | Illumina HiSeq 2500 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL16791 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249510,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978508 | GSM1098575 | GSE45176 | 0.006019 | Fibroblast | Public on Apr 14 2013 | Mar 14 2013 | 9606 | Fibroblast | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX249510 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01978508 |
|
1 | cell line: MDA-MB-453,cell type: breast cancer | 1400 Pressler Street | Houston | USA | University of Texas MD Anderson Cancer Center | Yiwen,,Chen | Basecalls performed using CASAVA version 1.9,RNA-seq reads were aligned to hg19 using TopHat v2.0.4,Differential expression was characterized using Cuffdiff (version 0.0.5).,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include FPKM values for each condition | Total RNA was prepared using RNeasy Mini Kit (Qiagen) according to the manufacturer's instruction. The polyadenylated mRNA was purified using oligo d(T)25 beads (NEB).,1 ng of mRNA was used for library preparation using Encore Complete RNA-seq kit (NuGEN) according to the manufacturer's instruction. | GSM1099035 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | polyA RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX250097,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978926 | GSM1099035 | GSE45202,GSE45203 | 0.189933 | MDA-MB-453 cells transfected with control siRNA followed by vehicle treatment | Public on Mar 16 2013 | Mar 15 2013 | 9606 | MDA-MB-453 siCtrl-veh | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX250097 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01978926 |
|
1 | cell line: MDA-MB-453,cell type: breast cancer | 1400 Pressler Street | Houston | USA | University of Texas MD Anderson Cancer Center | Yiwen,,Chen | Basecalls performed using CASAVA version 1.9,RNA-seq reads were aligned to hg19 using TopHat v2.0.4,Differential expression was characterized using Cuffdiff (version 0.0.5).,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include FPKM values for each condition | Total RNA was prepared using RNeasy Mini Kit (Qiagen) according to the manufacturer's instruction. The polyadenylated mRNA was purified using oligo d(T)25 beads (NEB).,1 ng of mRNA was used for library preparation using Encore Complete RNA-seq kit (NuGEN) according to the manufacturer's instruction. | GSM1099036 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | polyA RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX250098,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978927 | GSM1099036 | GSE45202,GSE45203 | 0.027956 | MDA-MB-453 cells transfected with control siRNA followed by DHT treatment | Public on Mar 16 2013 | Mar 15 2013 | 9606 | MDA-MB-453 siCtrl-DHT | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX250098 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01978927 |
|
1 | cell line: MDA-MB-453,cell type: breast cancer | 1400 Pressler Street | Houston | USA | University of Texas MD Anderson Cancer Center | Yiwen,,Chen | Basecalls performed using CASAVA version 1.9,RNA-seq reads were aligned to hg19 using TopHat v2.0.4,Differential expression was characterized using Cuffdiff (version 0.0.5).,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include FPKM values for each condition | Total RNA was prepared using RNeasy Mini Kit (Qiagen) according to the manufacturer's instruction. The polyadenylated mRNA was purified using oligo d(T)25 beads (NEB).,1 ng of mRNA was used for library preparation using Encore Complete RNA-seq kit (NuGEN) according to the manufacturer's instruction. | GSM1099037 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | polyA RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX250099,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978928 | GSM1099037 | GSE45202,GSE45203 | 0.16577 | MDA-MB-453 cells transfected with MYC siRNA followed by DHT treatment | Public on Mar 16 2013 | Mar 15 2013 | 9606 | MDA-MB-453 siMYC-DHT | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX250099 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01978928 |
|
1 | origen of cultured cells: RPE isolated from 16 weeks gestation human fetus,transepithelial electrical resistance: 730 ± 10 ohm*cm^2,peak transepitheilal electrical resistance (ksr only): N/A | 10 Amistad Street | New Haven | USA | Yale University | Mei,,Zhong | Basecalls performed using CASAVA version 1.7.0 and 1.8.1,Sequenced reads from the sequencing run were imported into the public Galaxy platform, a free online bioinformatics interface available at http://main.g2.bx.psu.edu. The sequences were aligned against the hg19 reference genome using the Tophat for Illumina (version 1.5.0) with default parameters.,Transcripts were assembled using Cufflinks (version 0.0.5) with quartile normalization and bias correction.,Fold change in transcript expression were analyzed using Cuffdiff (version 0.0.5) with false discovery rate of 0.05, minimum alignment count of 100, quartile normalization, and bias correction.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files for RPKM values of each sample and tab-delimited text files for fold changes between two compared cell types | Libraries were prepared according to Illuminaâs mRNA Sequencing Sample Preparation Guide for mRNA-Seq 8 Sample Prep Kit (Cat# RS-100-0801) for illumina Genome Analyzer II and TruSeq RNA Sample Preparation Guide for TruSeq RNA Sample Prep Kit v2 (Cat RS-122-2001) for HiSeq 2000. Briefly, poly-A containing mRNA molecules were purified from 10ug of total RNA using poly-T oligo-attached magnetic beads then fragmented into small pieces using divalent cations under elevated temperature. The cleaved RNA fragments are copied into first strand cDNA using reverse transcriptase and random primers followed by second strand cDNA synthesis using DNA Polymerase I and RNaseH. These cDNA fragments then go through an end repair process using a combination of T4 DNA polymerase, E. coli DNA Pol I large fragment (Klenow polymerase) and T4 polynucleotide kinase. The blunt, phosphorylated ends were treated with Klenow fragment (3â to 5â exo minus) and dATP to yield a protruding 3- 'A' base for ligation of Illumina's adapters which have a single 'T' base overhang at the 3â end. These products are then purified and enriched with 15 cycles of PCR to create the final cDNA library. Library fragments of 150 to 350 bp (insert plus adaptor and PCR primer sequences) were isolated from 2% E-Gel EX Gel (Invirotgen #G4020-02). The purified DNA was captured on an Illumina flow cell for cluster generation. Libraries were sequenced on the Genome Analyzer following the manufacturer's protocols. | GSM1099813 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX251952,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983922 | GSM1099813 | GSE36695 | 0 | Retinal Pigment Epithelium | Public on Mar 20 2013 | Mar 18 2013 | 9606 | hfRPESeq072611 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX251952 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01983922 |
|
1 | origen of cultured cells: hESC H1 line - derived RPE,transepithelial electrical resistance: 41±1 ohm*cm^2,peak transepitheilal electrical resistance (ksr only): 150±10 ohm*cm^2 | 10 Amistad Street | New Haven | USA | Yale University | Mei,,Zhong | Basecalls performed using CASAVA version 1.7.0 and 1.8.1,Sequenced reads from the sequencing run were imported into the public Galaxy platform, a free online bioinformatics interface available at http://main.g2.bx.psu.edu. The sequences were aligned against the hg19 reference genome using the Tophat for Illumina (version 1.5.0) with default parameters.,Transcripts were assembled using Cufflinks (version 0.0.5) with quartile normalization and bias correction.,Fold change in transcript expression were analyzed using Cuffdiff (version 0.0.5) with false discovery rate of 0.05, minimum alignment count of 100, quartile normalization, and bias correction.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files for RPKM values of each sample and tab-delimited text files for fold changes between two compared cell types | Libraries were prepared according to Illuminaâs mRNA Sequencing Sample Preparation Guide for mRNA-Seq 8 Sample Prep Kit (Cat# RS-100-0801) for illumina Genome Analyzer II and TruSeq RNA Sample Preparation Guide for TruSeq RNA Sample Prep Kit v2 (Cat RS-122-2001) for HiSeq 2000. Briefly, poly-A containing mRNA molecules were purified from 10ug of total RNA using poly-T oligo-attached magnetic beads then fragmented into small pieces using divalent cations under elevated temperature. The cleaved RNA fragments are copied into first strand cDNA using reverse transcriptase and random primers followed by second strand cDNA synthesis using DNA Polymerase I and RNaseH. These cDNA fragments then go through an end repair process using a combination of T4 DNA polymerase, E. coli DNA Pol I large fragment (Klenow polymerase) and T4 polynucleotide kinase. The blunt, phosphorylated ends were treated with Klenow fragment (3â to 5â exo minus) and dATP to yield a protruding 3- 'A' base for ligation of Illumina's adapters which have a single 'T' base overhang at the 3â end. These products are then purified and enriched with 15 cycles of PCR to create the final cDNA library. Library fragments of 150 to 350 bp (insert plus adaptor and PCR primer sequences) were isolated from 2% E-Gel EX Gel (Invirotgen #G4020-02). The purified DNA was captured on an Illumina flow cell for cluster generation. Libraries were sequenced on the Genome Analyzer following the manufacturer's protocols. | GSM1099814 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX251953,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983923 | GSM1099814 | GSE36695 | 0.000823 | Retinal Pigment Epithelium | Public on Mar 20 2013 | Mar 18 2013 | 9606 | H1RPE.ksr.061511 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX251953 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01983923 |
|
1 | origen of cultured cells: hESC H9 line - derived RPE,transepithelial electrical resistance: 37± 4 ohm*cm^2,peak transepitheilal electrical resistance (ksr only): 110±10 ohm*cm^2 | 10 Amistad Street | New Haven | USA | Yale University | Mei,,Zhong | Basecalls performed using CASAVA version 1.7.0 and 1.8.1,Sequenced reads from the sequencing run were imported into the public Galaxy platform, a free online bioinformatics interface available at http://main.g2.bx.psu.edu. The sequences were aligned against the hg19 reference genome using the Tophat for Illumina (version 1.5.0) with default parameters.,Transcripts were assembled using Cufflinks (version 0.0.5) with quartile normalization and bias correction.,Fold change in transcript expression were analyzed using Cuffdiff (version 0.0.5) with false discovery rate of 0.05, minimum alignment count of 100, quartile normalization, and bias correction.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files for RPKM values of each sample and tab-delimited text files for fold changes between two compared cell types | Libraries were prepared according to Illuminaâs mRNA Sequencing Sample Preparation Guide for mRNA-Seq 8 Sample Prep Kit (Cat# RS-100-0801) for illumina Genome Analyzer II and TruSeq RNA Sample Preparation Guide for TruSeq RNA Sample Prep Kit v2 (Cat RS-122-2001) for HiSeq 2000. Briefly, poly-A containing mRNA molecules were purified from 10ug of total RNA using poly-T oligo-attached magnetic beads then fragmented into small pieces using divalent cations under elevated temperature. The cleaved RNA fragments are copied into first strand cDNA using reverse transcriptase and random primers followed by second strand cDNA synthesis using DNA Polymerase I and RNaseH. These cDNA fragments then go through an end repair process using a combination of T4 DNA polymerase, E. coli DNA Pol I large fragment (Klenow polymerase) and T4 polynucleotide kinase. The blunt, phosphorylated ends were treated with Klenow fragment (3â to 5â exo minus) and dATP to yield a protruding 3- 'A' base for ligation of Illumina's adapters which have a single 'T' base overhang at the 3â end. These products are then purified and enriched with 15 cycles of PCR to create the final cDNA library. Library fragments of 150 to 350 bp (insert plus adaptor and PCR primer sequences) were isolated from 2% E-Gel EX Gel (Invirotgen #G4020-02). The purified DNA was captured on an Illumina flow cell for cluster generation. Libraries were sequenced on the Genome Analyzer following the manufacturer's protocols. | GSM1099815 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX251954,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983924 | GSM1099815 | GSE36695 | 0 | Retinal Pigment Epithelium | Public on Mar 20 2013 | Mar 18 2013 | 9606 | H9RPE.ksr.041511 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX251954 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01983924 |
|
1 | origen of cultured cells: hESC H9 line - derived RPE,transepithelial electrical resistance: 49± 4 ohm*cm^2,peak transepitheilal electrical resistance (ksr only): 55±4 ohm*cm^2 | 10 Amistad Street | New Haven | USA | Yale University | Mei,,Zhong | Basecalls performed using CASAVA version 1.7.0 and 1.8.1,Sequenced reads from the sequencing run were imported into the public Galaxy platform, a free online bioinformatics interface available at http://main.g2.bx.psu.edu. The sequences were aligned against the hg19 reference genome using the Tophat for Illumina (version 1.5.0) with default parameters.,Transcripts were assembled using Cufflinks (version 0.0.5) with quartile normalization and bias correction.,Fold change in transcript expression were analyzed using Cuffdiff (version 0.0.5) with false discovery rate of 0.05, minimum alignment count of 100, quartile normalization, and bias correction.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files for RPKM values of each sample and tab-delimited text files for fold changes between two compared cell types | Libraries were prepared according to Illuminaâs mRNA Sequencing Sample Preparation Guide for mRNA-Seq 8 Sample Prep Kit (Cat# RS-100-0801) for illumina Genome Analyzer II and TruSeq RNA Sample Preparation Guide for TruSeq RNA Sample Prep Kit v2 (Cat RS-122-2001) for HiSeq 2000. Briefly, poly-A containing mRNA molecules were purified from 10ug of total RNA using poly-T oligo-attached magnetic beads then fragmented into small pieces using divalent cations under elevated temperature. The cleaved RNA fragments are copied into first strand cDNA using reverse transcriptase and random primers followed by second strand cDNA synthesis using DNA Polymerase I and RNaseH. These cDNA fragments then go through an end repair process using a combination of T4 DNA polymerase, E. coli DNA Pol I large fragment (Klenow polymerase) and T4 polynucleotide kinase. The blunt, phosphorylated ends were treated with Klenow fragment (3â to 5â exo minus) and dATP to yield a protruding 3- 'A' base for ligation of Illumina's adapters which have a single 'T' base overhang at the 3â end. These products are then purified and enriched with 15 cycles of PCR to create the final cDNA library. Library fragments of 150 to 350 bp (insert plus adaptor and PCR primer sequences) were isolated from 2% E-Gel EX Gel (Invirotgen #G4020-02). The purified DNA was captured on an Illumina flow cell for cluster generation. Libraries were sequenced on the Genome Analyzer following the manufacturer's protocols. | GSM1099816 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX251955,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983925 | GSM1099816 | GSE36695 | 0 | Retinal Pigment Epithelium | Public on Mar 20 2013 | Mar 18 2013 | 9606 | H9RPE.ksr.060311 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX251955 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01983925 |
|
1 | cell type: mammary epithelial,cell line: MCF10A,sample type: 25 M reads | 415 Lane Road, MR5-Rm. 2225 | Charlottesville | USA | University of Virginia | Byong,Ha,Kang | RNA-seq reads were chastity filtered and assessed for overall quality with FastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/).,Sequenced reads were mapped using STAR 2.2.0 against the human genome build hg19.,Reads that map to each gene were counted with HTSeq (http://www-huber.embl.de/users/anders/HTSeq/) under the union set, whereby reads that do not completely overlap a gene are still counted. The counts were normalized by the library size (read depth).,RPKM calculations were performed by normalizing to the median transcript length for each gene and the total library size of each sample.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include normalized count in the first column and RPKM value in the second column for each sample | Total RNA was isolated with the RNeasy Mini Kit (Qiagen) according to the manufacturer's protocols.,Each cDNA library was prepared with the NEBNext first-strand synthesis, second-strand synthesis, end repair, dA tailing, and quick ligation modules (New England Biolabs). Libraries were indexed with standard Illumina-type adapters and sequenced on an Illumina HiSeq 2000 using version 3 reagents that generate 180â200M reads per lane. Samples were 50-bp paired-end sequenced in duplicate at 25M and 50M or 100M reads per sample. | GSM1100205 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX251969,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983939 | GSM1100205 | GSE45258 | 0.002925 | breast | Public on Aug 06 2013 | Mar 18 2013 | 9606 | MCF10A cells run at 25M reads | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX251969 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01983939 |
|
1 | cell type: mammary epithelial,cell line: MCF10A,sample type: 50 M reads | 415 Lane Road, MR5-Rm. 2225 | Charlottesville | USA | University of Virginia | Byong,Ha,Kang | RNA-seq reads were chastity filtered and assessed for overall quality with FastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/).,Sequenced reads were mapped using STAR 2.2.0 against the human genome build hg19.,Reads that map to each gene were counted with HTSeq (http://www-huber.embl.de/users/anders/HTSeq/) under the union set, whereby reads that do not completely overlap a gene are still counted. The counts were normalized by the library size (read depth).,RPKM calculations were performed by normalizing to the median transcript length for each gene and the total library size of each sample.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include normalized count in the first column and RPKM value in the second column for each sample | Total RNA was isolated with the RNeasy Mini Kit (Qiagen) according to the manufacturer's protocols.,Each cDNA library was prepared with the NEBNext first-strand synthesis, second-strand synthesis, end repair, dA tailing, and quick ligation modules (New England Biolabs). Libraries were indexed with standard Illumina-type adapters and sequenced on an Illumina HiSeq 2000 using version 3 reagents that generate 180â200M reads per lane. Samples were 50-bp paired-end sequenced in duplicate at 25M and 50M or 100M reads per sample. | GSM1100206 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX251970,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983940 | GSM1100206 | GSE45258 | 0.001486 | breast | Public on Aug 06 2013 | Mar 18 2013 | 9606 | MCF10A cells run at 100M reads | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX251970 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01983940 |
|
1 | cell type: colon adenocarcinoma,cell line: HT-29,treatment: IFN-g,sample type: 25 M reads | 415 Lane Road, MR5-Rm. 2225 | Charlottesville | USA | University of Virginia | Byong,Ha,Kang | RNA-seq reads were chastity filtered and assessed for overall quality with FastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/).,Sequenced reads were mapped using STAR 2.2.0 against the human genome build hg19.,Reads that map to each gene were counted with HTSeq (http://www-huber.embl.de/users/anders/HTSeq/) under the union set, whereby reads that do not completely overlap a gene are still counted. The counts were normalized by the library size (read depth).,RPKM calculations were performed by normalizing to the median transcript length for each gene and the total library size of each sample.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include normalized count in the first column and RPKM value in the second column for each sample | Total RNA was isolated with the RNeasy Mini Kit (Qiagen) according to the manufacturer's protocols.,Each cDNA library was prepared with the NEBNext first-strand synthesis, second-strand synthesis, end repair, dA tailing, and quick ligation modules (New England Biolabs). Libraries were indexed with standard Illumina-type adapters and sequenced on an Illumina HiSeq 2000 using version 3 reagents that generate 180â200M reads per lane. Samples were 50-bp paired-end sequenced in duplicate at 25M and 50M or 100M reads per sample. | GSM1100207 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX251971,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983941 | GSM1100207 | GSE45258 | 0.006352 | colon | Public on Aug 06 2013 | Mar 18 2013 | 9606 | IFN-g stimulated HT-29 cells run at 25M reads | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX251971 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01983941 |
|
1 | cell type: colon adenocarcinoma,cell line: HT-29,treatment: IFN-g,sample type: 50 M reads | 415 Lane Road, MR5-Rm. 2225 | Charlottesville | USA | University of Virginia | Byong,Ha,Kang | RNA-seq reads were chastity filtered and assessed for overall quality with FastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/).,Sequenced reads were mapped using STAR 2.2.0 against the human genome build hg19.,Reads that map to each gene were counted with HTSeq (http://www-huber.embl.de/users/anders/HTSeq/) under the union set, whereby reads that do not completely overlap a gene are still counted. The counts were normalized by the library size (read depth).,RPKM calculations were performed by normalizing to the median transcript length for each gene and the total library size of each sample.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include normalized count in the first column and RPKM value in the second column for each sample | Total RNA was isolated with the RNeasy Mini Kit (Qiagen) according to the manufacturer's protocols.,Each cDNA library was prepared with the NEBNext first-strand synthesis, second-strand synthesis, end repair, dA tailing, and quick ligation modules (New England Biolabs). Libraries were indexed with standard Illumina-type adapters and sequenced on an Illumina HiSeq 2000 using version 3 reagents that generate 180â200M reads per lane. Samples were 50-bp paired-end sequenced in duplicate at 25M and 50M or 100M reads per sample. | GSM1100208 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX251972,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983942 | GSM1100208 | GSE45258 | 0 | colon | Public on Aug 06 2013 | Mar 18 2013 | 9606 | IFN-g stimulated HT-29 cells run at 50M reads | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX251972 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01983942 |
|
1 | cell type: breast adenocarcinoma,cell line: MDA-MB-436,sample type: 25 M reads | 415 Lane Road, MR5-Rm. 2225 | Charlottesville | USA | University of Virginia | Byong,Ha,Kang | RNA-seq reads were chastity filtered and assessed for overall quality with FastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/).,Sequenced reads were mapped using STAR 2.2.0 against the human genome build hg19.,Reads that map to each gene were counted with HTSeq (http://www-huber.embl.de/users/anders/HTSeq/) under the union set, whereby reads that do not completely overlap a gene are still counted. The counts were normalized by the library size (read depth).,RPKM calculations were performed by normalizing to the median transcript length for each gene and the total library size of each sample.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include normalized count in the first column and RPKM value in the second column for each sample | Total RNA was isolated with the RNeasy Mini Kit (Qiagen) according to the manufacturer's protocols.,Each cDNA library was prepared with the NEBNext first-strand synthesis, second-strand synthesis, end repair, dA tailing, and quick ligation modules (New England Biolabs). Libraries were indexed with standard Illumina-type adapters and sequenced on an Illumina HiSeq 2000 using version 3 reagents that generate 180â200M reads per lane. Samples were 50-bp paired-end sequenced in duplicate at 25M and 50M or 100M reads per sample. | GSM1100209 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX251973,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983943 | GSM1100209 | GSE45258 | 0.000271 | breast | Public on Aug 06 2013 | Mar 18 2013 | 9606 | MDA-MB-436 cells run at 25M reads | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX251973 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01983943 |
|
1 | cell type: breast adenocarcinoma,cell line: MDA-MB-436,sample type: 50 M reads | 415 Lane Road, MR5-Rm. 2225 | Charlottesville | USA | University of Virginia | Byong,Ha,Kang | RNA-seq reads were chastity filtered and assessed for overall quality with FastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/).,Sequenced reads were mapped using STAR 2.2.0 against the human genome build hg19.,Reads that map to each gene were counted with HTSeq (http://www-huber.embl.de/users/anders/HTSeq/) under the union set, whereby reads that do not completely overlap a gene are still counted. The counts were normalized by the library size (read depth).,RPKM calculations were performed by normalizing to the median transcript length for each gene and the total library size of each sample.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include normalized count in the first column and RPKM value in the second column for each sample | Total RNA was isolated with the RNeasy Mini Kit (Qiagen) according to the manufacturer's protocols.,Each cDNA library was prepared with the NEBNext first-strand synthesis, second-strand synthesis, end repair, dA tailing, and quick ligation modules (New England Biolabs). Libraries were indexed with standard Illumina-type adapters and sequenced on an Illumina HiSeq 2000 using version 3 reagents that generate 180â200M reads per lane. Samples were 50-bp paired-end sequenced in duplicate at 25M and 50M or 100M reads per sample. | GSM1100210 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX251974,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983944 | GSM1100210 | GSE45258 | 0 | breast | Public on Aug 06 2013 | Mar 18 2013 | 9606 | MDA-MB-436 cells run at 50M reads | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX251974 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01983944 |
|
1 | tissue: Prefrontal Cortex,organism: human | 320 Yue Yang Road | Shanghai | China | PICB | Liu,,He | Illumina Casava1.7 software used for basecalling, and only the ones passing illumina quality controls were retained.,Reads were mapped onto correponding reference genomes (hg19, panTro3) by Tophat-1.4.1, with parameters: -a 8 -m 2 no-coverage-search microexon-search segment-mismatches 3 segment-length 25.,We made a reciprocal lift-over between chimpanzee and human (Ensembl annotation v. 69, coding exons only), and used only exons that could be lift-overed to calculate RPKMs for each gene.,Then quantile normalization was applied, and each gene was z-transformed.,Genome_build: hg19, panTro3,Supplementary_files_format_and_content: tab-delimited text files including expression measurements for each gene from each sample. | Total RNA was isolated using Trizol reagent (Cat. No. 15596-026, Invitrogen). The libraries were constructed from the isolated total RNA according to the "TruSeq RNA Sample Preparation Kit" protocol (www.illumina.com) without modification. As the protocol includes the procedure of enrichment for the mRNA, an additional polyA selection was not necessary.,RNA libraries were prepared for sequencing using Illumina TruSeq protocols | GSM1100295 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252083,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983956 | GSM1100295 | GSE45263 | 0.002116 | Prefrontal Cortex | Public on Mar 31 2014 | Mar 18 2013 | 9606 | Human_EU_1 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX252083 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01983956 |
|
1 | tissue: Prefrontal Cortex,organism: human | 320 Yue Yang Road | Shanghai | China | PICB | Liu,,He | Illumina Casava1.7 software used for basecalling, and only the ones passing illumina quality controls were retained.,Reads were mapped onto correponding reference genomes (hg19, panTro3) by Tophat-1.4.1, with parameters: -a 8 -m 2 no-coverage-search microexon-search segment-mismatches 3 segment-length 25.,We made a reciprocal lift-over between chimpanzee and human (Ensembl annotation v. 69, coding exons only), and used only exons that could be lift-overed to calculate RPKMs for each gene.,Then quantile normalization was applied, and each gene was z-transformed.,Genome_build: hg19, panTro3,Supplementary_files_format_and_content: tab-delimited text files including expression measurements for each gene from each sample. | Total RNA was isolated using Trizol reagent (Cat. No. 15596-026, Invitrogen). The libraries were constructed from the isolated total RNA according to the "TruSeq RNA Sample Preparation Kit" protocol (www.illumina.com) without modification. As the protocol includes the procedure of enrichment for the mRNA, an additional polyA selection was not necessary.,RNA libraries were prepared for sequencing using Illumina TruSeq protocols | GSM1100296 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252084,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983957 | GSM1100296 | GSE45263 | 0.001403 | Prefrontal Cortex | Public on Mar 31 2014 | Mar 18 2013 | 9606 | Human_AF_2 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX252084 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01983957 |
|
1 | tissue: Prefrontal Cortex,organism: human | 320 Yue Yang Road | Shanghai | China | PICB | Liu,,He | Illumina Casava1.7 software used for basecalling, and only the ones passing illumina quality controls were retained.,Reads were mapped onto correponding reference genomes (hg19, panTro3) by Tophat-1.4.1, with parameters: -a 8 -m 2 no-coverage-search microexon-search segment-mismatches 3 segment-length 25.,We made a reciprocal lift-over between chimpanzee and human (Ensembl annotation v. 69, coding exons only), and used only exons that could be lift-overed to calculate RPKMs for each gene.,Then quantile normalization was applied, and each gene was z-transformed.,Genome_build: hg19, panTro3,Supplementary_files_format_and_content: tab-delimited text files including expression measurements for each gene from each sample. | Total RNA was isolated using Trizol reagent (Cat. No. 15596-026, Invitrogen). The libraries were constructed from the isolated total RNA according to the "TruSeq RNA Sample Preparation Kit" protocol (www.illumina.com) without modification. As the protocol includes the procedure of enrichment for the mRNA, an additional polyA selection was not necessary.,RNA libraries were prepared for sequencing using Illumina TruSeq protocols | GSM1100297 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252085,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983958 | GSM1100297 | GSE45263 | 0 | Prefrontal Cortex | Public on Mar 31 2014 | Mar 18 2013 | 9606 | Human_EU_3 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX252085 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01983958 |
|
1 | tissue: Prefrontal Cortex,organism: human | 320 Yue Yang Road | Shanghai | China | PICB | Liu,,He | Illumina Casava1.7 software used for basecalling, and only the ones passing illumina quality controls were retained.,Reads were mapped onto correponding reference genomes (hg19, panTro3) by Tophat-1.4.1, with parameters: -a 8 -m 2 no-coverage-search microexon-search segment-mismatches 3 segment-length 25.,We made a reciprocal lift-over between chimpanzee and human (Ensembl annotation v. 69, coding exons only), and used only exons that could be lift-overed to calculate RPKMs for each gene.,Then quantile normalization was applied, and each gene was z-transformed.,Genome_build: hg19, panTro3,Supplementary_files_format_and_content: tab-delimited text files including expression measurements for each gene from each sample. | Total RNA was isolated using Trizol reagent (Cat. No. 15596-026, Invitrogen). The libraries were constructed from the isolated total RNA according to the "TruSeq RNA Sample Preparation Kit" protocol (www.illumina.com) without modification. As the protocol includes the procedure of enrichment for the mRNA, an additional polyA selection was not necessary.,RNA libraries were prepared for sequencing using Illumina TruSeq protocols | GSM1100298 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252086,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983959 | GSM1100298 | GSE45263 | 0.000652 | Prefrontal Cortex | Public on Mar 31 2014 | Mar 18 2013 | 9606 | Human_EU_4 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX252086 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01983959 |
|
1 | tissue: Prefrontal Cortex,organism: human | 320 Yue Yang Road | Shanghai | China | PICB | Liu,,He | Illumina Casava1.7 software used for basecalling, and only the ones passing illumina quality controls were retained.,Reads were mapped onto correponding reference genomes (hg19, panTro3) by Tophat-1.4.1, with parameters: -a 8 -m 2 no-coverage-search microexon-search segment-mismatches 3 segment-length 25.,We made a reciprocal lift-over between chimpanzee and human (Ensembl annotation v. 69, coding exons only), and used only exons that could be lift-overed to calculate RPKMs for each gene.,Then quantile normalization was applied, and each gene was z-transformed.,Genome_build: hg19, panTro3,Supplementary_files_format_and_content: tab-delimited text files including expression measurements for each gene from each sample. | Total RNA was isolated using Trizol reagent (Cat. No. 15596-026, Invitrogen). The libraries were constructed from the isolated total RNA according to the "TruSeq RNA Sample Preparation Kit" protocol (www.illumina.com) without modification. As the protocol includes the procedure of enrichment for the mRNA, an additional polyA selection was not necessary.,RNA libraries were prepared for sequencing using Illumina TruSeq protocols | GSM1100299 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252087,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983960 | GSM1100299 | GSE45263 | 0.001587 | Prefrontal Cortex | Public on Mar 31 2014 | Mar 18 2013 | 9606 | Human_AS_5 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX252087 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01983960 |
|
1 | tissue: Prefrontal Cortex,organism: human | 320 Yue Yang Road | Shanghai | China | PICB | Liu,,He | Illumina Casava1.7 software used for basecalling, and only the ones passing illumina quality controls were retained.,Reads were mapped onto correponding reference genomes (hg19, panTro3) by Tophat-1.4.1, with parameters: -a 8 -m 2 no-coverage-search microexon-search segment-mismatches 3 segment-length 25.,We made a reciprocal lift-over between chimpanzee and human (Ensembl annotation v. 69, coding exons only), and used only exons that could be lift-overed to calculate RPKMs for each gene.,Then quantile normalization was applied, and each gene was z-transformed.,Genome_build: hg19, panTro3,Supplementary_files_format_and_content: tab-delimited text files including expression measurements for each gene from each sample. | Total RNA was isolated using Trizol reagent (Cat. No. 15596-026, Invitrogen). The libraries were constructed from the isolated total RNA according to the "TruSeq RNA Sample Preparation Kit" protocol (www.illumina.com) without modification. As the protocol includes the procedure of enrichment for the mRNA, an additional polyA selection was not necessary.,RNA libraries were prepared for sequencing using Illumina TruSeq protocols | GSM1100300 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252088,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983961 | GSM1100300 | GSE45263 | 0.001369 | Prefrontal Cortex | Public on Mar 31 2014 | Mar 18 2013 | 9606 | Human_AF_6 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX252088 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01983961 |
|
1 | tissue: Prefrontal Cortex,organism: human | 320 Yue Yang Road | Shanghai | China | PICB | Liu,,He | Illumina Casava1.7 software used for basecalling, and only the ones passing illumina quality controls were retained.,Reads were mapped onto correponding reference genomes (hg19, panTro3) by Tophat-1.4.1, with parameters: -a 8 -m 2 no-coverage-search microexon-search segment-mismatches 3 segment-length 25.,We made a reciprocal lift-over between chimpanzee and human (Ensembl annotation v. 69, coding exons only), and used only exons that could be lift-overed to calculate RPKMs for each gene.,Then quantile normalization was applied, and each gene was z-transformed.,Genome_build: hg19, panTro3,Supplementary_files_format_and_content: tab-delimited text files including expression measurements for each gene from each sample. | Total RNA was isolated using Trizol reagent (Cat. No. 15596-026, Invitrogen). The libraries were constructed from the isolated total RNA according to the "TruSeq RNA Sample Preparation Kit" protocol (www.illumina.com) without modification. As the protocol includes the procedure of enrichment for the mRNA, an additional polyA selection was not necessary.,RNA libraries were prepared for sequencing using Illumina TruSeq protocols | GSM1100301 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252089,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983962 | GSM1100301 | GSE45263 | 0.027837 | Prefrontal Cortex | Public on Mar 31 2014 | Mar 18 2013 | 9606 | Human_AS_7 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX252089 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01983962 |
|
1 | tissue: Prefrontal Cortex,organism: human | 320 Yue Yang Road | Shanghai | China | PICB | Liu,,He | Illumina Casava1.7 software used for basecalling, and only the ones passing illumina quality controls were retained.,Reads were mapped onto correponding reference genomes (hg19, panTro3) by Tophat-1.4.1, with parameters: -a 8 -m 2 no-coverage-search microexon-search segment-mismatches 3 segment-length 25.,We made a reciprocal lift-over between chimpanzee and human (Ensembl annotation v. 69, coding exons only), and used only exons that could be lift-overed to calculate RPKMs for each gene.,Then quantile normalization was applied, and each gene was z-transformed.,Genome_build: hg19, panTro3,Supplementary_files_format_and_content: tab-delimited text files including expression measurements for each gene from each sample. | Total RNA was isolated using Trizol reagent (Cat. No. 15596-026, Invitrogen). The libraries were constructed from the isolated total RNA according to the "TruSeq RNA Sample Preparation Kit" protocol (www.illumina.com) without modification. As the protocol includes the procedure of enrichment for the mRNA, an additional polyA selection was not necessary.,RNA libraries were prepared for sequencing using Illumina TruSeq protocols | GSM1100302 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252090,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983963 | GSM1100302 | GSE45263 | 0.002247 | Prefrontal Cortex | Public on Mar 31 2014 | Mar 18 2013 | 9606 | Human_AF_8 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX252090 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01983963 |
|
1 | tissue: Prefrontal Cortex,organism: human | 320 Yue Yang Road | Shanghai | China | PICB | Liu,,He | Illumina Casava1.7 software used for basecalling, and only the ones passing illumina quality controls were retained.,Reads were mapped onto correponding reference genomes (hg19, panTro3) by Tophat-1.4.1, with parameters: -a 8 -m 2 no-coverage-search microexon-search segment-mismatches 3 segment-length 25.,We made a reciprocal lift-over between chimpanzee and human (Ensembl annotation v. 69, coding exons only), and used only exons that could be lift-overed to calculate RPKMs for each gene.,Then quantile normalization was applied, and each gene was z-transformed.,Genome_build: hg19, panTro3,Supplementary_files_format_and_content: tab-delimited text files including expression measurements for each gene from each sample. | Total RNA was isolated using Trizol reagent (Cat. No. 15596-026, Invitrogen). The libraries were constructed from the isolated total RNA according to the "TruSeq RNA Sample Preparation Kit" protocol (www.illumina.com) without modification. As the protocol includes the procedure of enrichment for the mRNA, an additional polyA selection was not necessary.,RNA libraries were prepared for sequencing using Illumina TruSeq protocols | GSM1100303 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252091,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983964 | GSM1100303 | GSE45263 | 0.000497 | Prefrontal Cortex | Public on Mar 31 2014 | Mar 18 2013 | 9606 | Human_AS_9 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX252091 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01983964 |
|
1 | tissue: Prefrontal Cortex,organism: human | 320 Yue Yang Road | Shanghai | China | PICB | Liu,,He | Illumina Casava1.7 software used for basecalling, and only the ones passing illumina quality controls were retained.,Reads were mapped onto correponding reference genomes (hg19, panTro3) by Tophat-1.4.1, with parameters: -a 8 -m 2 no-coverage-search microexon-search segment-mismatches 3 segment-length 25.,We made a reciprocal lift-over between chimpanzee and human (Ensembl annotation v. 69, coding exons only), and used only exons that could be lift-overed to calculate RPKMs for each gene.,Then quantile normalization was applied, and each gene was z-transformed.,Genome_build: hg19, panTro3,Supplementary_files_format_and_content: tab-delimited text files including expression measurements for each gene from each sample. | Total RNA was isolated using Trizol reagent (Cat. No. 15596-026, Invitrogen). The libraries were constructed from the isolated total RNA according to the "TruSeq RNA Sample Preparation Kit" protocol (www.illumina.com) without modification. As the protocol includes the procedure of enrichment for the mRNA, an additional polyA selection was not necessary.,RNA libraries were prepared for sequencing using Illumina TruSeq protocols | GSM1100304 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252092,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983965 | GSM1100304 | GSE45263 | 0.025625 | Prefrontal Cortex | Public on Mar 31 2014 | Mar 18 2013 | 9606 | Human_AS_10 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX252092 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01983965 |
|
1 | tissue: Prefrontal Cortex,organism: human | 320 Yue Yang Road | Shanghai | China | PICB | Liu,,He | Illumina Casava1.7 software used for basecalling, and only the ones passing illumina quality controls were retained.,Reads were mapped onto correponding reference genomes (hg19, panTro3) by Tophat-1.4.1, with parameters: -a 8 -m 2 no-coverage-search microexon-search segment-mismatches 3 segment-length 25.,We made a reciprocal lift-over between chimpanzee and human (Ensembl annotation v. 69, coding exons only), and used only exons that could be lift-overed to calculate RPKMs for each gene.,Then quantile normalization was applied, and each gene was z-transformed.,Genome_build: hg19, panTro3,Supplementary_files_format_and_content: tab-delimited text files including expression measurements for each gene from each sample. | Total RNA was isolated using Trizol reagent (Cat. No. 15596-026, Invitrogen). The libraries were constructed from the isolated total RNA according to the "TruSeq RNA Sample Preparation Kit" protocol (www.illumina.com) without modification. As the protocol includes the procedure of enrichment for the mRNA, an additional polyA selection was not necessary.,RNA libraries were prepared for sequencing using Illumina TruSeq protocols | GSM1100305 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252093,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983966 | GSM1100305 | GSE45263 | 0.009388 | Prefrontal Cortex | Public on Mar 31 2014 | Mar 18 2013 | 9606 | Human_EU_11 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX252093 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01983966 |
|
1 | tissue: Prefrontal Cortex,organism: human | 320 Yue Yang Road | Shanghai | China | PICB | Liu,,He | Illumina Casava1.7 software used for basecalling, and only the ones passing illumina quality controls were retained.,Reads were mapped onto correponding reference genomes (hg19, panTro3) by Tophat-1.4.1, with parameters: -a 8 -m 2 no-coverage-search microexon-search segment-mismatches 3 segment-length 25.,We made a reciprocal lift-over between chimpanzee and human (Ensembl annotation v. 69, coding exons only), and used only exons that could be lift-overed to calculate RPKMs for each gene.,Then quantile normalization was applied, and each gene was z-transformed.,Genome_build: hg19, panTro3,Supplementary_files_format_and_content: tab-delimited text files including expression measurements for each gene from each sample. | Total RNA was isolated using Trizol reagent (Cat. No. 15596-026, Invitrogen). The libraries were constructed from the isolated total RNA according to the "TruSeq RNA Sample Preparation Kit" protocol (www.illumina.com) without modification. As the protocol includes the procedure of enrichment for the mRNA, an additional polyA selection was not necessary.,RNA libraries were prepared for sequencing using Illumina TruSeq protocols | GSM1100306 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252094,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983967 | GSM1100306 | GSE45263 | 0.002902 | Prefrontal Cortex | Public on Mar 31 2014 | Mar 18 2013 | 9606 | Human_AF_12 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX252094 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01983967 |
|
1 | tissue: Prefrontal Cortex,organism: human | 320 Yue Yang Road | Shanghai | China | PICB | Liu,,He | Illumina Casava1.7 software used for basecalling, and only the ones passing illumina quality controls were retained.,Reads were mapped onto correponding reference genomes (hg19, panTro3) by Tophat-1.4.1, with parameters: -a 8 -m 2 no-coverage-search microexon-search segment-mismatches 3 segment-length 25.,We made a reciprocal lift-over between chimpanzee and human (Ensembl annotation v. 69, coding exons only), and used only exons that could be lift-overed to calculate RPKMs for each gene.,Then quantile normalization was applied, and each gene was z-transformed.,Genome_build: hg19, panTro3,Supplementary_files_format_and_content: tab-delimited text files including expression measurements for each gene from each sample. | Total RNA was isolated using Trizol reagent (Cat. No. 15596-026, Invitrogen). The libraries were constructed from the isolated total RNA according to the "TruSeq RNA Sample Preparation Kit" protocol (www.illumina.com) without modification. As the protocol includes the procedure of enrichment for the mRNA, an additional polyA selection was not necessary.,RNA libraries were prepared for sequencing using Illumina TruSeq protocols | GSM1100307 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252095,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983968 | GSM1100307 | GSE45263 | 0.000497 | Prefrontal Cortex | Public on Mar 31 2014 | Mar 18 2013 | 9606 | Human_AS_13 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX252095 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01983968 |
|
1 | tissue: Prefrontal Cortex,organism: human | 320 Yue Yang Road | Shanghai | China | PICB | Liu,,He | Illumina Casava1.7 software used for basecalling, and only the ones passing illumina quality controls were retained.,Reads were mapped onto correponding reference genomes (hg19, panTro3) by Tophat-1.4.1, with parameters: -a 8 -m 2 no-coverage-search microexon-search segment-mismatches 3 segment-length 25.,We made a reciprocal lift-over between chimpanzee and human (Ensembl annotation v. 69, coding exons only), and used only exons that could be lift-overed to calculate RPKMs for each gene.,Then quantile normalization was applied, and each gene was z-transformed.,Genome_build: hg19, panTro3,Supplementary_files_format_and_content: tab-delimited text files including expression measurements for each gene from each sample. | Total RNA was isolated using Trizol reagent (Cat. No. 15596-026, Invitrogen). The libraries were constructed from the isolated total RNA according to the "TruSeq RNA Sample Preparation Kit" protocol (www.illumina.com) without modification. As the protocol includes the procedure of enrichment for the mRNA, an additional polyA selection was not necessary.,RNA libraries were prepared for sequencing using Illumina TruSeq protocols | GSM1100308 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252096,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983969 | GSM1100308 | GSE45263 | 0.00199 | Prefrontal Cortex | Public on Mar 31 2014 | Mar 18 2013 | 9606 | Human_EU_14 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX252096 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01983969 |
|
1 | tissue: bladder | Palle Juul-Jensens Bouleward 99 | Aarhus | Denmark | Aarhus University | Morten,Muhlig,Nielsen | Illumina Casava software used for basecalling, and Tophat and Cufflinks used for transcript FPKM estiamtes.,Genome_build: hg18,Supplementary_files_format_and_content: Total transcript FPKM values in the GTF file format | Normal tissue provided by Biochain. Total RNA was isolated by a modified guanidine thiocyanate technique according to BioCahin certificate of analysis F-753-1-6 revA.,Using 500 ng of total-RNA from each of the samples, RNA-Seq libraries were constructed by depletion of rRNA followed by synthesis of directional, paired-end and indexed RNA-Seq libraries. The rRNA depleted RNA was purified using the RNA Clean & Concentratorâ¢-5 columns (Zymo Research). Speed-vac was used to reduce the remaining sample volume to 9.5μL followed by synthesis of directional, paired-end and indexed RNA-Seq libraries using the ScriptSeq kit (Epicentre). Briefly, rRNA depleted RNA was chemically fragmented and cDNA was synthesized from a tagged random hexamer. The cDNA was terminal tagged using a 3â-end blocked and tagged oligo followed by MiniElute (Qiagen) purification. The di-tagged cDNA was then used as template in a 10 cycle PCR reaction. Libraries were purified by agarose gel electrophoresis selecting elements of 200-600 bp in size. The RNA-Seq libraries were denaturated and diluted to 10 pM with pre-chilled Hybridization buffer (Illumina) and loaded into TruSeq PE v3 flowcells (Illumina) on an Illumina cBot followed by indexed paired-end sequencing (101+7+101 bp) on a Illumina HiSeq 2000 using TruSeq SBS Kit v3 chemistry. | GSM1101966 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252502,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01984805 | GSM1101966 | GSE45326 | 0.020581 | Biochain:R-1234010-P | Public on Sep 01 2013 | Mar 19 2013 | 9606 | Bladder | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX252502 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01984805 |
|
1 | tissue: brain | Palle Juul-Jensens Bouleward 99 | Aarhus | Denmark | Aarhus University | Morten,Muhlig,Nielsen | Illumina Casava software used for basecalling, and Tophat and Cufflinks used for transcript FPKM estiamtes.,Genome_build: hg18,Supplementary_files_format_and_content: Total transcript FPKM values in the GTF file format | Normal tissue provided by Biochain. Total RNA was isolated by a modified guanidine thiocyanate technique according to BioCahin certificate of analysis F-753-1-6 revA.,Using 500 ng of total-RNA from each of the samples, RNA-Seq libraries were constructed by depletion of rRNA followed by synthesis of directional, paired-end and indexed RNA-Seq libraries. The rRNA depleted RNA was purified using the RNA Clean & Concentratorâ¢-5 columns (Zymo Research). Speed-vac was used to reduce the remaining sample volume to 9.5μL followed by synthesis of directional, paired-end and indexed RNA-Seq libraries using the ScriptSeq kit (Epicentre). Briefly, rRNA depleted RNA was chemically fragmented and cDNA was synthesized from a tagged random hexamer. The cDNA was terminal tagged using a 3â-end blocked and tagged oligo followed by MiniElute (Qiagen) purification. The di-tagged cDNA was then used as template in a 10 cycle PCR reaction. Libraries were purified by agarose gel electrophoresis selecting elements of 200-600 bp in size. The RNA-Seq libraries were denaturated and diluted to 10 pM with pre-chilled Hybridization buffer (Illumina) and loaded into TruSeq PE v3 flowcells (Illumina) on an Illumina cBot followed by indexed paired-end sequencing (101+7+101 bp) on a Illumina HiSeq 2000 using TruSeq SBS Kit v3 chemistry. | GSM1101967 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252503,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01984806 | GSM1101967 | GSE45326 | 0.010386 | Biochain:R-1234035-P | Public on Sep 01 2013 | Mar 19 2013 | 9606 | Brain | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX252503 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01984806 |
|
1 | tissue: breast | Palle Juul-Jensens Bouleward 99 | Aarhus | Denmark | Aarhus University | Morten,Muhlig,Nielsen | Illumina Casava software used for basecalling, and Tophat and Cufflinks used for transcript FPKM estiamtes.,Genome_build: hg18,Supplementary_files_format_and_content: Total transcript FPKM values in the GTF file format | Normal tissue provided by Biochain. Total RNA was isolated by a modified guanidine thiocyanate technique according to BioCahin certificate of analysis F-753-1-6 revA.,Using 500 ng of total-RNA from each of the samples, RNA-Seq libraries were constructed by depletion of rRNA followed by synthesis of directional, paired-end and indexed RNA-Seq libraries. The rRNA depleted RNA was purified using the RNA Clean & Concentratorâ¢-5 columns (Zymo Research). Speed-vac was used to reduce the remaining sample volume to 9.5μL followed by synthesis of directional, paired-end and indexed RNA-Seq libraries using the ScriptSeq kit (Epicentre). Briefly, rRNA depleted RNA was chemically fragmented and cDNA was synthesized from a tagged random hexamer. The cDNA was terminal tagged using a 3â-end blocked and tagged oligo followed by MiniElute (Qiagen) purification. The di-tagged cDNA was then used as template in a 10 cycle PCR reaction. Libraries were purified by agarose gel electrophoresis selecting elements of 200-600 bp in size. The RNA-Seq libraries were denaturated and diluted to 10 pM with pre-chilled Hybridization buffer (Illumina) and loaded into TruSeq PE v3 flowcells (Illumina) on an Illumina cBot followed by indexed paired-end sequencing (101+7+101 bp) on a Illumina HiSeq 2000 using TruSeq SBS Kit v3 chemistry. | GSM1101968 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252504,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01984807 | GSM1101968 | GSE45326 | 0.006547 | Biochain:R-1234086-P | Public on Sep 01 2013 | Mar 19 2013 | 9606 | Breast | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX252504 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01984807 |
|
1 | tissue: colon | Palle Juul-Jensens Bouleward 99 | Aarhus | Denmark | Aarhus University | Morten,Muhlig,Nielsen | Illumina Casava software used for basecalling, and Tophat and Cufflinks used for transcript FPKM estiamtes.,Genome_build: hg18,Supplementary_files_format_and_content: Total transcript FPKM values in the GTF file format | Normal tissue provided by Biochain. Total RNA was isolated by a modified guanidine thiocyanate technique according to BioCahin certificate of analysis F-753-1-6 revA.,Using 500 ng of total-RNA from each of the samples, RNA-Seq libraries were constructed by depletion of rRNA followed by synthesis of directional, paired-end and indexed RNA-Seq libraries. The rRNA depleted RNA was purified using the RNA Clean & Concentratorâ¢-5 columns (Zymo Research). Speed-vac was used to reduce the remaining sample volume to 9.5μL followed by synthesis of directional, paired-end and indexed RNA-Seq libraries using the ScriptSeq kit (Epicentre). Briefly, rRNA depleted RNA was chemically fragmented and cDNA was synthesized from a tagged random hexamer. The cDNA was terminal tagged using a 3â-end blocked and tagged oligo followed by MiniElute (Qiagen) purification. The di-tagged cDNA was then used as template in a 10 cycle PCR reaction. Libraries were purified by agarose gel electrophoresis selecting elements of 200-600 bp in size. The RNA-Seq libraries were denaturated and diluted to 10 pM with pre-chilled Hybridization buffer (Illumina) and loaded into TruSeq PE v3 flowcells (Illumina) on an Illumina cBot followed by indexed paired-end sequencing (101+7+101 bp) on a Illumina HiSeq 2000 using TruSeq SBS Kit v3 chemistry. | GSM1101969 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252505,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01984808 | GSM1101969 | GSE45326 | 0.008579 | Biochain:R-1234090-P | Public on Sep 01 2013 | Mar 19 2013 | 9606 | Colon | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX252505 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01984808 |
|
1 | tissue: heart | Palle Juul-Jensens Bouleward 99 | Aarhus | Denmark | Aarhus University | Morten,Muhlig,Nielsen | Illumina Casava software used for basecalling, and Tophat and Cufflinks used for transcript FPKM estiamtes.,Genome_build: hg18,Supplementary_files_format_and_content: Total transcript FPKM values in the GTF file format | Normal tissue provided by Biochain. Total RNA was isolated by a modified guanidine thiocyanate technique according to BioCahin certificate of analysis F-753-1-6 revA.,Using 500 ng of total-RNA from each of the samples, RNA-Seq libraries were constructed by depletion of rRNA followed by synthesis of directional, paired-end and indexed RNA-Seq libraries. The rRNA depleted RNA was purified using the RNA Clean & Concentratorâ¢-5 columns (Zymo Research). Speed-vac was used to reduce the remaining sample volume to 9.5μL followed by synthesis of directional, paired-end and indexed RNA-Seq libraries using the ScriptSeq kit (Epicentre). Briefly, rRNA depleted RNA was chemically fragmented and cDNA was synthesized from a tagged random hexamer. The cDNA was terminal tagged using a 3â-end blocked and tagged oligo followed by MiniElute (Qiagen) purification. The di-tagged cDNA was then used as template in a 10 cycle PCR reaction. Libraries were purified by agarose gel electrophoresis selecting elements of 200-600 bp in size. The RNA-Seq libraries were denaturated and diluted to 10 pM with pre-chilled Hybridization buffer (Illumina) and loaded into TruSeq PE v3 flowcells (Illumina) on an Illumina cBot followed by indexed paired-end sequencing (101+7+101 bp) on a Illumina HiSeq 2000 using TruSeq SBS Kit v3 chemistry. | GSM1101970 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252506,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01984809 | GSM1101970 | GSE45326 | 0.014112 | Biochain:R-1234122-P | Public on Sep 01 2013 | Mar 19 2013 | 9606 | Heart | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX252506 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01984809 |
|
1 | tissue: kidney | Palle Juul-Jensens Bouleward 99 | Aarhus | Denmark | Aarhus University | Morten,Muhlig,Nielsen | Illumina Casava software used for basecalling, and Tophat and Cufflinks used for transcript FPKM estiamtes.,Genome_build: hg18,Supplementary_files_format_and_content: Total transcript FPKM values in the GTF file format | Normal tissue provided by Biochain. Total RNA was isolated by a modified guanidine thiocyanate technique according to BioCahin certificate of analysis F-753-1-6 revA.,Using 500 ng of total-RNA from each of the samples, RNA-Seq libraries were constructed by depletion of rRNA followed by synthesis of directional, paired-end and indexed RNA-Seq libraries. The rRNA depleted RNA was purified using the RNA Clean & Concentratorâ¢-5 columns (Zymo Research). Speed-vac was used to reduce the remaining sample volume to 9.5μL followed by synthesis of directional, paired-end and indexed RNA-Seq libraries using the ScriptSeq kit (Epicentre). Briefly, rRNA depleted RNA was chemically fragmented and cDNA was synthesized from a tagged random hexamer. The cDNA was terminal tagged using a 3â-end blocked and tagged oligo followed by MiniElute (Qiagen) purification. The di-tagged cDNA was then used as template in a 10 cycle PCR reaction. Libraries were purified by agarose gel electrophoresis selecting elements of 200-600 bp in size. The RNA-Seq libraries were denaturated and diluted to 10 pM with pre-chilled Hybridization buffer (Illumina) and loaded into TruSeq PE v3 flowcells (Illumina) on an Illumina cBot followed by indexed paired-end sequencing (101+7+101 bp) on a Illumina HiSeq 2000 using TruSeq SBS Kit v3 chemistry. | GSM1101971 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252507,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01984810 | GSM1101971 | GSE45326 | 0.007266 | Biochain:R-1234142-P | Public on Sep 01 2013 | Mar 19 2013 | 9606 | Kidney | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX252507 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01984810 |
|
1 | tissue: liver | Palle Juul-Jensens Bouleward 99 | Aarhus | Denmark | Aarhus University | Morten,Muhlig,Nielsen | Illumina Casava software used for basecalling, and Tophat and Cufflinks used for transcript FPKM estiamtes.,Genome_build: hg18,Supplementary_files_format_and_content: Total transcript FPKM values in the GTF file format | Normal tissue provided by Biochain. Total RNA was isolated by a modified guanidine thiocyanate technique according to BioCahin certificate of analysis F-753-1-6 revA.,Using 500 ng of total-RNA from each of the samples, RNA-Seq libraries were constructed by depletion of rRNA followed by synthesis of directional, paired-end and indexed RNA-Seq libraries. The rRNA depleted RNA was purified using the RNA Clean & Concentratorâ¢-5 columns (Zymo Research). Speed-vac was used to reduce the remaining sample volume to 9.5μL followed by synthesis of directional, paired-end and indexed RNA-Seq libraries using the ScriptSeq kit (Epicentre). Briefly, rRNA depleted RNA was chemically fragmented and cDNA was synthesized from a tagged random hexamer. The cDNA was terminal tagged using a 3â-end blocked and tagged oligo followed by MiniElute (Qiagen) purification. The di-tagged cDNA was then used as template in a 10 cycle PCR reaction. Libraries were purified by agarose gel electrophoresis selecting elements of 200-600 bp in size. The RNA-Seq libraries were denaturated and diluted to 10 pM with pre-chilled Hybridization buffer (Illumina) and loaded into TruSeq PE v3 flowcells (Illumina) on an Illumina cBot followed by indexed paired-end sequencing (101+7+101 bp) on a Illumina HiSeq 2000 using TruSeq SBS Kit v3 chemistry. | GSM1101972 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252508,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01984811 | GSM1101972 | GSE45326 | 0.008176 | Biochain:R-1234149-P | Public on Sep 01 2013 | Mar 19 2013 | 9606 | Liver | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX252508 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01984811 |
|
1 | tissue: lung | Palle Juul-Jensens Bouleward 99 | Aarhus | Denmark | Aarhus University | Morten,Muhlig,Nielsen | Illumina Casava software used for basecalling, and Tophat and Cufflinks used for transcript FPKM estiamtes.,Genome_build: hg18,Supplementary_files_format_and_content: Total transcript FPKM values in the GTF file format | Normal tissue provided by Biochain. Total RNA was isolated by a modified guanidine thiocyanate technique according to BioCahin certificate of analysis F-753-1-6 revA.,Using 500 ng of total-RNA from each of the samples, RNA-Seq libraries were constructed by depletion of rRNA followed by synthesis of directional, paired-end and indexed RNA-Seq libraries. The rRNA depleted RNA was purified using the RNA Clean & Concentratorâ¢-5 columns (Zymo Research). Speed-vac was used to reduce the remaining sample volume to 9.5μL followed by synthesis of directional, paired-end and indexed RNA-Seq libraries using the ScriptSeq kit (Epicentre). Briefly, rRNA depleted RNA was chemically fragmented and cDNA was synthesized from a tagged random hexamer. The cDNA was terminal tagged using a 3â-end blocked and tagged oligo followed by MiniElute (Qiagen) purification. The di-tagged cDNA was then used as template in a 10 cycle PCR reaction. Libraries were purified by agarose gel electrophoresis selecting elements of 200-600 bp in size. The RNA-Seq libraries were denaturated and diluted to 10 pM with pre-chilled Hybridization buffer (Illumina) and loaded into TruSeq PE v3 flowcells (Illumina) on an Illumina cBot followed by indexed paired-end sequencing (101+7+101 bp) on a Illumina HiSeq 2000 using TruSeq SBS Kit v3 chemistry. | GSM1101973 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252509,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01984812 | GSM1101973 | GSE45326 | 0.003979 | Biochain:R-1234152-P | Public on Sep 01 2013 | Mar 19 2013 | 9606 | Lung | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX252509 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01984812 |
|
1 | tissue: muscle | Palle Juul-Jensens Bouleward 99 | Aarhus | Denmark | Aarhus University | Morten,Muhlig,Nielsen | Illumina Casava software used for basecalling, and Tophat and Cufflinks used for transcript FPKM estiamtes.,Genome_build: hg18,Supplementary_files_format_and_content: Total transcript FPKM values in the GTF file format | Normal tissue provided by Biochain. Total RNA was isolated by a modified guanidine thiocyanate technique according to BioCahin certificate of analysis F-753-1-6 revA.,Using 500 ng of total-RNA from each of the samples, RNA-Seq libraries were constructed by depletion of rRNA followed by synthesis of directional, paired-end and indexed RNA-Seq libraries. The rRNA depleted RNA was purified using the RNA Clean & Concentratorâ¢-5 columns (Zymo Research). Speed-vac was used to reduce the remaining sample volume to 9.5μL followed by synthesis of directional, paired-end and indexed RNA-Seq libraries using the ScriptSeq kit (Epicentre). Briefly, rRNA depleted RNA was chemically fragmented and cDNA was synthesized from a tagged random hexamer. The cDNA was terminal tagged using a 3â-end blocked and tagged oligo followed by MiniElute (Qiagen) purification. The di-tagged cDNA was then used as template in a 10 cycle PCR reaction. Libraries were purified by agarose gel electrophoresis selecting elements of 200-600 bp in size. The RNA-Seq libraries were denaturated and diluted to 10 pM with pre-chilled Hybridization buffer (Illumina) and loaded into TruSeq PE v3 flowcells (Illumina) on an Illumina cBot followed by indexed paired-end sequencing (101+7+101 bp) on a Illumina HiSeq 2000 using TruSeq SBS Kit v3 chemistry. | GSM1101974 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252510,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01984813 | GSM1101974 | GSE45326 | 0.091524 | Biochain:R-1234171-P | Public on Sep 01 2013 | Mar 19 2013 | 9606 | Muscle | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX252510 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01984813 |
|
1 | tissue: ovary | Palle Juul-Jensens Bouleward 99 | Aarhus | Denmark | Aarhus University | Morten,Muhlig,Nielsen | Illumina Casava software used for basecalling, and Tophat and Cufflinks used for transcript FPKM estiamtes.,Genome_build: hg18,Supplementary_files_format_and_content: Total transcript FPKM values in the GTF file format | Normal tissue provided by Biochain. Total RNA was isolated by a modified guanidine thiocyanate technique according to BioCahin certificate of analysis F-753-1-6 revA.,Using 500 ng of total-RNA from each of the samples, RNA-Seq libraries were constructed by depletion of rRNA followed by synthesis of directional, paired-end and indexed RNA-Seq libraries. The rRNA depleted RNA was purified using the RNA Clean & Concentratorâ¢-5 columns (Zymo Research). Speed-vac was used to reduce the remaining sample volume to 9.5μL followed by synthesis of directional, paired-end and indexed RNA-Seq libraries using the ScriptSeq kit (Epicentre). Briefly, rRNA depleted RNA was chemically fragmented and cDNA was synthesized from a tagged random hexamer. The cDNA was terminal tagged using a 3â-end blocked and tagged oligo followed by MiniElute (Qiagen) purification. The di-tagged cDNA was then used as template in a 10 cycle PCR reaction. Libraries were purified by agarose gel electrophoresis selecting elements of 200-600 bp in size. The RNA-Seq libraries were denaturated and diluted to 10 pM with pre-chilled Hybridization buffer (Illumina) and loaded into TruSeq PE v3 flowcells (Illumina) on an Illumina cBot followed by indexed paired-end sequencing (101+7+101 bp) on a Illumina HiSeq 2000 using TruSeq SBS Kit v3 chemistry. | GSM1101975 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252511,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01984814 | GSM1101975 | GSE45326 | 0.011156 | Biochain:R-1234183-P | Public on Sep 01 2013 | Mar 19 2013 | 9606 | Ovary | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX252511 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01984814 |
|
1 | tissue: prostate | Palle Juul-Jensens Bouleward 99 | Aarhus | Denmark | Aarhus University | Morten,Muhlig,Nielsen | Illumina Casava software used for basecalling, and Tophat and Cufflinks used for transcript FPKM estiamtes.,Genome_build: hg18,Supplementary_files_format_and_content: Total transcript FPKM values in the GTF file format | Normal tissue provided by Biochain. Total RNA was isolated by a modified guanidine thiocyanate technique according to BioCahin certificate of analysis F-753-1-6 revA.,Using 500 ng of total-RNA from each of the samples, RNA-Seq libraries were constructed by depletion of rRNA followed by synthesis of directional, paired-end and indexed RNA-Seq libraries. The rRNA depleted RNA was purified using the RNA Clean & Concentratorâ¢-5 columns (Zymo Research). Speed-vac was used to reduce the remaining sample volume to 9.5μL followed by synthesis of directional, paired-end and indexed RNA-Seq libraries using the ScriptSeq kit (Epicentre). Briefly, rRNA depleted RNA was chemically fragmented and cDNA was synthesized from a tagged random hexamer. The cDNA was terminal tagged using a 3â-end blocked and tagged oligo followed by MiniElute (Qiagen) purification. The di-tagged cDNA was then used as template in a 10 cycle PCR reaction. Libraries were purified by agarose gel electrophoresis selecting elements of 200-600 bp in size. The RNA-Seq libraries were denaturated and diluted to 10 pM with pre-chilled Hybridization buffer (Illumina) and loaded into TruSeq PE v3 flowcells (Illumina) on an Illumina cBot followed by indexed paired-end sequencing (101+7+101 bp) on a Illumina HiSeq 2000 using TruSeq SBS Kit v3 chemistry. | GSM1101976 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252513,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01984815 | GSM1101976 | GSE45326 | 0.027888 | Biochain:R-1234201-P | Public on Sep 01 2013 | Mar 19 2013 | 9606 | Prostate | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX252513 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01984815 |
|
1 | tissue: skin | Palle Juul-Jensens Bouleward 99 | Aarhus | Denmark | Aarhus University | Morten,Muhlig,Nielsen | Illumina Casava software used for basecalling, and Tophat and Cufflinks used for transcript FPKM estiamtes.,Genome_build: hg18,Supplementary_files_format_and_content: Total transcript FPKM values in the GTF file format | Normal tissue provided by Biochain. Total RNA was isolated by a modified guanidine thiocyanate technique according to BioCahin certificate of analysis F-753-1-6 revA.,Using 500 ng of total-RNA from each of the samples, RNA-Seq libraries were constructed by depletion of rRNA followed by synthesis of directional, paired-end and indexed RNA-Seq libraries. The rRNA depleted RNA was purified using the RNA Clean & Concentratorâ¢-5 columns (Zymo Research). Speed-vac was used to reduce the remaining sample volume to 9.5μL followed by synthesis of directional, paired-end and indexed RNA-Seq libraries using the ScriptSeq kit (Epicentre). Briefly, rRNA depleted RNA was chemically fragmented and cDNA was synthesized from a tagged random hexamer. The cDNA was terminal tagged using a 3â-end blocked and tagged oligo followed by MiniElute (Qiagen) purification. The di-tagged cDNA was then used as template in a 10 cycle PCR reaction. Libraries were purified by agarose gel electrophoresis selecting elements of 200-600 bp in size. The RNA-Seq libraries were denaturated and diluted to 10 pM with pre-chilled Hybridization buffer (Illumina) and loaded into TruSeq PE v3 flowcells (Illumina) on an Illumina cBot followed by indexed paired-end sequencing (101+7+101 bp) on a Illumina HiSeq 2000 using TruSeq SBS Kit v3 chemistry. | GSM1101977 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252512,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01984816 | GSM1101977 | GSE45326 | 0.014822 | Biochain:R-1234218-P | Public on Sep 01 2013 | Mar 19 2013 | 9606 | Skin | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX252512 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01984816 |
|
1 | cell line: TIB-152 | 1101 University Ave. | Madison | USA | UW-Madison | Gloria,,Sheynkman | Basecalls performed using CASAVA version 1.8.,Annotated and unannotated junctions were detected using the Bowtie (v0.12.7) and Tophat (v1.4.0) splice-junction discovery programs (49, 50). All default Bowtie parameters were used. In Tophat, the mate inner distance was set to 150. Two rounds of Bowtie-Tophat processing were conducted with a supplied set of RefSeq gene model annotations in GTF format (7): the first round detected junctions only matching the gene annotation file (option --no-novel-junctions) and the second round detected all junctions, both aligning to the GTF file and novel (option -G).,RNA-Seq reads were processed by RSEM v1.1.20 (RNA-Seq by Expectation-Maximization) to estimate transcript abundances. All default parameters used for both Bowtie (v0.12.7) and RSEM.,Genome_build: hg19 | ~2e6 cells were pelleted, washed twice with cold PBS, and total RNA was extracted using the Trizol protocol.,RNA-Seq paired end libraries were prepared using the Illumina TruSeq RNA Sample Prep Rev. A (kit lot #6849988, Illumina, San Diego, CA). | GSM1104129 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX254396,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01985824 | GSM1104129 | GSE45428 | 0 | immortalized T-cell line | Public on May 17 2013 | Mar 22 2013 | 9606 | Jurkat Cells 216 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX254396 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01985824 |
|
1 | cell line: TIB-152 | 1101 University Ave. | Madison | USA | UW-Madison | Gloria,,Sheynkman | Basecalls performed using CASAVA version 1.8.,Annotated and unannotated junctions were detected using the Bowtie (v0.12.7) and Tophat (v1.4.0) splice-junction discovery programs (49, 50). All default Bowtie parameters were used. In Tophat, the mate inner distance was set to 150. Two rounds of Bowtie-Tophat processing were conducted with a supplied set of RefSeq gene model annotations in GTF format (7): the first round detected junctions only matching the gene annotation file (option --no-novel-junctions) and the second round detected all junctions, both aligning to the GTF file and novel (option -G).,RNA-Seq reads were processed by RSEM v1.1.20 (RNA-Seq by Expectation-Maximization) to estimate transcript abundances. All default parameters used for both Bowtie (v0.12.7) and RSEM.,Genome_build: hg19 | ~2e6 cells were pelleted, washed twice with cold PBS, and total RNA was extracted using the Trizol protocol.,RNA-Seq paired end libraries were prepared using the Illumina TruSeq RNA Sample Prep Rev. A (kit lot #6849988, Illumina, San Diego, CA). | GSM1104130 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX254397,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01985825 | GSM1104130 | GSE45428 | 0.006955 | immortalized T-cell line | Public on May 17 2013 | Mar 22 2013 | 9606 | Jurkat Cells 245 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX254397 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01985825 |
|
1 | cell line: TIB-152 | 1101 University Ave. | Madison | USA | UW-Madison | Gloria,,Sheynkman | Basecalls performed using CASAVA version 1.8.,Annotated and unannotated junctions were detected using the Bowtie (v0.12.7) and Tophat (v1.4.0) splice-junction discovery programs (49, 50). All default Bowtie parameters were used. In Tophat, the mate inner distance was set to 150. Two rounds of Bowtie-Tophat processing were conducted with a supplied set of RefSeq gene model annotations in GTF format (7): the first round detected junctions only matching the gene annotation file (option --no-novel-junctions) and the second round detected all junctions, both aligning to the GTF file and novel (option -G).,RNA-Seq reads were processed by RSEM v1.1.20 (RNA-Seq by Expectation-Maximization) to estimate transcript abundances. All default parameters used for both Bowtie (v0.12.7) and RSEM.,Genome_build: hg19 | ~2e6 cells were pelleted, washed twice with cold PBS, and total RNA was extracted using the Trizol protocol.,RNA-Seq paired end libraries were prepared using the Illumina TruSeq RNA Sample Prep Rev. A (kit lot #6849988, Illumina, San Diego, CA). | GSM1104131 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX254398,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01985826 | GSM1104131 | GSE45428 | 0.00928 | immortalized T-cell line | Public on May 17 2013 | Mar 22 2013 | 9606 | Jurkat Cells 236 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX254398 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01985826 |
|
1 | cell line: HeLa S3,treatment: siRNA control,internal reference: 120123_lane7_VLB1 | 3400 Civic Center Blvd - SCTR 9-111 | Philadelphia | USA | University of Pennsylvania | Roberto,,Bonasio | Trimmed sequences in 3' to 36 nts,mapped to hg19 with BOWTIE -m40 -v2,assigned counts to gene models in ENS65 with DEGseq,Genome_build: hg19 (HeLaS3) or mm9 (germ cells),Supplementary_files_format_and_content: RPKM and count table for ENS65 | RNA was isolated with TRIzol, depleted of polyA+ transcripts with oligo-dT beads, and depleted of rRNA with the Ribominus kit,libraries were prepared with the dUTP strand-specific protocol. After RT and second-strand synthesis, cDNA was end-repaired using End-It Repair Kit (Epicenter), tailed with an A using Klenow exo minus (NEB M0212), and ligated to custom adapters with T4 ligase (Enzymatics). Fragments of 200±50 bp were size-selected and subjected to ligation-mediated PCR amplification (LM-PCR), using Phusion DNA polymerase (NEB M0530) after removal of the 2nd strand with heat-labile UDG (Roche). | GSM1104373 | Illumina HiSeq 2000 | Feb 04 2022 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX254634,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01986103 | GSM1104373 | GSE45442,GSE45489 | 0.002883 | HeLa S3 | Public on Mar 26 2013 | Mar 22 2013 | 9606 | HeLaS3.siCtrl.R | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX254634 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01986103 |
|
1 | cell line: HeLa S3,treatment: siRNA against SFMBT1 (#1) + LSD1 (#2) + CoREST (#1),internal reference: 120123_lane7_VLB4 | 3400 Civic Center Blvd - SCTR 9-111 | Philadelphia | USA | University of Pennsylvania | Roberto,,Bonasio | Trimmed sequences in 3' to 36 nts,mapped to hg19 with BOWTIE -m40 -v2,assigned counts to gene models in ENS65 with DEGseq,Genome_build: hg19 (HeLaS3) or mm9 (germ cells),Supplementary_files_format_and_content: RPKM and count table for ENS65 | RNA was isolated with TRIzol, depleted of polyA+ transcripts with oligo-dT beads, and depleted of rRNA with the Ribominus kit,libraries were prepared with the dUTP strand-specific protocol. After RT and second-strand synthesis, cDNA was end-repaired using End-It Repair Kit (Epicenter), tailed with an A using Klenow exo minus (NEB M0212), and ligated to custom adapters with T4 ligase (Enzymatics). Fragments of 200±50 bp were size-selected and subjected to ligation-mediated PCR amplification (LM-PCR), using Phusion DNA polymerase (NEB M0530) after removal of the 2nd strand with heat-labile UDG (Roche). | GSM1104374 | Illumina HiSeq 2000 | Feb 04 2022 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX254635,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01986104 | GSM1104374 | GSE45442,GSE45489 | 0.002366 | HeLa S3 | Public on Mar 26 2013 | Mar 22 2013 | 9606 | HeLaS3.siSFMBT1-1_siLSD1-2_siCoREST-1.R | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX254635 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01986104 |
|
1 | cell line: gastric carcinoma cell line SNU-719,passage: 3-5,infection: EBV | 1430 Tulane Ave., SL79 | New Orleans | USA | Tulane Health Sciences Center | Erik,K,Flemington | alignments to hg19 (UCSC) using novoalign (v.2.08.02) using default settings,read counts were calculated using HT-seq count using the interesection-strict option and the GRCh37.70 annotation file.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include read counts for each sample | RNA was extracted using the Trizol protocol.,Two separate cDNA libraries were prepared from polyA selected and from Ribo-Zero selected RNAs using the Illumina Truseq Stranded Total RNA Sample Prep Kit (RS-122-2101). | GSM1104509 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX254850,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01990909 | GSM1104509 | GSE45453 | 0 | Gastric carcinoma cell line | Public on Jun 23 2013 | Mar 24 2013 | 9606 | poly-A-SNU-719 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX254850 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01990909 |
|
1 | cell line: gastric carcinoma cell line SNU-719,passage: 3-5,infection: EBV | 1430 Tulane Ave., SL79 | New Orleans | USA | Tulane Health Sciences Center | Erik,K,Flemington | alignments to hg19 (UCSC) using novoalign (v.2.08.02) using default settings,read counts were calculated using HT-seq count using the interesection-strict option and the GRCh37.70 annotation file.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include read counts for each sample | RNA was extracted using the Trizol protocol.,Two separate cDNA libraries were prepared from polyA selected and from Ribo-Zero selected RNAs using the Illumina Truseq Stranded Total RNA Sample Prep Kit (RS-122-2101). | GSM1104510 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX254851,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01990910 | GSM1104510 | GSE45453 | 0 | Gastric carcinoma cell line | Public on Jun 23 2013 | Mar 24 2013 | 9606 | ribo-zero-SNU-719 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX254851 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01990910 |
|
1 | treatment: non-targeting siRNA pool,cell line: 293T | 88 Dr. Aiguader | Barcelona | Spain | Centre for Genomic Regulation | Manuel,,Irimia | Full genomic sequences for the analyzed species were downloaded from the Ensembl database. Full transcriptomic sequences for all species were downloaded from Ensembl. For each gene, the canonical transcript was selected for gene expression analysis based on BioMart.,For each species, we assembled all canonical transcript (as defined above) sequences. In order to calculate the effective number of unique mappable positions in each transcript (i.e. the effective length) we performed the following steps. For each read length k, we extracted the L-k+1 (L being the transcript length) k-mer sequences from each canonical transcript and then aligned the full set of k-mers against the respective genome using Bowtie, allowing for a maximum of two mismatches. k-mers with no or one unique genomic alignment were then likewise aligned back to the canonical transcriptome. For each transcript, the number of such k-mers having a unique transcriptomic alignment was determined. This corresponds to the transcriptâs effective number of unique mappable positions for k-mer mRNA-Seq reads. For each sample, the corresponding mRNA-Seq data were aligned against the respective genome using Bowtie, allowing for a maximum of two mismatches. Reads with one unique genomic alignment were then aligned against the canonical transcriptome and, for each transcript, the number of reads with one unique transcriptomic alignment were counted. Gene expression levels were determined as reads per thousand mappable positions of target transcript sequence per million of reads, where the reads uniquely align to the analyzed transcriptome. This procedure for estimating gene expression levels is a corrected version of the widely used RPKM (reads per kilobase of target transcript sequence per million of total reads) metric, and is referred to as âcRPKMâ [Labbe RM et al. Stem Cells (2012)].,Genome_build: hg19, mm9,Supplementary_files_format_and_content: Tab-delimited text files include cRPKM values (as defined above), as well as the total read count for each gene's canonical transcript | Total RNA was extracted using Tri Reagent (Sigma) or RNeasy columns (Qiagen),Standard Illumina library preparation according to manufacturer | GSM1105743 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | polyA RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX255055,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01992326 | GSM1105743 | GSE45504,GSE45505 | 0.010696 | 293T cell line | Public on Jun 26 2013 | Mar 26 2013 | 9606 | 293T nt_control | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX255055 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01992326 |
|
1 | treatment: MBNL1 and MBNL2 SMART-pool siRNAs,cell line: 293T | 88 Dr. Aiguader | Barcelona | Spain | Centre for Genomic Regulation | Manuel,,Irimia | Full genomic sequences for the analyzed species were downloaded from the Ensembl database. Full transcriptomic sequences for all species were downloaded from Ensembl. For each gene, the canonical transcript was selected for gene expression analysis based on BioMart.,For each species, we assembled all canonical transcript (as defined above) sequences. In order to calculate the effective number of unique mappable positions in each transcript (i.e. the effective length) we performed the following steps. For each read length k, we extracted the L-k+1 (L being the transcript length) k-mer sequences from each canonical transcript and then aligned the full set of k-mers against the respective genome using Bowtie, allowing for a maximum of two mismatches. k-mers with no or one unique genomic alignment were then likewise aligned back to the canonical transcriptome. For each transcript, the number of such k-mers having a unique transcriptomic alignment was determined. This corresponds to the transcriptâs effective number of unique mappable positions for k-mer mRNA-Seq reads. For each sample, the corresponding mRNA-Seq data were aligned against the respective genome using Bowtie, allowing for a maximum of two mismatches. Reads with one unique genomic alignment were then aligned against the canonical transcriptome and, for each transcript, the number of reads with one unique transcriptomic alignment were counted. Gene expression levels were determined as reads per thousand mappable positions of target transcript sequence per million of reads, where the reads uniquely align to the analyzed transcriptome. This procedure for estimating gene expression levels is a corrected version of the widely used RPKM (reads per kilobase of target transcript sequence per million of total reads) metric, and is referred to as âcRPKMâ [Labbe RM et al. Stem Cells (2012)].,Genome_build: hg19, mm9,Supplementary_files_format_and_content: Tab-delimited text files include cRPKM values (as defined above), as well as the total read count for each gene's canonical transcript | Total RNA was extracted using Tri Reagent (Sigma) or RNeasy columns (Qiagen),Standard Illumina library preparation according to manufacturer | GSM1105744 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | polyA RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX255056,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01992327 | GSM1105744 | GSE45504,GSE45505 | 0.005734 | 293T cell line | Public on Jun 26 2013 | Mar 26 2013 | 9606 | 293T siMBNL1+2 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX255056 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01992327 |
|
1 | treatment: non-targeting siRNA pool,cell line: HeLa | 88 Dr. Aiguader | Barcelona | Spain | Centre for Genomic Regulation | Manuel,,Irimia | Full genomic sequences for the analyzed species were downloaded from the Ensembl database. Full transcriptomic sequences for all species were downloaded from Ensembl. For each gene, the canonical transcript was selected for gene expression analysis based on BioMart.,For each species, we assembled all canonical transcript (as defined above) sequences. In order to calculate the effective number of unique mappable positions in each transcript (i.e. the effective length) we performed the following steps. For each read length k, we extracted the L-k+1 (L being the transcript length) k-mer sequences from each canonical transcript and then aligned the full set of k-mers against the respective genome using Bowtie, allowing for a maximum of two mismatches. k-mers with no or one unique genomic alignment were then likewise aligned back to the canonical transcriptome. For each transcript, the number of such k-mers having a unique transcriptomic alignment was determined. This corresponds to the transcriptâs effective number of unique mappable positions for k-mer mRNA-Seq reads. For each sample, the corresponding mRNA-Seq data were aligned against the respective genome using Bowtie, allowing for a maximum of two mismatches. Reads with one unique genomic alignment were then aligned against the canonical transcriptome and, for each transcript, the number of reads with one unique transcriptomic alignment were counted. Gene expression levels were determined as reads per thousand mappable positions of target transcript sequence per million of reads, where the reads uniquely align to the analyzed transcriptome. This procedure for estimating gene expression levels is a corrected version of the widely used RPKM (reads per kilobase of target transcript sequence per million of total reads) metric, and is referred to as âcRPKMâ [Labbe RM et al. Stem Cells (2012)].,Genome_build: hg19, mm9,Supplementary_files_format_and_content: Tab-delimited text files include cRPKM values (as defined above), as well as the total read count for each gene's canonical transcript | Total RNA was extracted using Tri Reagent (Sigma) or RNeasy columns (Qiagen),Standard Illumina library preparation according to manufacturer | GSM1105745 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | polyA RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX255057,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01992328 | GSM1105745 | GSE45504,GSE45505 | 0.004763 | HeLa cell line | Public on Jun 26 2013 | Mar 26 2013 | 9606 | HeLa nt_control | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX255057 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01992328 |
|
1 | treatment: MBNL1 and MBNL2 SMART-pool siRNAs,cell line: HeLa | 88 Dr. Aiguader | Barcelona | Spain | Centre for Genomic Regulation | Manuel,,Irimia | Full genomic sequences for the analyzed species were downloaded from the Ensembl database. Full transcriptomic sequences for all species were downloaded from Ensembl. For each gene, the canonical transcript was selected for gene expression analysis based on BioMart.,For each species, we assembled all canonical transcript (as defined above) sequences. In order to calculate the effective number of unique mappable positions in each transcript (i.e. the effective length) we performed the following steps. For each read length k, we extracted the L-k+1 (L being the transcript length) k-mer sequences from each canonical transcript and then aligned the full set of k-mers against the respective genome using Bowtie, allowing for a maximum of two mismatches. k-mers with no or one unique genomic alignment were then likewise aligned back to the canonical transcriptome. For each transcript, the number of such k-mers having a unique transcriptomic alignment was determined. This corresponds to the transcriptâs effective number of unique mappable positions for k-mer mRNA-Seq reads. For each sample, the corresponding mRNA-Seq data were aligned against the respective genome using Bowtie, allowing for a maximum of two mismatches. Reads with one unique genomic alignment were then aligned against the canonical transcriptome and, for each transcript, the number of reads with one unique transcriptomic alignment were counted. Gene expression levels were determined as reads per thousand mappable positions of target transcript sequence per million of reads, where the reads uniquely align to the analyzed transcriptome. This procedure for estimating gene expression levels is a corrected version of the widely used RPKM (reads per kilobase of target transcript sequence per million of total reads) metric, and is referred to as âcRPKMâ [Labbe RM et al. Stem Cells (2012)].,Genome_build: hg19, mm9,Supplementary_files_format_and_content: Tab-delimited text files include cRPKM values (as defined above), as well as the total read count for each gene's canonical transcript | Total RNA was extracted using Tri Reagent (Sigma) or RNeasy columns (Qiagen),Standard Illumina library preparation according to manufacturer | GSM1105746 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | polyA RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX255058,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01992329 | GSM1105746 | GSE45504,GSE45505 | 0.005762 | HeLa cell line | Public on Jun 26 2013 | Mar 26 2013 | 9606 | HeLa siMBNL1+2 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX255058 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01992329 |
|
1 | subject id: 154,lactation stage: Transitional,extraction protocol: Soft spin, Unwashed | 451 Health Sciences Dr | Davis | USA | University of California Davis | Danielle,G,Lemay | Basecalls performed using Illumina software,Reads mapped to the genome using TopHat with these options: tophat -G hg19.gtf -o tophat -p 4 -r 0,Mapped reads were indexed using samtools: samtools index tophat/accepted_hits.bam,Normalized transcript abundances determined using Cufflinks: cufflinks -u -b hg19.fa -G hg19.gtf -p 4 -o cufflinks tophat/accepted_hits.bam,Genome_build: hg19,Supplementary_files_format_and_content: Compressed tab-delimited text files contain transcript abundance measurements (FPKM) summarized at the gene level | Soft Spin: Whole milk samples were centrifuged at 300 g for 10 min at 4 degrees C. The milk fat layers from three, 2.0 mL aliquots were transferred into a single new tube to which 500 µL TRIzol® was added and stored at -80 degrees C,Hard Spin: Whole milk samples were centrifuged at 15000 g for 10 min at 4 degrees C. The milk fat layers from three, 2.0 mL aliquots were transferred into a single new tube to which 500 µL TRIzol® was added and stored at -80 degrees C,Wash: After a hard spin at a warmer temperature, (15,000 g at 12 degrees C) the milk fat layers were transferred to a clean set of 3 tubes and re-suspended in 1 mL PBS+10µM EDTA. After centrifuging again (15,000 g at 12 degrees C), the milk fat layers from all 3 tubes were transferred to a single tube, re-suspended in 1 mL PBS, and centrifuged a final time (15,000 g at 12 degrees C). The remaining milk fat layer was transferred into a single new tube to which 500 µL TRIzol® was added and stored at -80 degrees C.,RNA Isolation: Total RNA was extracted and purified in batches of 16 using the PROMEGA Maxwell 16⢠integrated system (Promega Corporation, Madison, WI).,RNA libraries were prepared for sequencing using the Illumina TruSeq RNA Kit and standard Illumina Protocols | GSM1111646 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | polyA RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX258169,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01996054 | GSM1111646 | GSE45669 | 0.006163 | Milk Fat Layer | Public on Jul 22 2013 | Apr 01 2013 | 9606 | 154-D_RNA_c0_0 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX258169 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01996054 |
|
1 | subject id: 179,lactation stage: Mature,extraction protocol: Hard spin, Washed twice | 451 Health Sciences Dr | Davis | USA | University of California Davis | Danielle,G,Lemay | Basecalls performed using Illumina software,Reads mapped to the genome using TopHat with these options: tophat -G hg19.gtf -o tophat -p 4 -r 0,Mapped reads were indexed using samtools: samtools index tophat/accepted_hits.bam,Normalized transcript abundances determined using Cufflinks: cufflinks -u -b hg19.fa -G hg19.gtf -p 4 -o cufflinks tophat/accepted_hits.bam,Genome_build: hg19,Supplementary_files_format_and_content: Compressed tab-delimited text files contain transcript abundance measurements (FPKM) summarized at the gene level | Soft Spin: Whole milk samples were centrifuged at 300 g for 10 min at 4 degrees C. The milk fat layers from three, 2.0 mL aliquots were transferred into a single new tube to which 500 µL TRIzol® was added and stored at -80 degrees C,Hard Spin: Whole milk samples were centrifuged at 15000 g for 10 min at 4 degrees C. The milk fat layers from three, 2.0 mL aliquots were transferred into a single new tube to which 500 µL TRIzol® was added and stored at -80 degrees C,Wash: After a hard spin at a warmer temperature, (15,000 g at 12 degrees C) the milk fat layers were transferred to a clean set of 3 tubes and re-suspended in 1 mL PBS+10µM EDTA. After centrifuging again (15,000 g at 12 degrees C), the milk fat layers from all 3 tubes were transferred to a single tube, re-suspended in 1 mL PBS, and centrifuged a final time (15,000 g at 12 degrees C). The remaining milk fat layer was transferred into a single new tube to which 500 µL TRIzol® was added and stored at -80 degrees C.,RNA Isolation: Total RNA was extracted and purified in batches of 16 using the PROMEGA Maxwell 16⢠integrated system (Promega Corporation, Madison, WI).,RNA libraries were prepared for sequencing using the Illumina TruSeq RNA Kit and standard Illumina Protocols | GSM1111658 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | polyA RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX258181,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01996066 | GSM1111658 | GSE45669 | 0.063019 | Milk Fat Layer | Public on Jul 22 2013 | Apr 01 2013 | 9606 | 179-C_RNA_m2_2 | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX258181 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01996066 |
|
1 | tissue: blood,fraction: exosome | 8701 Watertown Plank Rd. | Milwaukee | USA | Medical College of Wisconsin | Liang,,Wang | Perl Scripts were developed to process data from RNA sequencing. Raw reads were firstly extracted from FASTQ files, and trimmed with sequencing quality control of Q > 13 , and then cleaned up 3â adaptor sequences within read sequences. Those prepared sequences filtered with the length â¥16 nt were combined into a FASTA file and aligned against human miRNA sequences downloaded from miRBase (Release 19, 2043 entries) and human genome reference sequences downloaded from NCBI ftp site (Release 103) with Bowtie (version 0.12.8) , of which the parameters for alignment were -m 3 -n 1 -f -a -best --strata. Normalization of miRNA profiling was the read counts of a target miRNA by million bases versus the sum of read counts of all mappable miRNAs on human miRNA sequences.,Genome_build: miRNA from miRBase(release19),Supplementary_files_format_and_content: Data frame of normalized miRNA transcription level in *.txt | we selected plasma samples (samples A, B and C) from 3 anonymous blood donors and split each sample into two for technical replication.,We tested the six samples (A1 and A2, B1 and B2, C1 and C2) using two small RNA library preparation kits: NEBNext Multiplex Small RNA library Prep Set from New England Biolab (NEB) and NEXTflex Small RNA Sequencing Kit from Bioo Scientific (BS). We also tested Illuminaâs TrueSeq Small RNA Sample Preparation Kit (ILMN) in sample A1 and A2. Together, we tested these plasma samples by sequencing 14 indexed libraries.,Human plasma samples were obtained from Mayo Clinic and stored at -80°C before use. Exosomes were isolated from 250 µL of plasma prepared from whole blood using the ExoQuick Exosome Precipitation Solution (SBI) according to the manufacturerâs instructions with minor modifications. Briefly, the plasma was incubated with Thromboplastin D (Thermo) for 15 min at 37oC. After centrifugation at 10,000 rpm for 5 min, the supernatant was mixed with 75 µL of ExoQuick Solution and RNase A (Sigma) at final concentration of 10 µg/mL. The mixture was kept at 4oC overnight and then further mixed with 150 units/mL of murine RNase inhibitor (NEB) before centrifugation at 1500 g for 30 min. The exosome pellet was dissolved in 25 µL 1ÃPBS, 2 µL of which was reserved for evaluation of exosome size and concentration using NanoSight LM 10 instrument (Particle Characterization Laboratories). The remainder was subjected to RNA extraction immediately. The usage of human biospecimen for this study was approved by Institutional Review Board of Medical College of Wisconsin and Mayo Clinic.,RNA was prepared by using miRNeasy Micro Kit (QIAGEN). Twenty-three µL of exosome suspension was mixed with 700 µL QIAzol Lysis buffer, and was processed by the standard protocol from the manufacturer. The extracted RNA was eluted with 14 µL of RNase-free water. The quantity and quality of the RNA were determined by Agilent Bioanalyzer 2100 with Small RNA Chip and RNA 6000 Pico Kit as indicated (Agilent Technologies).,The concentration and the size distribution of isolated exosomes were measured using NanoSight. Prior to sampling, the sample solutions were homogenized by vortexing, followed by serial dilution to the final dilution of 1:100,000 in 0.2 µm-filtered 1x PBS. NIST (National Institute of Standards and Technology) traceable 97 nm ± 3 nm polystyrene latex standards were added and analyzed in conjunction with the diluted exosome solution to validate the operation of the instrumentation. A blank 0.2 µm-filtered 1x PBS sample was also run as a negative control. Each sample analysis was conducted for 90 seconds. The Nanosightâs automatic analysis settings (High Sensitivity, Blue laser [405 nm, 645 mW]) were utilized for the processing of the data. All samples were evaluated in triplicates. | GSM1112869 | Illumina HiSeq 2000 | May 15 2019 | size fractionation | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX258926,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01997249 | GSM1112869 | GSE45722 | 0.561508 | microRNA from sample A constructed by the kit from Bioo scientific | Public on May 15 2013 | Apr 03 2013 | 9606 | microRNA from sample A constructed by the kit from Bioo scientific [LW_AB_1] | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX258926 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01997249 |
|
1 | tissue: blood,fraction: exosome | 8701 Watertown Plank Rd. | Milwaukee | USA | Medical College of Wisconsin | Liang,,Wang | Perl Scripts were developed to process data from RNA sequencing. Raw reads were firstly extracted from FASTQ files, and trimmed with sequencing quality control of Q > 13 , and then cleaned up 3â adaptor sequences within read sequences. Those prepared sequences filtered with the length â¥16 nt were combined into a FASTA file and aligned against human miRNA sequences downloaded from miRBase (Release 19, 2043 entries) and human genome reference sequences downloaded from NCBI ftp site (Release 103) with Bowtie (version 0.12.8) , of which the parameters for alignment were -m 3 -n 1 -f -a -best --strata. Normalization of miRNA profiling was the read counts of a target miRNA by million bases versus the sum of read counts of all mappable miRNAs on human miRNA sequences.,Genome_build: miRNA from miRBase(release19),Supplementary_files_format_and_content: Data frame of normalized miRNA transcription level in *.txt | we selected plasma samples (samples A, B and C) from 3 anonymous blood donors and split each sample into two for technical replication.,We tested the six samples (A1 and A2, B1 and B2, C1 and C2) using two small RNA library preparation kits: NEBNext Multiplex Small RNA library Prep Set from New England Biolab (NEB) and NEXTflex Small RNA Sequencing Kit from Bioo Scientific (BS). We also tested Illuminaâs TrueSeq Small RNA Sample Preparation Kit (ILMN) in sample A1 and A2. Together, we tested these plasma samples by sequencing 14 indexed libraries.,Human plasma samples were obtained from Mayo Clinic and stored at -80°C before use. Exosomes were isolated from 250 µL of plasma prepared from whole blood using the ExoQuick Exosome Precipitation Solution (SBI) according to the manufacturerâs instructions with minor modifications. Briefly, the plasma was incubated with Thromboplastin D (Thermo) for 15 min at 37oC. After centrifugation at 10,000 rpm for 5 min, the supernatant was mixed with 75 µL of ExoQuick Solution and RNase A (Sigma) at final concentration of 10 µg/mL. The mixture was kept at 4oC overnight and then further mixed with 150 units/mL of murine RNase inhibitor (NEB) before centrifugation at 1500 g for 30 min. The exosome pellet was dissolved in 25 µL 1ÃPBS, 2 µL of which was reserved for evaluation of exosome size and concentration using NanoSight LM 10 instrument (Particle Characterization Laboratories). The remainder was subjected to RNA extraction immediately. The usage of human biospecimen for this study was approved by Institutional Review Board of Medical College of Wisconsin and Mayo Clinic.,RNA was prepared by using miRNeasy Micro Kit (QIAGEN). Twenty-three µL of exosome suspension was mixed with 700 µL QIAzol Lysis buffer, and was processed by the standard protocol from the manufacturer. The extracted RNA was eluted with 14 µL of RNase-free water. The quantity and quality of the RNA were determined by Agilent Bioanalyzer 2100 with Small RNA Chip and RNA 6000 Pico Kit as indicated (Agilent Technologies).,The concentration and the size distribution of isolated exosomes were measured using NanoSight. Prior to sampling, the sample solutions were homogenized by vortexing, followed by serial dilution to the final dilution of 1:100,000 in 0.2 µm-filtered 1x PBS. NIST (National Institute of Standards and Technology) traceable 97 nm ± 3 nm polystyrene latex standards were added and analyzed in conjunction with the diluted exosome solution to validate the operation of the instrumentation. A blank 0.2 µm-filtered 1x PBS sample was also run as a negative control. Each sample analysis was conducted for 90 seconds. The Nanosightâs automatic analysis settings (High Sensitivity, Blue laser [405 nm, 645 mW]) were utilized for the processing of the data. All samples were evaluated in triplicates. | GSM1112870 | Illumina HiSeq 2000 | May 15 2019 | size fractionation | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX258927,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01997250 | GSM1112870 | GSE45722 | 0.676602 | microRNA from sample A constructed by the kit from Bioo scientific | Public on May 15 2013 | Apr 03 2013 | 9606 | microRNA from sample A constructed by the kit from Bioo scientific [LW_AB_2] | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX258927 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01997250 |
|
1 | tissue: blood,fraction: exosome | 8701 Watertown Plank Rd. | Milwaukee | USA | Medical College of Wisconsin | Liang,,Wang | Perl Scripts were developed to process data from RNA sequencing. Raw reads were firstly extracted from FASTQ files, and trimmed with sequencing quality control of Q > 13 , and then cleaned up 3â adaptor sequences within read sequences. Those prepared sequences filtered with the length â¥16 nt were combined into a FASTA file and aligned against human miRNA sequences downloaded from miRBase (Release 19, 2043 entries) and human genome reference sequences downloaded from NCBI ftp site (Release 103) with Bowtie (version 0.12.8) , of which the parameters for alignment were -m 3 -n 1 -f -a -best --strata. Normalization of miRNA profiling was the read counts of a target miRNA by million bases versus the sum of read counts of all mappable miRNAs on human miRNA sequences.,Genome_build: miRNA from miRBase(release19),Supplementary_files_format_and_content: Data frame of normalized miRNA transcription level in *.txt | we selected plasma samples (samples A, B and C) from 3 anonymous blood donors and split each sample into two for technical replication.,We tested the six samples (A1 and A2, B1 and B2, C1 and C2) using two small RNA library preparation kits: NEBNext Multiplex Small RNA library Prep Set from New England Biolab (NEB) and NEXTflex Small RNA Sequencing Kit from Bioo Scientific (BS). We also tested Illuminaâs TrueSeq Small RNA Sample Preparation Kit (ILMN) in sample A1 and A2. Together, we tested these plasma samples by sequencing 14 indexed libraries.,Human plasma samples were obtained from Mayo Clinic and stored at -80°C before use. Exosomes were isolated from 250 µL of plasma prepared from whole blood using the ExoQuick Exosome Precipitation Solution (SBI) according to the manufacturerâs instructions with minor modifications. Briefly, the plasma was incubated with Thromboplastin D (Thermo) for 15 min at 37oC. After centrifugation at 10,000 rpm for 5 min, the supernatant was mixed with 75 µL of ExoQuick Solution and RNase A (Sigma) at final concentration of 10 µg/mL. The mixture was kept at 4oC overnight and then further mixed with 150 units/mL of murine RNase inhibitor (NEB) before centrifugation at 1500 g for 30 min. The exosome pellet was dissolved in 25 µL 1ÃPBS, 2 µL of which was reserved for evaluation of exosome size and concentration using NanoSight LM 10 instrument (Particle Characterization Laboratories). The remainder was subjected to RNA extraction immediately. The usage of human biospecimen for this study was approved by Institutional Review Board of Medical College of Wisconsin and Mayo Clinic.,RNA was prepared by using miRNeasy Micro Kit (QIAGEN). Twenty-three µL of exosome suspension was mixed with 700 µL QIAzol Lysis buffer, and was processed by the standard protocol from the manufacturer. The extracted RNA was eluted with 14 µL of RNase-free water. The quantity and quality of the RNA were determined by Agilent Bioanalyzer 2100 with Small RNA Chip and RNA 6000 Pico Kit as indicated (Agilent Technologies).,The concentration and the size distribution of isolated exosomes were measured using NanoSight. Prior to sampling, the sample solutions were homogenized by vortexing, followed by serial dilution to the final dilution of 1:100,000 in 0.2 µm-filtered 1x PBS. NIST (National Institute of Standards and Technology) traceable 97 nm ± 3 nm polystyrene latex standards were added and analyzed in conjunction with the diluted exosome solution to validate the operation of the instrumentation. A blank 0.2 µm-filtered 1x PBS sample was also run as a negative control. Each sample analysis was conducted for 90 seconds. The Nanosightâs automatic analysis settings (High Sensitivity, Blue laser [405 nm, 645 mW]) were utilized for the processing of the data. All samples were evaluated in triplicates. | GSM1112871 | Illumina HiSeq 2000 | May 15 2019 | size fractionation | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX258928,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01997251 | GSM1112871 | GSE45722 | 0.341471 | microRNA from sample A constructed by the kit from NEB | Public on May 15 2013 | Apr 03 2013 | 9606 | microRNA from sample A constructed by the kit from NEB [LW_AN_1] | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX258928 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01997251 |
|
1 | tissue: blood,fraction: exosome | 8701 Watertown Plank Rd. | Milwaukee | USA | Medical College of Wisconsin | Liang,,Wang | Perl Scripts were developed to process data from RNA sequencing. Raw reads were firstly extracted from FASTQ files, and trimmed with sequencing quality control of Q > 13 , and then cleaned up 3â adaptor sequences within read sequences. Those prepared sequences filtered with the length â¥16 nt were combined into a FASTA file and aligned against human miRNA sequences downloaded from miRBase (Release 19, 2043 entries) and human genome reference sequences downloaded from NCBI ftp site (Release 103) with Bowtie (version 0.12.8) , of which the parameters for alignment were -m 3 -n 1 -f -a -best --strata. Normalization of miRNA profiling was the read counts of a target miRNA by million bases versus the sum of read counts of all mappable miRNAs on human miRNA sequences.,Genome_build: miRNA from miRBase(release19),Supplementary_files_format_and_content: Data frame of normalized miRNA transcription level in *.txt | we selected plasma samples (samples A, B and C) from 3 anonymous blood donors and split each sample into two for technical replication.,We tested the six samples (A1 and A2, B1 and B2, C1 and C2) using two small RNA library preparation kits: NEBNext Multiplex Small RNA library Prep Set from New England Biolab (NEB) and NEXTflex Small RNA Sequencing Kit from Bioo Scientific (BS). We also tested Illuminaâs TrueSeq Small RNA Sample Preparation Kit (ILMN) in sample A1 and A2. Together, we tested these plasma samples by sequencing 14 indexed libraries.,Human plasma samples were obtained from Mayo Clinic and stored at -80°C before use. Exosomes were isolated from 250 µL of plasma prepared from whole blood using the ExoQuick Exosome Precipitation Solution (SBI) according to the manufacturerâs instructions with minor modifications. Briefly, the plasma was incubated with Thromboplastin D (Thermo) for 15 min at 37oC. After centrifugation at 10,000 rpm for 5 min, the supernatant was mixed with 75 µL of ExoQuick Solution and RNase A (Sigma) at final concentration of 10 µg/mL. The mixture was kept at 4oC overnight and then further mixed with 150 units/mL of murine RNase inhibitor (NEB) before centrifugation at 1500 g for 30 min. The exosome pellet was dissolved in 25 µL 1ÃPBS, 2 µL of which was reserved for evaluation of exosome size and concentration using NanoSight LM 10 instrument (Particle Characterization Laboratories). The remainder was subjected to RNA extraction immediately. The usage of human biospecimen for this study was approved by Institutional Review Board of Medical College of Wisconsin and Mayo Clinic.,RNA was prepared by using miRNeasy Micro Kit (QIAGEN). Twenty-three µL of exosome suspension was mixed with 700 µL QIAzol Lysis buffer, and was processed by the standard protocol from the manufacturer. The extracted RNA was eluted with 14 µL of RNase-free water. The quantity and quality of the RNA were determined by Agilent Bioanalyzer 2100 with Small RNA Chip and RNA 6000 Pico Kit as indicated (Agilent Technologies).,The concentration and the size distribution of isolated exosomes were measured using NanoSight. Prior to sampling, the sample solutions were homogenized by vortexing, followed by serial dilution to the final dilution of 1:100,000 in 0.2 µm-filtered 1x PBS. NIST (National Institute of Standards and Technology) traceable 97 nm ± 3 nm polystyrene latex standards were added and analyzed in conjunction with the diluted exosome solution to validate the operation of the instrumentation. A blank 0.2 µm-filtered 1x PBS sample was also run as a negative control. Each sample analysis was conducted for 90 seconds. The Nanosightâs automatic analysis settings (High Sensitivity, Blue laser [405 nm, 645 mW]) were utilized for the processing of the data. All samples were evaluated in triplicates. | GSM1112872 | Illumina HiSeq 2000 | May 15 2019 | size fractionation | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX258929,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01997252 | GSM1112872 | GSE45722 | 0.465001 | microRNA from sample A constructed by the kit from NEB | Public on May 15 2013 | Apr 03 2013 | 9606 | microRNA from sample A constructed by the kit from NEB [LW_AN_2] | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX258929 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01997252 |
|
1 | tissue: blood,fraction: exosome | 8701 Watertown Plank Rd. | Milwaukee | USA | Medical College of Wisconsin | Liang,,Wang | Perl Scripts were developed to process data from RNA sequencing. Raw reads were firstly extracted from FASTQ files, and trimmed with sequencing quality control of Q > 13 , and then cleaned up 3â adaptor sequences within read sequences. Those prepared sequences filtered with the length â¥16 nt were combined into a FASTA file and aligned against human miRNA sequences downloaded from miRBase (Release 19, 2043 entries) and human genome reference sequences downloaded from NCBI ftp site (Release 103) with Bowtie (version 0.12.8) , of which the parameters for alignment were -m 3 -n 1 -f -a -best --strata. Normalization of miRNA profiling was the read counts of a target miRNA by million bases versus the sum of read counts of all mappable miRNAs on human miRNA sequences.,Genome_build: miRNA from miRBase(release19),Supplementary_files_format_and_content: Data frame of normalized miRNA transcription level in *.txt | we selected plasma samples (samples A, B and C) from 3 anonymous blood donors and split each sample into two for technical replication.,We tested the six samples (A1 and A2, B1 and B2, C1 and C2) using two small RNA library preparation kits: NEBNext Multiplex Small RNA library Prep Set from New England Biolab (NEB) and NEXTflex Small RNA Sequencing Kit from Bioo Scientific (BS). We also tested Illuminaâs TrueSeq Small RNA Sample Preparation Kit (ILMN) in sample A1 and A2. Together, we tested these plasma samples by sequencing 14 indexed libraries.,Human plasma samples were obtained from Mayo Clinic and stored at -80°C before use. Exosomes were isolated from 250 µL of plasma prepared from whole blood using the ExoQuick Exosome Precipitation Solution (SBI) according to the manufacturerâs instructions with minor modifications. Briefly, the plasma was incubated with Thromboplastin D (Thermo) for 15 min at 37oC. After centrifugation at 10,000 rpm for 5 min, the supernatant was mixed with 75 µL of ExoQuick Solution and RNase A (Sigma) at final concentration of 10 µg/mL. The mixture was kept at 4oC overnight and then further mixed with 150 units/mL of murine RNase inhibitor (NEB) before centrifugation at 1500 g for 30 min. The exosome pellet was dissolved in 25 µL 1ÃPBS, 2 µL of which was reserved for evaluation of exosome size and concentration using NanoSight LM 10 instrument (Particle Characterization Laboratories). The remainder was subjected to RNA extraction immediately. The usage of human biospecimen for this study was approved by Institutional Review Board of Medical College of Wisconsin and Mayo Clinic.,RNA was prepared by using miRNeasy Micro Kit (QIAGEN). Twenty-three µL of exosome suspension was mixed with 700 µL QIAzol Lysis buffer, and was processed by the standard protocol from the manufacturer. The extracted RNA was eluted with 14 µL of RNase-free water. The quantity and quality of the RNA were determined by Agilent Bioanalyzer 2100 with Small RNA Chip and RNA 6000 Pico Kit as indicated (Agilent Technologies).,The concentration and the size distribution of isolated exosomes were measured using NanoSight. Prior to sampling, the sample solutions were homogenized by vortexing, followed by serial dilution to the final dilution of 1:100,000 in 0.2 µm-filtered 1x PBS. NIST (National Institute of Standards and Technology) traceable 97 nm ± 3 nm polystyrene latex standards were added and analyzed in conjunction with the diluted exosome solution to validate the operation of the instrumentation. A blank 0.2 µm-filtered 1x PBS sample was also run as a negative control. Each sample analysis was conducted for 90 seconds. The Nanosightâs automatic analysis settings (High Sensitivity, Blue laser [405 nm, 645 mW]) were utilized for the processing of the data. All samples were evaluated in triplicates. | GSM1112873 | Illumina HiSeq 2000 | May 15 2019 | size fractionation | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX258930,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01997253 | GSM1112873 | GSE45722 | 0.630554 | microRNA from sample A constructed by the kit from Illumina | Public on May 15 2013 | Apr 03 2013 | 9606 | microRNA from sample A constructed by the kit from Illumina [LW_AI_1] | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX258930 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01997253 |
|
1 | tissue: blood,fraction: exosome | 8701 Watertown Plank Rd. | Milwaukee | USA | Medical College of Wisconsin | Liang,,Wang | Perl Scripts were developed to process data from RNA sequencing. Raw reads were firstly extracted from FASTQ files, and trimmed with sequencing quality control of Q > 13 , and then cleaned up 3â adaptor sequences within read sequences. Those prepared sequences filtered with the length â¥16 nt were combined into a FASTA file and aligned against human miRNA sequences downloaded from miRBase (Release 19, 2043 entries) and human genome reference sequences downloaded from NCBI ftp site (Release 103) with Bowtie (version 0.12.8) , of which the parameters for alignment were -m 3 -n 1 -f -a -best --strata. Normalization of miRNA profiling was the read counts of a target miRNA by million bases versus the sum of read counts of all mappable miRNAs on human miRNA sequences.,Genome_build: miRNA from miRBase(release19),Supplementary_files_format_and_content: Data frame of normalized miRNA transcription level in *.txt | we selected plasma samples (samples A, B and C) from 3 anonymous blood donors and split each sample into two for technical replication.,We tested the six samples (A1 and A2, B1 and B2, C1 and C2) using two small RNA library preparation kits: NEBNext Multiplex Small RNA library Prep Set from New England Biolab (NEB) and NEXTflex Small RNA Sequencing Kit from Bioo Scientific (BS). We also tested Illuminaâs TrueSeq Small RNA Sample Preparation Kit (ILMN) in sample A1 and A2. Together, we tested these plasma samples by sequencing 14 indexed libraries.,Human plasma samples were obtained from Mayo Clinic and stored at -80°C before use. Exosomes were isolated from 250 µL of plasma prepared from whole blood using the ExoQuick Exosome Precipitation Solution (SBI) according to the manufacturerâs instructions with minor modifications. Briefly, the plasma was incubated with Thromboplastin D (Thermo) for 15 min at 37oC. After centrifugation at 10,000 rpm for 5 min, the supernatant was mixed with 75 µL of ExoQuick Solution and RNase A (Sigma) at final concentration of 10 µg/mL. The mixture was kept at 4oC overnight and then further mixed with 150 units/mL of murine RNase inhibitor (NEB) before centrifugation at 1500 g for 30 min. The exosome pellet was dissolved in 25 µL 1ÃPBS, 2 µL of which was reserved for evaluation of exosome size and concentration using NanoSight LM 10 instrument (Particle Characterization Laboratories). The remainder was subjected to RNA extraction immediately. The usage of human biospecimen for this study was approved by Institutional Review Board of Medical College of Wisconsin and Mayo Clinic.,RNA was prepared by using miRNeasy Micro Kit (QIAGEN). Twenty-three µL of exosome suspension was mixed with 700 µL QIAzol Lysis buffer, and was processed by the standard protocol from the manufacturer. The extracted RNA was eluted with 14 µL of RNase-free water. The quantity and quality of the RNA were determined by Agilent Bioanalyzer 2100 with Small RNA Chip and RNA 6000 Pico Kit as indicated (Agilent Technologies).,The concentration and the size distribution of isolated exosomes were measured using NanoSight. Prior to sampling, the sample solutions were homogenized by vortexing, followed by serial dilution to the final dilution of 1:100,000 in 0.2 µm-filtered 1x PBS. NIST (National Institute of Standards and Technology) traceable 97 nm ± 3 nm polystyrene latex standards were added and analyzed in conjunction with the diluted exosome solution to validate the operation of the instrumentation. A blank 0.2 µm-filtered 1x PBS sample was also run as a negative control. Each sample analysis was conducted for 90 seconds. The Nanosightâs automatic analysis settings (High Sensitivity, Blue laser [405 nm, 645 mW]) were utilized for the processing of the data. All samples were evaluated in triplicates. | GSM1112874 | Illumina HiSeq 2000 | May 15 2019 | size fractionation | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX258931,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01997254 | GSM1112874 | GSE45722 | 0.52746 | microRNA from sample A constructed by the kit from Illumina | Public on May 15 2013 | Apr 03 2013 | 9606 | microRNA from sample A constructed by the kit from Illumina [LW_AI_2] | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX258931 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01997254 |
|
1 | tissue: blood,fraction: exosome | 8701 Watertown Plank Rd. | Milwaukee | USA | Medical College of Wisconsin | Liang,,Wang | Perl Scripts were developed to process data from RNA sequencing. Raw reads were firstly extracted from FASTQ files, and trimmed with sequencing quality control of Q > 13 , and then cleaned up 3â adaptor sequences within read sequences. Those prepared sequences filtered with the length â¥16 nt were combined into a FASTA file and aligned against human miRNA sequences downloaded from miRBase (Release 19, 2043 entries) and human genome reference sequences downloaded from NCBI ftp site (Release 103) with Bowtie (version 0.12.8) , of which the parameters for alignment were -m 3 -n 1 -f -a -best --strata. Normalization of miRNA profiling was the read counts of a target miRNA by million bases versus the sum of read counts of all mappable miRNAs on human miRNA sequences.,Genome_build: miRNA from miRBase(release19),Supplementary_files_format_and_content: Data frame of normalized miRNA transcription level in *.txt | we selected plasma samples (samples A, B and C) from 3 anonymous blood donors and split each sample into two for technical replication.,We tested the six samples (A1 and A2, B1 and B2, C1 and C2) using two small RNA library preparation kits: NEBNext Multiplex Small RNA library Prep Set from New England Biolab (NEB) and NEXTflex Small RNA Sequencing Kit from Bioo Scientific (BS). We also tested Illuminaâs TrueSeq Small RNA Sample Preparation Kit (ILMN) in sample A1 and A2. Together, we tested these plasma samples by sequencing 14 indexed libraries.,Human plasma samples were obtained from Mayo Clinic and stored at -80°C before use. Exosomes were isolated from 250 µL of plasma prepared from whole blood using the ExoQuick Exosome Precipitation Solution (SBI) according to the manufacturerâs instructions with minor modifications. Briefly, the plasma was incubated with Thromboplastin D (Thermo) for 15 min at 37oC. After centrifugation at 10,000 rpm for 5 min, the supernatant was mixed with 75 µL of ExoQuick Solution and RNase A (Sigma) at final concentration of 10 µg/mL. The mixture was kept at 4oC overnight and then further mixed with 150 units/mL of murine RNase inhibitor (NEB) before centrifugation at 1500 g for 30 min. The exosome pellet was dissolved in 25 µL 1ÃPBS, 2 µL of which was reserved for evaluation of exosome size and concentration using NanoSight LM 10 instrument (Particle Characterization Laboratories). The remainder was subjected to RNA extraction immediately. The usage of human biospecimen for this study was approved by Institutional Review Board of Medical College of Wisconsin and Mayo Clinic.,RNA was prepared by using miRNeasy Micro Kit (QIAGEN). Twenty-three µL of exosome suspension was mixed with 700 µL QIAzol Lysis buffer, and was processed by the standard protocol from the manufacturer. The extracted RNA was eluted with 14 µL of RNase-free water. The quantity and quality of the RNA were determined by Agilent Bioanalyzer 2100 with Small RNA Chip and RNA 6000 Pico Kit as indicated (Agilent Technologies).,The concentration and the size distribution of isolated exosomes were measured using NanoSight. Prior to sampling, the sample solutions were homogenized by vortexing, followed by serial dilution to the final dilution of 1:100,000 in 0.2 µm-filtered 1x PBS. NIST (National Institute of Standards and Technology) traceable 97 nm ± 3 nm polystyrene latex standards were added and analyzed in conjunction with the diluted exosome solution to validate the operation of the instrumentation. A blank 0.2 µm-filtered 1x PBS sample was also run as a negative control. Each sample analysis was conducted for 90 seconds. The Nanosightâs automatic analysis settings (High Sensitivity, Blue laser [405 nm, 645 mW]) were utilized for the processing of the data. All samples were evaluated in triplicates. | GSM1112875 | Illumina HiSeq 2000 | May 15 2019 | size fractionation | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX258932,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01997255 | GSM1112875 | GSE45722 | 0.528227 | microRNA from sample B constructed by the kit from Bioo scientific | Public on May 15 2013 | Apr 03 2013 | 9606 | microRNA from sample B constructed by the kit from Bioo scientific [LW_BB_1] | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX258932 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01997255 |
|
1 | tissue: blood,fraction: exosome | 8701 Watertown Plank Rd. | Milwaukee | USA | Medical College of Wisconsin | Liang,,Wang | Perl Scripts were developed to process data from RNA sequencing. Raw reads were firstly extracted from FASTQ files, and trimmed with sequencing quality control of Q > 13 , and then cleaned up 3â adaptor sequences within read sequences. Those prepared sequences filtered with the length â¥16 nt were combined into a FASTA file and aligned against human miRNA sequences downloaded from miRBase (Release 19, 2043 entries) and human genome reference sequences downloaded from NCBI ftp site (Release 103) with Bowtie (version 0.12.8) , of which the parameters for alignment were -m 3 -n 1 -f -a -best --strata. Normalization of miRNA profiling was the read counts of a target miRNA by million bases versus the sum of read counts of all mappable miRNAs on human miRNA sequences.,Genome_build: miRNA from miRBase(release19),Supplementary_files_format_and_content: Data frame of normalized miRNA transcription level in *.txt | we selected plasma samples (samples A, B and C) from 3 anonymous blood donors and split each sample into two for technical replication.,We tested the six samples (A1 and A2, B1 and B2, C1 and C2) using two small RNA library preparation kits: NEBNext Multiplex Small RNA library Prep Set from New England Biolab (NEB) and NEXTflex Small RNA Sequencing Kit from Bioo Scientific (BS). We also tested Illuminaâs TrueSeq Small RNA Sample Preparation Kit (ILMN) in sample A1 and A2. Together, we tested these plasma samples by sequencing 14 indexed libraries.,Human plasma samples were obtained from Mayo Clinic and stored at -80°C before use. Exosomes were isolated from 250 µL of plasma prepared from whole blood using the ExoQuick Exosome Precipitation Solution (SBI) according to the manufacturerâs instructions with minor modifications. Briefly, the plasma was incubated with Thromboplastin D (Thermo) for 15 min at 37oC. After centrifugation at 10,000 rpm for 5 min, the supernatant was mixed with 75 µL of ExoQuick Solution and RNase A (Sigma) at final concentration of 10 µg/mL. The mixture was kept at 4oC overnight and then further mixed with 150 units/mL of murine RNase inhibitor (NEB) before centrifugation at 1500 g for 30 min. The exosome pellet was dissolved in 25 µL 1ÃPBS, 2 µL of which was reserved for evaluation of exosome size and concentration using NanoSight LM 10 instrument (Particle Characterization Laboratories). The remainder was subjected to RNA extraction immediately. The usage of human biospecimen for this study was approved by Institutional Review Board of Medical College of Wisconsin and Mayo Clinic.,RNA was prepared by using miRNeasy Micro Kit (QIAGEN). Twenty-three µL of exosome suspension was mixed with 700 µL QIAzol Lysis buffer, and was processed by the standard protocol from the manufacturer. The extracted RNA was eluted with 14 µL of RNase-free water. The quantity and quality of the RNA were determined by Agilent Bioanalyzer 2100 with Small RNA Chip and RNA 6000 Pico Kit as indicated (Agilent Technologies).,The concentration and the size distribution of isolated exosomes were measured using NanoSight. Prior to sampling, the sample solutions were homogenized by vortexing, followed by serial dilution to the final dilution of 1:100,000 in 0.2 µm-filtered 1x PBS. NIST (National Institute of Standards and Technology) traceable 97 nm ± 3 nm polystyrene latex standards were added and analyzed in conjunction with the diluted exosome solution to validate the operation of the instrumentation. A blank 0.2 µm-filtered 1x PBS sample was also run as a negative control. Each sample analysis was conducted for 90 seconds. The Nanosightâs automatic analysis settings (High Sensitivity, Blue laser [405 nm, 645 mW]) were utilized for the processing of the data. All samples were evaluated in triplicates. | GSM1112876 | Illumina HiSeq 2000 | May 15 2019 | size fractionation | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX258933,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01997256 | GSM1112876 | GSE45722 | 0.630344 | microRNA from sample B constructed by the kit from Bioo scientific | Public on May 15 2013 | Apr 03 2013 | 9606 | microRNA from sample B constructed by the kit from Bioo scientific [LW_BB_2] | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX258933 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01997256 |
|
1 | tissue: blood,fraction: exosome | 8701 Watertown Plank Rd. | Milwaukee | USA | Medical College of Wisconsin | Liang,,Wang | Perl Scripts were developed to process data from RNA sequencing. Raw reads were firstly extracted from FASTQ files, and trimmed with sequencing quality control of Q > 13 , and then cleaned up 3â adaptor sequences within read sequences. Those prepared sequences filtered with the length â¥16 nt were combined into a FASTA file and aligned against human miRNA sequences downloaded from miRBase (Release 19, 2043 entries) and human genome reference sequences downloaded from NCBI ftp site (Release 103) with Bowtie (version 0.12.8) , of which the parameters for alignment were -m 3 -n 1 -f -a -best --strata. Normalization of miRNA profiling was the read counts of a target miRNA by million bases versus the sum of read counts of all mappable miRNAs on human miRNA sequences.,Genome_build: miRNA from miRBase(release19),Supplementary_files_format_and_content: Data frame of normalized miRNA transcription level in *.txt | we selected plasma samples (samples A, B and C) from 3 anonymous blood donors and split each sample into two for technical replication.,We tested the six samples (A1 and A2, B1 and B2, C1 and C2) using two small RNA library preparation kits: NEBNext Multiplex Small RNA library Prep Set from New England Biolab (NEB) and NEXTflex Small RNA Sequencing Kit from Bioo Scientific (BS). We also tested Illuminaâs TrueSeq Small RNA Sample Preparation Kit (ILMN) in sample A1 and A2. Together, we tested these plasma samples by sequencing 14 indexed libraries.,Human plasma samples were obtained from Mayo Clinic and stored at -80°C before use. Exosomes were isolated from 250 µL of plasma prepared from whole blood using the ExoQuick Exosome Precipitation Solution (SBI) according to the manufacturerâs instructions with minor modifications. Briefly, the plasma was incubated with Thromboplastin D (Thermo) for 15 min at 37oC. After centrifugation at 10,000 rpm for 5 min, the supernatant was mixed with 75 µL of ExoQuick Solution and RNase A (Sigma) at final concentration of 10 µg/mL. The mixture was kept at 4oC overnight and then further mixed with 150 units/mL of murine RNase inhibitor (NEB) before centrifugation at 1500 g for 30 min. The exosome pellet was dissolved in 25 µL 1ÃPBS, 2 µL of which was reserved for evaluation of exosome size and concentration using NanoSight LM 10 instrument (Particle Characterization Laboratories). The remainder was subjected to RNA extraction immediately. The usage of human biospecimen for this study was approved by Institutional Review Board of Medical College of Wisconsin and Mayo Clinic.,RNA was prepared by using miRNeasy Micro Kit (QIAGEN). Twenty-three µL of exosome suspension was mixed with 700 µL QIAzol Lysis buffer, and was processed by the standard protocol from the manufacturer. The extracted RNA was eluted with 14 µL of RNase-free water. The quantity and quality of the RNA were determined by Agilent Bioanalyzer 2100 with Small RNA Chip and RNA 6000 Pico Kit as indicated (Agilent Technologies).,The concentration and the size distribution of isolated exosomes were measured using NanoSight. Prior to sampling, the sample solutions were homogenized by vortexing, followed by serial dilution to the final dilution of 1:100,000 in 0.2 µm-filtered 1x PBS. NIST (National Institute of Standards and Technology) traceable 97 nm ± 3 nm polystyrene latex standards were added and analyzed in conjunction with the diluted exosome solution to validate the operation of the instrumentation. A blank 0.2 µm-filtered 1x PBS sample was also run as a negative control. Each sample analysis was conducted for 90 seconds. The Nanosightâs automatic analysis settings (High Sensitivity, Blue laser [405 nm, 645 mW]) were utilized for the processing of the data. All samples were evaluated in triplicates. | GSM1112877 | Illumina HiSeq 2000 | May 15 2019 | size fractionation | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX258934,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01997257 | GSM1112877 | GSE45722 | 0.346684 | microRNA from sample B constructed by the kit from NEB | Public on May 15 2013 | Apr 03 2013 | 9606 | microRNA from sample B constructed by the kit from NEB [LW_BN_1] | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX258934 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01997257 |
|
1 | tissue: blood,fraction: exosome | 8701 Watertown Plank Rd. | Milwaukee | USA | Medical College of Wisconsin | Liang,,Wang | Perl Scripts were developed to process data from RNA sequencing. Raw reads were firstly extracted from FASTQ files, and trimmed with sequencing quality control of Q > 13 , and then cleaned up 3â adaptor sequences within read sequences. Those prepared sequences filtered with the length â¥16 nt were combined into a FASTA file and aligned against human miRNA sequences downloaded from miRBase (Release 19, 2043 entries) and human genome reference sequences downloaded from NCBI ftp site (Release 103) with Bowtie (version 0.12.8) , of which the parameters for alignment were -m 3 -n 1 -f -a -best --strata. Normalization of miRNA profiling was the read counts of a target miRNA by million bases versus the sum of read counts of all mappable miRNAs on human miRNA sequences.,Genome_build: miRNA from miRBase(release19),Supplementary_files_format_and_content: Data frame of normalized miRNA transcription level in *.txt | we selected plasma samples (samples A, B and C) from 3 anonymous blood donors and split each sample into two for technical replication.,We tested the six samples (A1 and A2, B1 and B2, C1 and C2) using two small RNA library preparation kits: NEBNext Multiplex Small RNA library Prep Set from New England Biolab (NEB) and NEXTflex Small RNA Sequencing Kit from Bioo Scientific (BS). We also tested Illuminaâs TrueSeq Small RNA Sample Preparation Kit (ILMN) in sample A1 and A2. Together, we tested these plasma samples by sequencing 14 indexed libraries.,Human plasma samples were obtained from Mayo Clinic and stored at -80°C before use. Exosomes were isolated from 250 µL of plasma prepared from whole blood using the ExoQuick Exosome Precipitation Solution (SBI) according to the manufacturerâs instructions with minor modifications. Briefly, the plasma was incubated with Thromboplastin D (Thermo) for 15 min at 37oC. After centrifugation at 10,000 rpm for 5 min, the supernatant was mixed with 75 µL of ExoQuick Solution and RNase A (Sigma) at final concentration of 10 µg/mL. The mixture was kept at 4oC overnight and then further mixed with 150 units/mL of murine RNase inhibitor (NEB) before centrifugation at 1500 g for 30 min. The exosome pellet was dissolved in 25 µL 1ÃPBS, 2 µL of which was reserved for evaluation of exosome size and concentration using NanoSight LM 10 instrument (Particle Characterization Laboratories). The remainder was subjected to RNA extraction immediately. The usage of human biospecimen for this study was approved by Institutional Review Board of Medical College of Wisconsin and Mayo Clinic.,RNA was prepared by using miRNeasy Micro Kit (QIAGEN). Twenty-three µL of exosome suspension was mixed with 700 µL QIAzol Lysis buffer, and was processed by the standard protocol from the manufacturer. The extracted RNA was eluted with 14 µL of RNase-free water. The quantity and quality of the RNA were determined by Agilent Bioanalyzer 2100 with Small RNA Chip and RNA 6000 Pico Kit as indicated (Agilent Technologies).,The concentration and the size distribution of isolated exosomes were measured using NanoSight. Prior to sampling, the sample solutions were homogenized by vortexing, followed by serial dilution to the final dilution of 1:100,000 in 0.2 µm-filtered 1x PBS. NIST (National Institute of Standards and Technology) traceable 97 nm ± 3 nm polystyrene latex standards were added and analyzed in conjunction with the diluted exosome solution to validate the operation of the instrumentation. A blank 0.2 µm-filtered 1x PBS sample was also run as a negative control. Each sample analysis was conducted for 90 seconds. The Nanosightâs automatic analysis settings (High Sensitivity, Blue laser [405 nm, 645 mW]) were utilized for the processing of the data. All samples were evaluated in triplicates. | GSM1112878 | Illumina HiSeq 2000 | May 15 2019 | size fractionation | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX258935,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01997258 | GSM1112878 | GSE45722 | 0.566353 | microRNA from sample B constructed by the kit from NEB | Public on May 15 2013 | Apr 03 2013 | 9606 | microRNA from sample B constructed by the kit from NEB [LW_BN_2] | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX258935 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01997258 |
|
1 | tissue: blood,fraction: exosome | 8701 Watertown Plank Rd. | Milwaukee | USA | Medical College of Wisconsin | Liang,,Wang | Perl Scripts were developed to process data from RNA sequencing. Raw reads were firstly extracted from FASTQ files, and trimmed with sequencing quality control of Q > 13 , and then cleaned up 3â adaptor sequences within read sequences. Those prepared sequences filtered with the length â¥16 nt were combined into a FASTA file and aligned against human miRNA sequences downloaded from miRBase (Release 19, 2043 entries) and human genome reference sequences downloaded from NCBI ftp site (Release 103) with Bowtie (version 0.12.8) , of which the parameters for alignment were -m 3 -n 1 -f -a -best --strata. Normalization of miRNA profiling was the read counts of a target miRNA by million bases versus the sum of read counts of all mappable miRNAs on human miRNA sequences.,Genome_build: miRNA from miRBase(release19),Supplementary_files_format_and_content: Data frame of normalized miRNA transcription level in *.txt | we selected plasma samples (samples A, B and C) from 3 anonymous blood donors and split each sample into two for technical replication.,We tested the six samples (A1 and A2, B1 and B2, C1 and C2) using two small RNA library preparation kits: NEBNext Multiplex Small RNA library Prep Set from New England Biolab (NEB) and NEXTflex Small RNA Sequencing Kit from Bioo Scientific (BS). We also tested Illuminaâs TrueSeq Small RNA Sample Preparation Kit (ILMN) in sample A1 and A2. Together, we tested these plasma samples by sequencing 14 indexed libraries.,Human plasma samples were obtained from Mayo Clinic and stored at -80°C before use. Exosomes were isolated from 250 µL of plasma prepared from whole blood using the ExoQuick Exosome Precipitation Solution (SBI) according to the manufacturerâs instructions with minor modifications. Briefly, the plasma was incubated with Thromboplastin D (Thermo) for 15 min at 37oC. After centrifugation at 10,000 rpm for 5 min, the supernatant was mixed with 75 µL of ExoQuick Solution and RNase A (Sigma) at final concentration of 10 µg/mL. The mixture was kept at 4oC overnight and then further mixed with 150 units/mL of murine RNase inhibitor (NEB) before centrifugation at 1500 g for 30 min. The exosome pellet was dissolved in 25 µL 1ÃPBS, 2 µL of which was reserved for evaluation of exosome size and concentration using NanoSight LM 10 instrument (Particle Characterization Laboratories). The remainder was subjected to RNA extraction immediately. The usage of human biospecimen for this study was approved by Institutional Review Board of Medical College of Wisconsin and Mayo Clinic.,RNA was prepared by using miRNeasy Micro Kit (QIAGEN). Twenty-three µL of exosome suspension was mixed with 700 µL QIAzol Lysis buffer, and was processed by the standard protocol from the manufacturer. The extracted RNA was eluted with 14 µL of RNase-free water. The quantity and quality of the RNA were determined by Agilent Bioanalyzer 2100 with Small RNA Chip and RNA 6000 Pico Kit as indicated (Agilent Technologies).,The concentration and the size distribution of isolated exosomes were measured using NanoSight. Prior to sampling, the sample solutions were homogenized by vortexing, followed by serial dilution to the final dilution of 1:100,000 in 0.2 µm-filtered 1x PBS. NIST (National Institute of Standards and Technology) traceable 97 nm ± 3 nm polystyrene latex standards were added and analyzed in conjunction with the diluted exosome solution to validate the operation of the instrumentation. A blank 0.2 µm-filtered 1x PBS sample was also run as a negative control. Each sample analysis was conducted for 90 seconds. The Nanosightâs automatic analysis settings (High Sensitivity, Blue laser [405 nm, 645 mW]) were utilized for the processing of the data. All samples were evaluated in triplicates. | GSM1112879 | Illumina HiSeq 2000 | May 15 2019 | size fractionation | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX258936,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01997259 | GSM1112879 | GSE45722 | 0.564652 | microRNA from sample C constructed by the kit from Bioo scientific | Public on May 15 2013 | Apr 03 2013 | 9606 | microRNA from sample C constructed by the kit from Bioo scientific [LW_CB_1] | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX258936 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01997259 |
|
1 | tissue: blood,fraction: exosome | 8701 Watertown Plank Rd. | Milwaukee | USA | Medical College of Wisconsin | Liang,,Wang | Perl Scripts were developed to process data from RNA sequencing. Raw reads were firstly extracted from FASTQ files, and trimmed with sequencing quality control of Q > 13 , and then cleaned up 3â adaptor sequences within read sequences. Those prepared sequences filtered with the length â¥16 nt were combined into a FASTA file and aligned against human miRNA sequences downloaded from miRBase (Release 19, 2043 entries) and human genome reference sequences downloaded from NCBI ftp site (Release 103) with Bowtie (version 0.12.8) , of which the parameters for alignment were -m 3 -n 1 -f -a -best --strata. Normalization of miRNA profiling was the read counts of a target miRNA by million bases versus the sum of read counts of all mappable miRNAs on human miRNA sequences.,Genome_build: miRNA from miRBase(release19),Supplementary_files_format_and_content: Data frame of normalized miRNA transcription level in *.txt | we selected plasma samples (samples A, B and C) from 3 anonymous blood donors and split each sample into two for technical replication.,We tested the six samples (A1 and A2, B1 and B2, C1 and C2) using two small RNA library preparation kits: NEBNext Multiplex Small RNA library Prep Set from New England Biolab (NEB) and NEXTflex Small RNA Sequencing Kit from Bioo Scientific (BS). We also tested Illuminaâs TrueSeq Small RNA Sample Preparation Kit (ILMN) in sample A1 and A2. Together, we tested these plasma samples by sequencing 14 indexed libraries.,Human plasma samples were obtained from Mayo Clinic and stored at -80°C before use. Exosomes were isolated from 250 µL of plasma prepared from whole blood using the ExoQuick Exosome Precipitation Solution (SBI) according to the manufacturerâs instructions with minor modifications. Briefly, the plasma was incubated with Thromboplastin D (Thermo) for 15 min at 37oC. After centrifugation at 10,000 rpm for 5 min, the supernatant was mixed with 75 µL of ExoQuick Solution and RNase A (Sigma) at final concentration of 10 µg/mL. The mixture was kept at 4oC overnight and then further mixed with 150 units/mL of murine RNase inhibitor (NEB) before centrifugation at 1500 g for 30 min. The exosome pellet was dissolved in 25 µL 1ÃPBS, 2 µL of which was reserved for evaluation of exosome size and concentration using NanoSight LM 10 instrument (Particle Characterization Laboratories). The remainder was subjected to RNA extraction immediately. The usage of human biospecimen for this study was approved by Institutional Review Board of Medical College of Wisconsin and Mayo Clinic.,RNA was prepared by using miRNeasy Micro Kit (QIAGEN). Twenty-three µL of exosome suspension was mixed with 700 µL QIAzol Lysis buffer, and was processed by the standard protocol from the manufacturer. The extracted RNA was eluted with 14 µL of RNase-free water. The quantity and quality of the RNA were determined by Agilent Bioanalyzer 2100 with Small RNA Chip and RNA 6000 Pico Kit as indicated (Agilent Technologies).,The concentration and the size distribution of isolated exosomes were measured using NanoSight. Prior to sampling, the sample solutions were homogenized by vortexing, followed by serial dilution to the final dilution of 1:100,000 in 0.2 µm-filtered 1x PBS. NIST (National Institute of Standards and Technology) traceable 97 nm ± 3 nm polystyrene latex standards were added and analyzed in conjunction with the diluted exosome solution to validate the operation of the instrumentation. A blank 0.2 µm-filtered 1x PBS sample was also run as a negative control. Each sample analysis was conducted for 90 seconds. The Nanosightâs automatic analysis settings (High Sensitivity, Blue laser [405 nm, 645 mW]) were utilized for the processing of the data. All samples were evaluated in triplicates. | GSM1112880 | Illumina HiSeq 2000 | May 15 2019 | size fractionation | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX258937,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01997260 | GSM1112880 | GSE45722 | 0.577046 | microRNA from sample C constructed by the kit from Bioo scientific | Public on May 15 2013 | Apr 03 2013 | 9606 | microRNA from sample C constructed by the kit from Bioo scientific [LW_CB_2] | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX258937 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01997260 |
|
1 | tissue: blood,fraction: exosome | 8701 Watertown Plank Rd. | Milwaukee | USA | Medical College of Wisconsin | Liang,,Wang | Perl Scripts were developed to process data from RNA sequencing. Raw reads were firstly extracted from FASTQ files, and trimmed with sequencing quality control of Q > 13 , and then cleaned up 3â adaptor sequences within read sequences. Those prepared sequences filtered with the length â¥16 nt were combined into a FASTA file and aligned against human miRNA sequences downloaded from miRBase (Release 19, 2043 entries) and human genome reference sequences downloaded from NCBI ftp site (Release 103) with Bowtie (version 0.12.8) , of which the parameters for alignment were -m 3 -n 1 -f -a -best --strata. Normalization of miRNA profiling was the read counts of a target miRNA by million bases versus the sum of read counts of all mappable miRNAs on human miRNA sequences.,Genome_build: miRNA from miRBase(release19),Supplementary_files_format_and_content: Data frame of normalized miRNA transcription level in *.txt | we selected plasma samples (samples A, B and C) from 3 anonymous blood donors and split each sample into two for technical replication.,We tested the six samples (A1 and A2, B1 and B2, C1 and C2) using two small RNA library preparation kits: NEBNext Multiplex Small RNA library Prep Set from New England Biolab (NEB) and NEXTflex Small RNA Sequencing Kit from Bioo Scientific (BS). We also tested Illuminaâs TrueSeq Small RNA Sample Preparation Kit (ILMN) in sample A1 and A2. Together, we tested these plasma samples by sequencing 14 indexed libraries.,Human plasma samples were obtained from Mayo Clinic and stored at -80°C before use. Exosomes were isolated from 250 µL of plasma prepared from whole blood using the ExoQuick Exosome Precipitation Solution (SBI) according to the manufacturerâs instructions with minor modifications. Briefly, the plasma was incubated with Thromboplastin D (Thermo) for 15 min at 37oC. After centrifugation at 10,000 rpm for 5 min, the supernatant was mixed with 75 µL of ExoQuick Solution and RNase A (Sigma) at final concentration of 10 µg/mL. The mixture was kept at 4oC overnight and then further mixed with 150 units/mL of murine RNase inhibitor (NEB) before centrifugation at 1500 g for 30 min. The exosome pellet was dissolved in 25 µL 1ÃPBS, 2 µL of which was reserved for evaluation of exosome size and concentration using NanoSight LM 10 instrument (Particle Characterization Laboratories). The remainder was subjected to RNA extraction immediately. The usage of human biospecimen for this study was approved by Institutional Review Board of Medical College of Wisconsin and Mayo Clinic.,RNA was prepared by using miRNeasy Micro Kit (QIAGEN). Twenty-three µL of exosome suspension was mixed with 700 µL QIAzol Lysis buffer, and was processed by the standard protocol from the manufacturer. The extracted RNA was eluted with 14 µL of RNase-free water. The quantity and quality of the RNA were determined by Agilent Bioanalyzer 2100 with Small RNA Chip and RNA 6000 Pico Kit as indicated (Agilent Technologies).,The concentration and the size distribution of isolated exosomes were measured using NanoSight. Prior to sampling, the sample solutions were homogenized by vortexing, followed by serial dilution to the final dilution of 1:100,000 in 0.2 µm-filtered 1x PBS. NIST (National Institute of Standards and Technology) traceable 97 nm ± 3 nm polystyrene latex standards were added and analyzed in conjunction with the diluted exosome solution to validate the operation of the instrumentation. A blank 0.2 µm-filtered 1x PBS sample was also run as a negative control. Each sample analysis was conducted for 90 seconds. The Nanosightâs automatic analysis settings (High Sensitivity, Blue laser [405 nm, 645 mW]) were utilized for the processing of the data. All samples were evaluated in triplicates. | GSM1112881 | Illumina HiSeq 2000 | May 15 2019 | size fractionation | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX258938,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01997261 | GSM1112881 | GSE45722 | 0.834073 | microRNA from sample C constructed by the kit from NEB | Public on May 15 2013 | Apr 03 2013 | 9606 | microRNA from sample C constructed by the kit from NEB [LW_CN_1] | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX258938 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01997261 |
|
1 | tissue: blood,fraction: exosome | 8701 Watertown Plank Rd. | Milwaukee | USA | Medical College of Wisconsin | Liang,,Wang | Perl Scripts were developed to process data from RNA sequencing. Raw reads were firstly extracted from FASTQ files, and trimmed with sequencing quality control of Q > 13 , and then cleaned up 3â adaptor sequences within read sequences. Those prepared sequences filtered with the length â¥16 nt were combined into a FASTA file and aligned against human miRNA sequences downloaded from miRBase (Release 19, 2043 entries) and human genome reference sequences downloaded from NCBI ftp site (Release 103) with Bowtie (version 0.12.8) , of which the parameters for alignment were -m 3 -n 1 -f -a -best --strata. Normalization of miRNA profiling was the read counts of a target miRNA by million bases versus the sum of read counts of all mappable miRNAs on human miRNA sequences.,Genome_build: miRNA from miRBase(release19),Supplementary_files_format_and_content: Data frame of normalized miRNA transcription level in *.txt | we selected plasma samples (samples A, B and C) from 3 anonymous blood donors and split each sample into two for technical replication.,We tested the six samples (A1 and A2, B1 and B2, C1 and C2) using two small RNA library preparation kits: NEBNext Multiplex Small RNA library Prep Set from New England Biolab (NEB) and NEXTflex Small RNA Sequencing Kit from Bioo Scientific (BS). We also tested Illuminaâs TrueSeq Small RNA Sample Preparation Kit (ILMN) in sample A1 and A2. Together, we tested these plasma samples by sequencing 14 indexed libraries.,Human plasma samples were obtained from Mayo Clinic and stored at -80°C before use. Exosomes were isolated from 250 µL of plasma prepared from whole blood using the ExoQuick Exosome Precipitation Solution (SBI) according to the manufacturerâs instructions with minor modifications. Briefly, the plasma was incubated with Thromboplastin D (Thermo) for 15 min at 37oC. After centrifugation at 10,000 rpm for 5 min, the supernatant was mixed with 75 µL of ExoQuick Solution and RNase A (Sigma) at final concentration of 10 µg/mL. The mixture was kept at 4oC overnight and then further mixed with 150 units/mL of murine RNase inhibitor (NEB) before centrifugation at 1500 g for 30 min. The exosome pellet was dissolved in 25 µL 1ÃPBS, 2 µL of which was reserved for evaluation of exosome size and concentration using NanoSight LM 10 instrument (Particle Characterization Laboratories). The remainder was subjected to RNA extraction immediately. The usage of human biospecimen for this study was approved by Institutional Review Board of Medical College of Wisconsin and Mayo Clinic.,RNA was prepared by using miRNeasy Micro Kit (QIAGEN). Twenty-three µL of exosome suspension was mixed with 700 µL QIAzol Lysis buffer, and was processed by the standard protocol from the manufacturer. The extracted RNA was eluted with 14 µL of RNase-free water. The quantity and quality of the RNA were determined by Agilent Bioanalyzer 2100 with Small RNA Chip and RNA 6000 Pico Kit as indicated (Agilent Technologies).,The concentration and the size distribution of isolated exosomes were measured using NanoSight. Prior to sampling, the sample solutions were homogenized by vortexing, followed by serial dilution to the final dilution of 1:100,000 in 0.2 µm-filtered 1x PBS. NIST (National Institute of Standards and Technology) traceable 97 nm ± 3 nm polystyrene latex standards were added and analyzed in conjunction with the diluted exosome solution to validate the operation of the instrumentation. A blank 0.2 µm-filtered 1x PBS sample was also run as a negative control. Each sample analysis was conducted for 90 seconds. The Nanosightâs automatic analysis settings (High Sensitivity, Blue laser [405 nm, 645 mW]) were utilized for the processing of the data. All samples were evaluated in triplicates. | GSM1112882 | Illumina HiSeq 2000 | May 15 2019 | size fractionation | transcriptomic | RNA-Seq | total RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX258939,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01997262 | GSM1112882 | GSE45722 | 0.645251 | microRNA from sample C constructed by the kit from NEB | Public on May 15 2013 | Apr 03 2013 | 9606 | microRNA from sample C constructed by the kit from NEB [LW_CN_2] | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX258939 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01997262 |
|
1 | cell line: MCF7,cell type: breast cancer cells,transfection: control siRNA | 450 Brookline Ave | Boston | USA | Dana-Farber Cancer Institute | Kornelia,,Polyak | Basecalls performed using CASAVA version 1.7 or 1.8.,RNA-Seq raw data was mapped by Tophat to hg19.,Read counting and differential gene expression analysis were done using GFold using significance cutoff = 0.05.,Genome_build: hg19,Supplementary_files_format_and_content: Text file (.cnt) of mapped read counts was generated using Gfold. | Total RNA was isolated from cells using RNeasy Mini Kit (Qiagen) following the manufacturerâs protocol. Then polyA RNA were purified using the MACS mRNA isolation kit (Miltenyi Biotec).,PolyA RNA was fragmented by RNA fragmentation reagent (Ambion), and subjected to first strand synthesis by using SupeScript II (Invitrogen) and random hexamer oligos. The second strand was synthesized, and then subjected to end repair, A-tailing, ligation of Illumia paired end adaptor. Following PCR amplification for 18 cycles, the final library underwent gel purification. | GSM1113298 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | polyA RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX259553,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01997737 | GSM1113298 | GSE45732,GSE46073 | 0.051349 | breast cancer cells | Public on Jun 17 2014 | Apr 03 2013 | 9606 | MCF7_RNAseq_Control | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX259553 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01997737 |
|
1 | cell line: MCF7,cell type: breast cancer cells,transfection: siJARID1B | 450 Brookline Ave | Boston | USA | Dana-Farber Cancer Institute | Kornelia,,Polyak | Basecalls performed using CASAVA version 1.7 or 1.8.,RNA-Seq raw data was mapped by Tophat to hg19.,Read counting and differential gene expression analysis were done using GFold using significance cutoff = 0.05.,Genome_build: hg19,Supplementary_files_format_and_content: Text file (.cnt) of mapped read counts was generated using Gfold. | Total RNA was isolated from cells using RNeasy Mini Kit (Qiagen) following the manufacturerâs protocol. Then polyA RNA were purified using the MACS mRNA isolation kit (Miltenyi Biotec).,PolyA RNA was fragmented by RNA fragmentation reagent (Ambion), and subjected to first strand synthesis by using SupeScript II (Invitrogen) and random hexamer oligos. The second strand was synthesized, and then subjected to end repair, A-tailing, ligation of Illumia paired end adaptor. Following PCR amplification for 18 cycles, the final library underwent gel purification. | GSM1113299 | Illumina HiSeq 2000 | May 15 2019 | cDNA | transcriptomic | RNA-Seq | polyA RNA | Homo sapiens | GPL11154 | SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX259554,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01997738 | GSM1113299 | GSE45732,GSE46073 | 0.048785 | breast cancer cells | Public on Jun 17 2014 | Apr 03 2013 | 9606 | MCF7_RNAseq_siJARID1B | SRA | https://www.ncbi.nlm.nih.gov/sra?term=SRX259554 | https://www.ncbi.nlm.nih.gov/biosample/SAMN01997738 |